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University of Nebraska, 2017 
Advisor: Robert Powers 
The prevailing dogma in structural genomics is the existence of a strong 
correlation between protein sequence, structure, and biological function. Proteins with 
high sequence similarity typically have a similar, if not the same, structure and function. 
In many cases this logic can fail due to distantly related proteins having very low 
sequence similarity, a lack of a representative structure, structural novelty, or the absence 
of a characterized function. Further, the paradigm fails to account for dynamics, which 
have a significant effect on structural stability and enzymatic efficacy.  
Nuclear magnetic resonance (NMR) spectroscopy is uniquely capable of solving 
the structure, assisting with annotation, and deriving the dynamics of previously 
unstudied proteins. Historically, NMR has been used to calculate structures and dynamics 
of small or disordered proteins, which could then be used with computational methods to 
predict function. Predicted annotations are then confirmed by further experimentation 
such as ligand screens or titrations. The combination of NMR and bioinformatics, 
therefore, works synergistically to yield significant results, which has the ability to 
characterize highly complex proteins and fill gaps in the sequence to structure to function 
paradigm. 
This dissertation begins with work accomplished using the Comparison of Active 
Site Structures (CPASS) software to show the functional evolution of a class of cofactor 
dependent enzymes and also expands on the utility of CPASS with the implementation of 
  
a functional clustering of its database. Described next is an emphasis on protein and 
peptide structure and the relationship between the experimentally derived ensembles and 
biological function and dynamics. Recent improvements in the calculation of protein fast-
timescale dynamics are then introduced before a final concluding chapter. 
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Chapter 1  
Introduction 
1.1 The Application of Nuclear Magnetic Resonance Spectroscopy and 
Bioinformatics in Structural Genomics 
Upon completion of the human genome project and other genomics initiatives, it became 
possible to find relationships between organisms using their whole genome sequences.
1, 2
 
The relationships are leveraged to discover homologous proteins with similar functions. 
However, an enormous amount of genomic data now exists which contains “gaps” where 
genes are structurally and functionally uncharacterized. The field of structural genomics 
has arisen to meet this exceptional challenge. Rather than solving the three-dimensional 
structure of every protein encoded within a particular genome, the aim is to concentrate 
on representative domain targets for each globular fold.
2
 The known structures can 
subsequently be used in computational homology modeling to then predict the remainder 
of the structures.  
Thus far, structural genomics has greatly diversified the range of structural information 
available for many different protein families.
3
 High-throughput methods have been used 
to steadily produce structural representatives of previously uncharacterized genes. 
Although the new structures have been deposited in the Protein Data Bank (PDB)
4
,  
relatively few papers have been published by structural genomics centers and a distant 
lack of novel folds have been discovered.
3
 In contrast, structural biology groups produce 
fewer protein structures, but the structures typically contain novel folds and are deposited 
  
2 
with a corresponding publication. The authors go further in their analysis and also add 
detail pertaining to the protein’s function and physiological importance. Therefore, the 
roles of individual structural biology groups and structural genomics centers are 
synergistic. Structural genomics builds a comprehensive profile of the structural 
landscape while structural biology characterizes protein function. 
Protein structures are traditionally determined by X-ray crystallography or nuclear 
magnetic resonance (NMR) spectroscopy.
5
 Most of the structures are determined by 
crystallography, although not all protein targets are amenable to crystallization. Further, 
crystal structures are static snapshots of the protein in a non-physiological environment, 
which may contain structural elements that are not present in the native conformation. 
For example, crystallization has the tendency to produce non-biological symmetry in 
proteins.
6
 NMR complements X-ray crystallography in that it is capable of solving 
structures in the solution state. The aqueous solution can be additionally adjusted to 
mimic the physiologic conditions for the protein. Conditions can be matched to the pH, 
ionic strength, and temperature of the physiological environment of the protein to be 
studied. Rather than producing a single conformer, NMR structures are presented as an 
ensemble of low-energy conformers. Therefore, the ensemble represents a set of 
structures that the protein may transiently sample while in solution. A significant 
limitation to NMR structure determination is the limitation to proteins less than 25kDa.
7
  
Higher molecular weight proteins are possible, but require more advanced methods and 
significantly more time to solve.
7
 Nonetheless, it has been estimated that at least 25% of 
uncharacterized open reading frames (ORFs) are under the molecular weight cutoff for an 
  
3 
NMR solution structure.
8
 This ensures that NMR will remain an essential tool in 
structural genomics for years to come. 
The insurmountable amount of genomic data that now exists cannot possibly be 
completely analyzed using only experimentation. Bioinformatics, the study of complex 
biological data using computational methods, can be employed to quickly determine 
function and structure for uncharacterized genes. Many methods have been developed to 
predict structure and function from amino acid sequences and function from structure.
9-11
 
These tools have been essential to the field of structural genomics for annotating families 
of proteins from very little preliminary information. As with most tools and methods, 
there are limitations to what can be predicted and inferred. There is significant difficulty 
and error associated with comparative studies involving proteins at or below 30% 
sequence similarity.
12
 For sequence comparison methods, low similarity leads too poor 
functional characterization and poor evolutionary relationship construction. It becomes 
necessary to compare proteins at the structural level using their tertiary structure or active 
sites to infer function and evolution.
13
 However, the problem is further compounded in de 
novo structure prediction where low accuracy models are generated for proteins with less 
than 30% similarity.
14
 This instance highlights the mutually beneficial relationship 
between bioinformatics and structural biology. A representative protein from an 
uncharacterized and ancient family can be structurally elucidated, and the resulting 
structure can be used to model the remainder of the family. 
 
  
4 
1.2 Overview of Work 
This dissertation describes a body of work focused on the application of bioinformatics 
and structural biology towards the understanding of novel and physiologically relevant 
proteins. It begins with an original way to phylogenetically model distantly related 
proteins and describes the advantageousness of using active site structures to cluster 
proteins. Next are practical applications of NMR toward the structure determination of 
previously unsolved peptides and proteins. A deeper understanding of protein dynamics 
is then developed in the subsequent chapters, which includes new methods in their 
derivation.  
Chapter 2 introduces the utility of the Comparison of Protein Active Sites Software 
(CPASS)
15, 16
 in the discovery of evolutionary relationships between proteins.
13
 Typically 
evolutionary relationships between proteins are inferred using sequence comparison 
methods. These methods, however, fail for families of distantly related proteins due to 
very low sequence identity. This further hinders functional annotation and 
characterization of the protein family. Slowly evolving structural moieties of proteins, 
such as an active site, are therefore valuable for annotating putative and distantly related 
proteins. CPASS compares the similarity and geometry of active site residues and acts as 
a sensitive measure of active site evolution. Similar methods compare putative cavities,
17
 
local structures,
18
 active site shapes,
19
 and have been extensively reviewed.
20
 CPASS 
differs from these other methods because it uniquely uses ligand-defined active sites. An 
active site must have a known and bound ligand in its 3D structure file to be considered 
for CPASS analysis. Thus, this is both an advantage and disadvantage of the software. It 
  
5 
compares real ligand binding sites, rather than putative, but is also limited by the 
necessity to have a bound ligand. 
Pyridoxal-5’-phosphate (PLP) dependent enzymes are primordial enzymes that 
diversified in the last universal ancestor. Molecular evolution efforts focusing on these 
enzymes have been limited to small subgroups due to the low sequence identity within 
the family.
21-23
 Using CPASS, we show that the active site structures of PLP-dependent 
enzymes can be used to infer evolutionary relationships based on functional similarity. 
The enzymes successfully clustered together based on substrate specificity, function, and 
three-dimensional fold. This chapter reveals the first ever successful clustering of the 
entire PLP-dependent enzyme family. Furthermore, it demonstrates the value of using 
active site structures for functional evolutionary analysis and the effectiveness of CPASS. 
Adam Caprez, Ashu Guru, and David Swanson assisted with the “all versus all” 
comparison used in this project and were instrumental in the organization of the data. 
Chapter 3 further expands upon the expediency of CPASS with the addition of an 
improved active site comparison search. A standard CPASS search compares the query 
active site to all members in the database. This search, although optimized, takes several 
hours due to the enormity of the database (approximately 40,000 active sites), which will 
continue to increase as the number of deposits in the Protein Data Bank (PDB) grows. 
While an exhaustive search may produce the top result, the time required may be 
detrimental when doing multiple queries. Therefore, a search against a representative 
subset of the CPASS database, approximately 10% in size, would be advantageous and 
would only become more optimized upon further addition to the PDB. Enzyme 
classification (EC) numbers are generally used to group proteins and enzymes according 
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to function. The application of these EC numbers to CPASS actives sites creates 
functional clusters for each ligand, which can then be used for subset generation. Cluster 
representatives are then found by applying principal component analysis (PCA) to the 
CPASS distance matrix for each ligand where 95% confidence ellipses are calculated for 
each EC number. The active site with the closest Euclidean distance to the center of each 
confidence ellipse is chosen as the cluster representative. This chapter demonstrates the 
effectiveness of using the CPASS representative subset, the effect it has on computational 
time, and novelty of functional clustering based on active site structures. For this project, 
Adam Caprez and David Swanson helped with the organization of the data and with the 
implementation of the representative tree into the CPASS webserver. 
Chapter 4 pivots to more biophysical and structural studies of peptides and the 
relationship between the structural moieties and antibacterial properties. The rapid 
emergence of multidrug resistant bacterial strains and the development of permanent 
biofilms have made the search for new antibacterial agents of paramount importance.
24
 
Newer approaches have been developed which employ existing antibiotics in 
combination with other antibiotics, adjuvants, and other previously approved drugs.
24
 
Nonetheless, the dire need still exists for the discovery of new antibiotics. Cationic 
antimicrobial peptides (AMPs) are a class of agents that have received a lot of attention 
lately due to an ability to eliminate resistant pathogens and to inhibit bacterial biofilms.
25
 
The mechanism of action of AMPs differs from current antibiotics, which makes their 
potential use appealing. In general, the AMPs act as detergents that are selective for 
bacterial membranes and this mode of action greatly reduces the ability of infectious 
bacterial to gain resistance. However, beyond gross cationic, helical and hydrophobic 
  
7 
properties of AMPs little is known about the structural requirements for activity. 
Citropin 1.1 is a helical AMP found on the skin of amphibians that exhibits both 
antibacterial and anticancer activity.
26
 Previous studies suggested that Citropin 1.1 acts 
through an α-helical agglomerative mechanism known as carpeting.25, 26 Employing 
finely tuned analogs of Citropin 1.1, we explore how slight structural variations have a 
remarkable influence on the AMP secondary structure and activity. Our study identified 
the AMP regions responsible for essential interactions that also regulate antibacterial 
activity and go beyond the “charge-only paradigm”. Projection of the residue side chains 
was found to be essential to the activity of the peptides. Surprisingly, shortening the 
lysine side chains by one carbon led to a significant decrease in antimicrobial activity. 
Additionally, we found that the hydrogen bond network at the N-terminus of the peptides 
was crucial in helix stabilization and in the subsequent monomer to aggregate 
equilibrium. Active Citropin 1.1 analogs displayed a greater tendency to form α-helices 
and to consequently dimerize when in contact with a negatively charged membrane. In 
this regard, our results support the carpet-model mechanism of AMP biological activity. 
AMPs may be used to augment conventional antibacterial therapeutics to overcome drug 
resistance as part of a multidrug treatment. However, significant challenges must be 
solved, such as in vivo stability and toxicity, before they can be approved for systemic or 
topical use.
27
 This study considerably contributes to the understanding of the biophysical 
properties of α-helical AMPs and will hopefully assist with future endeavors towards 
producing a novel antibacterial therapy. Mehdi Bin Samad, Nathalia Rodrigues de 
Almeida, and Martin Conda-Sheridan synthesized the peptides, performed the MIC 
assays, and completed the microscopy experiments during this collaborative project. 
  
8 
Sequence analysis was essential to the work done with Citropin 1.1. We compared 
sequences of known peptides with high antimicrobial activity and were able to make 
hypotheses about the effects of mutations or modifications. In the end, the sequence 
analysis was the first, and probably most significant, step towards the synthesis of an 
enhanced AMP. Protein function elucidation also relies heavily on amino acid sequence 
analysis and other bioinformatics approaches. The reliance is extended to structure 
homology modeling for ligand docking and protein-protein interaction mapping. 
Structural genomics initiatives, such as the Northeast Structure Genomics Consortium 
(NESG),
28
 identify protein families that are sequentially similar but lack functional 
annotation and a representative structure. The NESG identified RPA3313, a putative 
protein from Rhodopseudomonas palustris, as a potential target. Sequence analysis of 
RPA3313 exposes a large, unannotated class of hypothetical proteins mostly from the 
Rhizobiales order. In the absence of sequence and structure information, further 
functional elucidation of this class of proteins has been significantly hindered. In chapter 
5 we reveal the NMR structure of RPA3313, which adopts a novel split ββαβ fold with a 
conserved ligand binding pocket between the first β-strand and the N-terminus of the α-
helix.
29
 Conserved residue analysis and protein-protein interaction prediction analyses 
reveal multiple protein binding sites and conserved functional residues. Results of a mass 
spectrometry proteomic analysis strongly point toward interaction with the ribosome and 
its subunits. The combined structural and proteomic analyses suggest that RPA3313 by 
itself or in a larger complex may assist in the transportation of substrates to or from the 
ribosome for further processing. Importantly, this analysis of RPA3313 can be further 
extended to the remainder of the previously uncharacterized protein family identified by 
  
9 
the NESG and aptly fulfills the core purpose of structural genomics. This work could 
not have been done without the assistance of Austin Lowe and Ronald Cerny, who helped 
with protein purification and mass spectrometry analysis, respectively. 
Chapter 6 continues with structural biology in the analysis of the C-terminal domain 
(CTD) of DnaG primase.
30
 Bacterial DNA replication initiates through a crucial 
interaction between two highly conserved proteins, DnaG primase and DnaB helicase. 
The interface between the DnaG primase C-terminal domain and the N-terminal domain 
of DnaB helicase is essential for bacterial DNA replication because it allows coordinated 
priming of DNA synthesis at the replication fork while the DNA is being unwound. Since 
these two proteins are conserved in all bacteria and distinct from those in eukaryotes, 
their interface is an attractive antibiotic target. To learn more about this interface, we 
determined the solution structure and dynamics of the DnaG primase CTD from 
Staphylococcus aureus, a medically important bacterial species. Comparison with the 
known primase CTD structures shows there are two biologically relevant conformations 
– an open conformation that likely binds to DnaB helicase and a closed conformation that 
does not. The S. aureus primase CTD is in the closed conformation, but NMR dynamic 
studies indicates there is considerable movement in the linker between the two 
subdomains and that N564 is the most dynamic residue within the linker. A high-
throughput NMR ligand-affinity screen identified potential binding compounds, among 
which were acycloguanosine and myricetin. Although the affinity for these compounds 
and adenosine was in the millimolar range, all three bind to a common pocket that is only 
present on the closed conformation of CTD. This binding pocket is at the opposite end of 
helices 6 and 7 from N564, the key hinge residue. The identification of this binding 
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pocket should allow the development of stronger-binding ligands that can prevent 
formation of the CTD open conformation that binds to DnaB helicase. Preventing the 
interaction between the primase CTD and helicase would significantly hinder bacterial 
DNA synthesis and, ultimately, reproduction. Although blocking this interaction would 
not result in immediate cell death, in combination with another antibiotic the treatment 
could potentially overcome multidrug resistance. This work was done in collaboration 
with Jessica Periago and Mark Griep. 
Proteins are inherently dynamic and adopt various conformations at physiological 
conditions. The study of their dynamic behavior and discovering all of their hidden 
conformations is, consequently, essential to completely understanding their function. This 
was especially true for the primase CTD from S. aureus. From the dynamics study we 
were able to identify a key hinge residue and binding site that may provide a novel 
therapeutic target. Knowing firsthand the importance of dynamics relative to protein 
function we accomplished a similar study on human protein DJ-1, which is presented in 
chapter 7. 
Various missense mutations in the cytoprotective protein DJ-1 (PARK7) cause rare forms 
of inherited Parkinsonism. One such mutation, M26I, diminishes DJ-1 protein levels in 
the cell but does not result in large changes in the three-dimensional structure or thermal 
stability of the protein. Therefore, the molecular basis for M26I DJ-1 instability and 
dysfunction is unknown. Chapter 7 reveals that by using NMR spectroscopy the 
picosecond-nanosecond timescale dynamics of wild-type and M26I DJ-1 are similar, but 
longer timescale (minutes to hours) dynamics are enhanced in M26I DJ-1 near 
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physiological temperature.
31
 These slow conformational fluctuations transiently expose 
part of the hydrophobic core of M26I DJ-1 to solvent and cause the protein to aggregate 
in vitro at 37°C. Aggregation of the protein effectively diminishes its function and 
removes the protein from the cellular composition. The non-pathogenic M26L mutation, 
in contrast, does not aggregate at 37°C and is less dynamic than M26I at physiological 
temperature. Therefore, M26I DJ-1 is an example of a pathogenic change in protein 
conformational dynamics causing a temperature-dependent loss of stability in the cell. 
Furthermore, the onset of M26I DJ-1 instability at physiological temperature illustrates 
the pitfalls of characterizing proteins exclusively at room temperature or below, as key 
aspects of their behavior may not be apparent. Given the prevalence of structurally 
conservative disease-causing mutations in proteins, we suggest that disruption of protein 
dynamics could be a more common pathogenic event than is currently appreciated. 
Moving forward with the dynamics of DJ-1, chapter 8 introduces a methodological 
development that expands on the amount of interpretable data that can be obtained from 
an NMR experiment. NMR dynamics experiments have traditionally been collected using 
1
H-
15
N HSQC R1, R2, and heteronuclear NOE experiments with the Carr-Purcell-
Meiboom-Gill (CPMG) relaxation dispersion approach.
32
 However, these approaches 
take significant time to complete and often require are large amount of protein divided 
over multiple samples. In the case of M26I DJ-1, the protein would aggregate at 
physiological temperature and required a fresh sample for each experiment. Accordingly, 
there is an immediate need for new methods that reduce experimental time or extract 
additional information from existing datasets. Previous studies have shown that 
relaxation parameters and fast protein dynamics can be quickly elucidated from 
15
N-
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CEST experiments. Longitudinal R1 and transverse R2 values were reliably derived 
from fitting of CEST profiles. We show that 
15
N-CEST experiments and traditional 
modelfree analysis provide the internal dynamics of three states of human protein DJ-1 at 
physiological temperature. The chemical exchange profiles show the absence of a minor 
state conformation and, in conjunction with 
1
H-
15
N NOEs, show increased mobility. R1 
and R2 values remained relatively unchanged at the three naturally occurring oxidation 
states of DJ-1, but exhibit striking NOE differences. The NOE data was, therefore, 
essential in determining the internal motions of the DJ-1 proteins. To our knowledge, we 
present the first study that combines 
15
N CEST data with traditional model-free analyses 
in the study of a biological system and affirm that more ‘lean’ model-free approaches 
should be used cautiously. The DJ-1 work was done in collaboration with Nicole 
Milkovic, Mark Wilson, and Tessa Andrews. 
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Chapter 2 
Functional Evolution of PLP-dependent Enzymes Based on Active site 
Structural Similarities 
2.1 Introduction 
Sequence comparison methods and structural homology models are often used to imply 
evolutionary relationships between proteins in the same family or of the same function.
1, 2
 
These analyses are additionally used to infer the function of uncharacterized proteins.
3, 4
 
Enhancing our understanding of protein evolution furthers our insights into cellular 
processes, enables the discovery of drug targets and disease markers, while validating or 
establishing phylogenies of organisms, among numerous other beneficial impacts.
5
 
However, evolutionary studies are limited for distantly related proteins in which sequence 
and structural similarity may not be easily deduced. Sequence comparison methods 
assume a constant rate of amino acid substitution and are not suitable for all phylogenetic 
reconstructions of ancestral sequences. Correspondingly, for sequences with minimal 
identity local conformations can vary greatly and may inhibit structural studies.
6
 
It is understood that although the rate of sequence evolution is highly variable, residues 
essential to function and active site chemistry will remain highly conserved over time.
7
 
Slight changes in the position and identity of an active site residue can lead to changes in 
both substrate and reaction specificity.
1, 8
 In fact, it has been proposed that catalytic 
residues maintain their position and identity longer than the configuration of some 
secondary structures.
9
 The importance of these residues has spawned many 
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computational approaches to assist with the prediction of active site residues,
10-12
 the 
functional annotation of proteins based on active sites,
13-15
 as well as gene functional 
annotation.
16, 17
 Additionally, the evolution of homologous proteins sharing low sequence 
identities has been inferred using active site structure geometries.
9, 18, 19
 These 
observations are consistent with the premise that molecular evolution and functional 
evolution proceed through distinct processes. Molecular evolution is driven by random 
mutational events where maintaining function is paramount.
1, 2
 Conversely, protein 
functional evolution requires a new gene through duplication, acquisition or creation that 
enables protein functional drift while avoiding a negative impact on cell fitness.
20-22
 
Correspondingly, analyzing functional evolution may require a different approach from 
the global sequence comparisons routinely used for molecular evolution.
1, 2
 In this 
manner, active site structures may be a suitable alternative for inferring an evolutionary 
relationship based on function.
23
  
Some of the most diverse and versatile classes of enzymes are those that utilize 
pyridoxal-5’-phosphate (PLP) as a cofactor.24 These enzymes are found in five of the six 
classes defined by the Enzyme Commission and catalyze a multitude of different 
reactions.
25
 The diversity of the reactions can be attributed to the electron sink properties 
of the cofactor
26
 and the stereochemical restraints in the active site of the enzyme.
27-29
 
PLP-dependent enzymes acting on amino acid substrates can be separated into four 
families of paralogous proteins annotated as fold-types I-IV.
26, 30
 Interestingly, each of 
the fold-types are highly promiscuous in terms of function, and multiple examples of 
convergent evolution have been discovered.
24
 These observations have led to the 
hypothesis that the four lineages of PLP-dependent enzymes developed in the last 
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common universal ancestor.  
Extensive work has been done with sequence-based methods to establish a phylogenetic 
relationship among PLP-dependent enzymes.
24, 31, 32
 These studies, however, have been 
limited to small subgroups due to the low sequence identity within each fold-type and 
across all PLP-dependent enzymes. Remarkably, the functions of these enzymes are 
highly dependent on the structure of their active sites. Although these enzymes lend 
themselves to an evolutionary study based on active site structures, one has not yet been 
undertaken. 
Here, we use a novel method to compare the active site structures of 204 PLP-dependent 
enzymes from the four different fold-types that are specifically involved in amino acid 
metabolism. The Comparison of Protein Active Site Structures (CPASS) software and 
database was developed to aid in the functional annotation of uncharacterized proteins by 
comparing ligand defined active sites.
15, 33
 As a sensitive measure of active site geometry, 
it was proposed that CPASS could also be used to model families of divergent proteins. 
In this work we present the functional evolution of PLP-dependent enzymes based on 
active site structures. To the authors’ knowledge, this is the first study of its kind that 
models the functional evolution of a superfamily of proteins by active site comparisons, 
and the first to model all PLP-dependent fold-types together on one network. Results 
were compared to previous studies using both sequence and structure-guided methods. 
We find that the active site comparisons successfully cluster the enzymes based on both 
function and three-dimensional fold-type.  
 
  
21 
2.2 Materials and Methods 
2.2.1 Active Site Structure Comparison 
Three-dimensional structures with ligand-defined active sites were gathered from the 
Protein Data Bank on May 9, 2014.
34
 An all versus all comparison was carried out 
between the active site structures using the Comparison of Protein Active Site Structures 
(CPASS) software. CPASS finds the optimum structural alignment between two active 
sites by maximizing a scoring function based on structure (C and C RMSD) and 
sequence (BLOSUM62) similarity.
35, 36
 The scoring function is the summation of an ideal 
pairing of residues between each of the active sites rather than a summation of all 
possible pairings. Therefore, it is possible that active site residues remain unpaired during 
analysis. Since the CPASS algorithm is dependent upon the size of the active site query, 
an asymmetrical similarity matrix was generated from the all versus all comparison. The 
lower score of the two pairwise comparisons was extracted and converted to a distance by 
subtracting from 100% similarity. From the resulting distance matrix, only the PLP 
bound proteins that acted on amino acid substrates were extracted. Redundancies in the 
PLP-distance matrix were removed. A total of 204 X-ray crystal structures and 
corresponding active sites were analyzed in this study. 
 
2.2.2 Protein Annotation 
A total of 204 PLP-dependent proteins were functionally annotated with Enzyme 
Commission (EC) numbers using the UniProt database
37
 and in-house software. Enzymes 
that did not have an EC number in the UniProt database were assigned manually using 
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the PDB. For enzymes with more than one number or classification, only the first was 
taken. Species, phylogenetic kingdom, and fold-type annotations were done manually 
using the PDB and UniProt databases as well as literature sources. 
 
2.2.3 Phylogenetic Analysis 
A phylogenetic network using all of the PLP-dependent enzymes was generated with 
Splitstree4
38
 using the Neighbor-Net algorithm.
39
 The network represents a deterministic 
model of the distances obtained from the CPASS algorithm and software. Identification 
of the four fold-type clusters was accomplished by visual inspection of the network. Each 
of the clusters is continuous and does not contain enzymes that are not of the same fold-
type. Phylogenetic trees were created for each of the fold-types using Dendroscope,
40
 
CPASS distances, and the Neighbor-join algorithm. Neighbor joining is an agglomerative 
clustering method in which a tree is built from a distance matrix. Briefly, the two closest 
taxa in the distance matrix are joined to create a new node. Distances from each of the 
remaining taxa to the new node are recalculated and the matrix is updated. As this 
process is repeated, the distance matrix shrinks until only a pair of nodes remains. 
 
2.2.4 Sequence Identity 
The PDB IDs for the 204 PLP-dependent enzymes in this study were submitted to the 
UniProt database for primary sequence retrieval. The sequences were subsequently 
submitted to Clustal Omega
41
 for multiple sequence alignment (MSA) using the default 
parameters. The MSA and percent identity matrix were retrieved upon completion and 
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visualized in the R software environment. A histogram was generated with intervals of 
0.2 percent identity and represents the entire, non-condensed percent identity matrix. A 
heat map of the entire matrix was also generated with a white to red gradient 
corresponding to low and high percent identity. The ordering of the sequences in the heat 
map corresponds to the ordering in Table S1. 
 
2.2.5 Structure Alignment 
The 204 PLP-dependent enzymes were further subjected to an all versus all structural 
alignment using TM-align.
42
 Results from the pairwise comparisons were organized into 
a matrix and were visualized in the R software environment. A histogram was generated 
with TM-align score intervals of 0.001 and represents the entire symmetrical matrix. 
Correspondingly, a heat map of the matrix was generated with a white to red gradient 
representing low and high TM-align scores, respectively. Ordering of the heat map is the 
same as the sequence identity ordering and follows the order in Table S1. 
 
2.2.6 Comparison of Type-I Transaminase Active Sites 
From the 204 PLP-dependent enzymes in the CPASS dataset, 4 enzymes were selected to 
elucidate the active site differences that encode substrate specificity. An acetylornithine 
(ACO) transaminase (PDB ID: 2ORD), a γ-aminobutyric acid (GABA) transaminase 
(PDB ID: 1OHW), an aspartate (Asp) transaminase (PDB ID: 1ARG), and a tyrosine 
(Tyr) transaminase (PDB ID: 3DYD) were selected from functional clusters 1, 1, 4b, and 
4a, respectively. Active site residues for each of the enzymes were selected based on their 
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proximity to the PLP ligand (6 Å) as defined by CPASS. Active sites were overlaid in 
Chimera
43
 and visually inspected for the changes resulting in different substrate 
specificity. Additional transaminases with the same function as the four in question were 
subjected to individual multiple sequence alignments in Clustal Omega. The additional 
enzymes were manually selected from the PDB and were not present in our original 
dataset because a bound ligand was not present in the structure. 
 
2.3 Results 
2.3.1 Phylogenetic Network Analysis 
Phylogenetic analyses were carried out on 204 PLP-dependent enzymes with bound 
cofactor (Table S1) from each of the four fold-types previously defined in the literature.
26
 
It is well known that each of the fold-types originated from separate evolutionary 
lineages. Using sequence-based phylogenetic methods,
24
 each of the lineages has been 
visualized with a molecular evolutionary tree structure. However, due to their low 
sequence identity visualizing all of the fold-types together has not yet been accomplished. 
Using active site similarity comparisons, it is possible to display all of the PLP-dependent 
enzymes in one phylogenetic network that demonstrates an evolutionary relationship 
based on function (Figure 1). Type-I enzymes make up the largest portion of the PLP 
enzymes and encompasses most of the enzymes that act at the Cα position of the 
substrate. Type-II enzymes catalyze reactions at the Cα and Cβ positions and contain 
fewer members compared to Type-I. The final two folds, Types III and IV, have the 
fewest members of PLP-dependent enzymes. The function-based phylogenetic network 
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suggests that each of the fold-types originated from an independent lineage. The main 
branches of the network all spawn from the center, indicating a universal organism 
contained ancestral enzymes for each of the fold-types. Also evident are clear separations 
within each of the groups that form function-specific clusters (numbered 1 through 13).  
 
 
Figure 1: Active site network analysis of PLP-dependent enzymes. A phylogenetic 
network analysis of 204 PLP-dependent enzymes with ligand defined active sites in the 
PDB. The red, yellow, green and blue colored regions and protein structures correspond 
to fold-types I, II, III and IV, respectively. Individual clusters found within each of the 
  
26 
folds represent groups of function specific enzymes and are numbered 1-13. The 
network was generated using CPASS similarity scores and the Neighbor-net method. 
 
The functional network also highlights the advantages of using an enzyme’s active site to 
elucidate an evolutionary relationship. Each of the PLP-dependent fold-types has a 
defined active site geometry, and within each type, each function-specific cluster has a 
unique variation in the active site geometry. However, the functional network only gives 
a general overview of the relatedness between each of the functions in the fold-types and 
between the fold-types. To make valid inferences of functional evolutions, further 
analysis is still necessary.  
 
2.3.2 Phylogenetic Analysis of Type-I Enzymes 
Active site similarity scores from the enzymes in the Type-I fold-type were analyzed in 
detail to find a phylogenetic relationship among functional clusters 1-7 (Figure 2). The 
dominating function of fold-type I involves transaminase activity (EC 2.6.1), which is 
found in clusters 1, 2, 4 and 7. Clusters 3, 5 and 6 are primarily comprised of carbon-
sulfur lyases (EC 4.4.1), decarboxylases (EC 4.1.1), and glycine 
hydroxymethyltransferases (EC 2.1.2.1), respectively. Although clusters 1, 2, 4 and 7 
share a broad transaminase activity, these clusters are punctuated in the phylogenetic tree 
by the remaining functional clusters.  This observation suggests multiple Type-I enzymes 
existed in a common ancestor with specialized function. Conversely, a continuous 
grouping of all the transaminases would have implied the existence of a single 
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transaminase with broad substrate specificity. Previous studies have recognized similar 
divisions within the Type-I fold using sequence homology methods and structural 
alignment tools; and came to the same conclusion.
44-46
 The punctuation in the active site 
similarity tree highlights the sensitivity of CPASS for comparing residues and geometries 
of active sites; and supports its use as a phylogenetic tool.  
Figure 2: Type-I PLP-dependent enzyme phylogenetic analysis. The phylogenetic tree 
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of PLP-dependent enzymes belonging to the Type-I fold. Each leaf of the tree is 
annotated with PDB ID, EC number and species. Branch lengths represent the 
evolutionary distance between enzymes based on active site structure comparisons. 
Functional clusters 1-7 correspond to the numbers in the network analysis of all PLP-
dependent enzymes (Figure 1). The tree was constructed using CPASS similarity scores 
and the Neighbor-join algorithm. 
 
There are multiple examples of bacterial and eukaryotic species with homologous 
enzymes within the Type-I functional clusters (Table S1). A general idea of the extent of 
enzyme divergence from a universal ancestor can be elucidated based on how these 
homologous enzymes group within the Type-I functional clusters. In cluster 3, the 
methionine gamma-lyases (EC 4.4.1.11) belonging to eukaryotic T. vaginalis and 
bacterial P. putida were found to be closely related. Directly following in the phylogentic 
tree are the cystathionine gamma-lyases (EC 4.4.1.1) for both eukaryotes and bacteria. 
This indicates that a methionine gamma-lyase and a cystathionine gamma-lyase existed 
in a universal ancestor. Similar examples are also found in clusters 2, 6, and 7 for 
phosphoserine transaminases (EC 2.6.1.52), kynureninases (EC 3.7.1.3) and glycine 
hydroxymethyltransferases (EC 2.1.2.1), respectively. 
Aspartate transaminases are present in both clusters 4a and 4b, but a clear separation 
between these two clusters is apparent in the phylogenetic tree shown in Figure 1. This is 
due to the fact that eukaryotic aspartate transaminases are only found in cluster 4b, while 
bacterial aspartate transaminases are found in both clusters 4a and 4b. The eukaryotic 
enzymes in cluster 4a are comprised of carboxylate synthases (EC 4.4.1) from the 
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kingdom Plantae, and tyrosine and alanine transaminases (EC 2.6.1.5 and 2.6.1.2) 
from the kingdom Animalia. This finding does not support the idea that all Type-I 
enzymes became highly specialized in the last universal ancestor. Instead, our results 
suggest that a promiscuous aspartate transaminase was passed on to emergent species 
and, through subsequent speciation and gene duplication events, the enzymes in clusters 
4a and 4b became more functionally specialized and more substrate specific. 
 
2.3.3 Phylogenetic Analysis of Type-II Enzymes 
A detailed phylogenetic analysis was also carried out on the Type-II PLP-dependent 
enzymes using CPASS similarity scores and the Neighbor-Join algorithm (Figure 3a). 
Three functional clusters based on active site similarity were identified for this fold-type 
and are labeled as clusters 8, 9 and 10. Enzymes catalyzing deaminase reactions on 1-
aminocyclopropane-1-carboxylate (EC 3.5.99.7) are found exclusively in cluster 8. These 
enzymes belong to species in archaeal and eukaryal domains indicating that their function 
was specialized in a common ancestor. The same observation was made for the enzymes 
in cluster 10. Threonine synthase (EC 4.2.3.1), tryptophan synthase (EC 4.2.1.20), and 
serine dehydratase/threonine deaminase (EC 4.3.1.17/4.3.1.19) enzymes from archaeal, 
bacterial, and eukaryal species cluster by function rather than by domain. Cluster 9 
contains cysteine synthases (EC 2.5.1.47) from the bacterial, archaeal, and eukaryal 
domains and cystathionine -synthases (EC 4.2.1.22) from the eukaryal domain. The 
clustering of the cysteine synthases by function rather than by domain once again 
indicates specialization in a common ancestor; however, an insufficient number of 
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cystathionine -synthases are represented in the dataset to elucidate its functional 
evolution. 
 
2.3.4 Phylogenetic Analysis of Type-III Enzymes 
Phylogenetic analysis was also undertaken to explain the emergence of enzymes 
belonging to the Type-III fold-type (Figure 3b). Clusters 11 and 12 were found to be 
discernibly different from one another in the phylogenetic network (Figure 1) and, 
correspondingly, separate from one another on the phylogenetic tree created with the 
Neighbor-Join algorithm. Alanine racemases (EC 5.1.1.1) exclusively populate functional 
cluster 12; whereas, functional cluster 11 is made up of three comparable decarboxylases. 
Unlike most of the enzymes in fold-types I and II, it does not appear the Type-III 
enzymes specialized in the last common ancestor. 
 
Figure 3: Types-II, -III, and -IV PLP-dependent enzyme phylogenetic analysis. 
Phylogenetic reconstructions of PLP-dependent enzymes from Types-II (A), -III (B), and 
-IV (C) folds were built using CPASS similarity scores and the Neighbor-join algorithm. 
Enzymes are labeled with their PDB ID, an EC number and organism. Tree branch 
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lengths correspond to the evolutionary distance between the active sites of the 
enzymes. Numbers 8-13 represent the functional clusters found in the network analysis 
(Figure 1). 
 
In our dataset, diaminopimelate decarboxylases (DAPDC, EC 4.1.1.20) and arginine 
decarboxylases (ADC, EC 4.1.1.19) from bacterial and archaeal species are present while 
ornithine decarboxylases (OCD, EC 4.1.1.17) appear only from eukaryal species. 
However, function specific clustering of the enzymes in cluster 11 is not observed. It is 
likely that a decarboxylase with a very generic active site existed in a common ancestor 
due to the kingdom specific characteristics of the current enzymes.
47, 48
 Additionally, 
ODCs for bacterial species can be found in functional cluster 5 of the Type-I enzymes. 
This example of convergent evolution further supports the idea of a broad-based 
decarboxylase belonging to the Type-III fold. A viral ADC (PDB ID: 2NV9) is also 
present within functional cluster 11, but does not cluster with the bacterial ADCs. It was 
previously hypothesized that this enzyme was acquired from a bacterial ornithine 
decarboxylase and subsequently mutated toward arginine specificity.
49
 CPASS analysis 
supports this proposal as the enzyme clusters with eukaryal ODCs and a bacterial 
DAPDC instead of the bacterial ADCs. Specifically, this finding represents an example 
of convergent evolution within the Type-III fold. 
 
2.3.5 Phylogenetic Analysis of Type-IV Enzymes 
Type-IV enzymes occupy the smallest portion of all PLP-dependent enzymes and form 
  
32 
only one functional cluster (Figure 3c). Cluster 13 contains aminodeoxychorismate 
lyases (EC 4.1.3.38), branched chain amino acid transaminases (EC 2.6.1.42) and a D-
amino acid transaminase (EC 2.6.1.21). Similar to the other three fold-types, the function 
specific enzymes in this family group together. However, because there is only one D-
amino acid transaminase represented in the dataset, the enzyme is grouped with the 
branched chain amino acid transaminases. Interestingly, D-amino acid transaminases 
share similar active site characteristics with the Type-I transaminases.
50
 The geometry 
and residue identity is different enough, however, to distinguish between Types I and IV 
enzymes without having to look at the three-dimensional structure.  
 
2.3.6 Sequence Identity and Structural Similarity 
A heat map and corresponding histogram was generated from a multiple sequence 
alignment (MSA) of the 204 PLP-dependent enzymes (Figure 4a-b). Values above 20% 
identity belong to self-comparisons and comparisons of closely related homologous 
enzymes within the same organism. This can be seen visually as the diagonal line in the 
corresponding heat map. As expected, the histogram shows that the majority of the 
pairwise comparisons are well-below 20% sequence identity. This is consistent with prior 
observations that PLP-dependent enzymes have very low sequence identity.
24, 31, 32
 
Importantly, establishing a protein function based solely on sequence homology 
significantly decreases in reliability as sequence identity falls below 50%.
51
 Presumably, 
a similar high level of uncertainty in establishing a functional evolutionary relationship 
would occur for proteins with sequence identity well-below 20%.   
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The 3D structures of PLP-dependent enzymes were also analyzed to ascertain the 
reliability of using structures of distantly related proteins to generate a functional 
evolutionary model. Figure 5a-b illustrates the resulting histogram and heat map of the 
pairwise structural alignments of the 204 PLP-dependent enzymes. The histogram shows 
a bimodal distribution of TM-align scores. TM-align scores greater than 0.5 are 
consistent with two proteins sharing the same CATH or SCOP fold. Correspondingly, the 
~0.6 TM-align scores occur for PLP-dependent enzymes within the same fold-type. 
Conversely, the lower TM-align scores result from comparisons between fold-types. 
 
Figure 4: Sequence identity histogram and heat map. (A) A histogram of the percent 
similarity matrix representing 204 PLP-dependent protein sequences. The entire 
similarity matrix was analyzed in 0.2% intervals to generate the plot. (B) A heat map of 
the percent similarity matrix used in (A). The white to red coloring of the heat map 
corresponds to the percent similarity and color gradient in (A). The order of the 
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sequences is the same as in Table S1 and the associated network map is illustrated in 
Figure S1. 
 
 
Figure 5: Structural alignment histogram and heat map. (A) A histogram of the 
pairwise TMalign scores for the 204 PLP-dependent proteins in the dataset. The entire 
symmetrical score matrix was evaluated in 0.002 intervals to produce the plot. (B) A heat 
map of the corresponding TMalign score matrix used in (A). The white to red coloring 
scheme of the heat map corresponds to the score and gradient in the respective histogram. 
The order of the sequences is the same as in Table S1 and the associated network map is 
illustrated in Figure S2. 
 
The associated heat map of TM-align scores clarifies this point; high TM-align scores are 
clustered by fold-type. Although structural alignments are able to separate the fold-types 
and determine proper PLP-dependent enzyme membership within a fold-type, the global 
structural information is not sensitive enough to cluster the PLP-dependent enzymes 
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based on function. In essence, the global structural similarity between enzymes within 
a fold-type over-whelms any subtle differences related to functional divergence. 
Similarly, the large structural differences between fold-types negate any local similarities 
that may be present due to a common functional ancestor. 
 
2.3.7 Comparison of Type-I Transaminase Active Sites 
The evolutionary network based on active site similarity depicted in Figure 1 identified 
acetylornithine (ACO) transaminase (EC 2.6.1.11, PDB ID: 2ORD) and a γ-aminobutyric 
acid (GABA) transaminase (EC 2.6.1.19, PDB ID: 1OHW) as nearest neighbors in the 
network. Both enzymes correspond to fold-type I and are located in cluster 1, but the 
enzymes have different EC numbers and substrate specificity. Thus, the active sites were 
compared in order to reveal structural change(s) that contribute to the different substrate 
specificities that led to a functional divergence (Figures 6a-b). The goal was to further 
explore the validity of the phylogenetic network based on CPASS similarity scores to 
provide insights on the pathway of functional evolution. Further pairwise comparisons 
were also made with enzymes from functional clusters 4a and 4b in order to show a 
progressive, step-wise transition of one active site structure to the next. An aspartate 
(Asp) transaminase belonging to functional cluster 4b (EC 2.6.1.1, PDB ID: 1ARG) was 
overlaid with the GABA transaminase to show the active site structural change between 
functional clusters (Figures 6b, d). The final comparison between the Asp transaminase 
and a tyrosine (Tyr) transaminase (EC 2.6.1.5, PDB ID: 3DYD) was undertaken to show 
the active site differences between functional clusters 4b and 4a as well as the structural 
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changes necessary to accommodate the larger substrate (Figures 6c-d). 
 
Figure 6: Side by side alignment of ACO, GABA, Asp, and Tyr transaminase active 
sites. (A) The active site of 2ORD, an ACO transaminase. Circled in red is the threonine 
residue that stabilizes the substrate (not shown) in the active site. (B) The active site of 
1OHW, a GABA transaminase. The red circle indicates the position of the asparagine 
residue relative to the position of the threonine residue from (A). (C) The active site of 
3DYD, a Tyr transaminase. Indicated in the red triangle is the conserved tyrosine residue 
relative to the position of the asparagine residue in (D). (D) The active site structure of 
1ARG, an Asp transaminase. The red box indicates the addition of a tyrosine residue in 
the active site relative to the GABA transaminase active site in (B). 
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2.4 Discussion 
Sequence and structural homology models are typically used to infer descent from a 
common ancestor – molecular evolution. Many examples of protein evolution have been 
constructed based solely on sequence information. The advent of computational 
algorithms based on probability theory has provided a powerful means for inferring 
sequence homology and evolutionary relationships.
52, 53
 However, these methods 
encounter difficulties when dealing with very divergent sequences. At low sequence 
identity, the incorporation of gaps for a suitable alignment may produce results that are 
not genuine.
54
 The spatial arrangement of local structures begins to define the function of 
a protein and represents an important, but distinct, evolutionary signal – functional 
evolution.
23
 Several methods have been developed that use structural templates to help 
guide and ultimately improve the alignment of divergent sequences.
55, 56
 Conversely, 
when both sequence and structure are divergent these methods become less reliable.
51
 
Critically, while molecular evolution and functional evolution are related, they proceed 
through distinctly different mechanisms.
1, 2, 20
 Correspondingly, different approaches are 
needed to measure the evolution of homologous proteins across multiple species 
compared to investigating the evolutionary relationship of various protein functions. 
Thus, instead of applying global sequence similarities to infer an evolutionary 
relationship between distantly related proteins, investigating functional evolution requires 
a targeted approach by analyzing the sequence and structural characteristics of functional 
epitopes or protein active sites. 
The CPASS software and database was initially designed to functionally annotate novel 
proteins based on ligand defined active site structures and to act as a complement to drug 
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discovery programs.
15, 33
 CPASS finds the optimal sequence and structural alignment 
between two active sites, exclusive of sequence connectivity, and returns a similarity 
score. It was found that CPASS could effectively group and annotate proteins that bound 
the same ligand based on specific function.
15
 Further analysis of the results led to the 
hypothesis that CPASS may also infer an evolutionary relationship based on function 
since active site structure and geometry is primarily functionally dependent. CPASS 
does, however, have an inherent disadvantage since it requires a 3D structure of the 
enzyme with a bound ligand.  
PLP-dependent enzymes encompass a broad-range of catalytic functions and represent a 
significant percentage of an organism’s genome.57 Correspondingly, PLP-dependent 
enzymes are a common target for investigating protein evolution.
24, 31, 32
 Complicating 
these analyses is the fact that PLP-dependent enzymes suffer from low sequence identity 
within and between the four different fold-types.
45, 58
 For these very distantly related 
proteins, any sequence similarity that still remains will only be found in the regions of the 
proteins that evolve at a significantly slower rate (functionally important) rather than over 
the entire sequence length. The incorporation of additional sequence information, which 
is not associated with these functionally conserved regions, is likely to negatively impact 
a global analysis. Instead, CPASS presents an alternative approach to investigate the 
functional evolution of PLP-dependent enzymes by restricting the analysis to the 
conserved, functionally relevant active site sequence and structure. A total of 204 PLP-
dependent enzymes had a structure deposited in the RCSB PDB
34
 that contained a bound 
PLP and could be used for a CPASS analysis of functional evolution. 
The results from the CPASS analysis of the PLP-dependent enzymes agree with previous 
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findings that the enzymes developed from four different fold-types in the last universal 
ancestor (Figure 1). CPASS further clustered the enzymes together by specific function 
within each of the four fold-types. Again, this is consistent with the existing functional 
annotation for the PLP-dependent enzymes. It is critical to point out that the CPASS 
analysis did not utilize the fold-type classification or the available functional annotation 
to generate the phylogenetic network depicted in Figure 1. The network was generated 
strictly based on the CPASS active site similarity scores. The fold-type classification and 
functional cluster labels were simply added to the network after the fact. 
Correspondingly, these results demonstrate the reliability of using enzyme active sites for 
comparing distantly related proteins to infer an evolutionary and functional relationship. 
Conversely, it was not possible to generate a similar function-based network for PLP-
dependent enzymes for the four fold types using either global sequence or structure 
similarity. A network generated from sequence alignment data results in an essentially 
random, nonsensical map because of the extremely low sequence alignment within and 
between the fold-types (Figure S1). Similarly, a network generated from structure 
homology data groups the PLP-dependent enzymes into the four fold-types, which of 
course is not surprising since the fold types were defined by structure homology (Figure 
S2). But, any further refinement into functional clusters or any association between the 
four fold-types is, again, essentially random and irrelevant.     
In order to maintain function, the active site of a protein remains highly conserved. 
Similarly, as the function of an enzyme evolves to accommodate a different substrate or 
catalyze a different reaction, only subtle changes in the geometry of the active site or 
moderate sequence substitutions, deletions or insertions are necessary. These active site 
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changes are likely to occur in a slow and step-wise process utilizing the same 
mechanisms that drive overall molecular evolution. Maintaining an active site change 
will depend on how the new (if any) enzymatic activity is contributing to cell fitness. In 
essence, a sequential path from one active site to another is expected where the observed 
sequence and structural changes directly contribute to the functional differences between 
the enzymes. This is exactly what was observed in the CPASS derived phylogenetic 
network. Nearest neighbors identifies subtle differences in active site sequences and 
structures that occur as the enzymatic activity and substrate specificity diverges. In effect, 
these changes identify an evolutionary path for the divergence of enzyme function. As an 
example, ACO transaminase, GABA transaminase, L-tyrosine transaminase, and 
aspartate transaminase are fold-type I enzymes belonging to clusters 1, 1, 4a, and 4b, 
respectively, in our CPASS-based network (Figures 1 and 2).   
A direct comparison between the ACO and GABA transaminase active site structures 
identified a single amino acid substitution from a threonine to an asparagine, respectively, 
at the entrance to the active site (Figures 6a-b). A MSA of several ACO transaminase 
enzymes further verifies that a serine/threonine is conserved at this position (Figure 7a). 
The serine/threonine is most likely necessary to stabilize the larger ACO ligand through 
the formation of additional hydrogen bonds. Previous work has recognized the function 
of the conserved serine/threonine,
59, 60
 but has not identified the residue as being a 
primary difference between ACO and GABA transaminases. Conversely, a MSA of 
GABA transaminases confirms the presence of a conserved glycine/asparagine at the 
entrance to the binding pocket (Figure 7b). 
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Figure 7: MSAs of ACO, GABA, Asp, and Tyr transaminases. Segments of individual 
MSAs from ACO (A), GABA (B), Asp (C), and Tyr (D) transaminases. Each segment 
highlights a conserved residue corresponding to the active sites in Figure 7.  PDB IDs of 
the selected enzymes are on the far right of the alignment.  
 
A small amino-acid at this location may open-up the binding pocket and/or increase 
flexibility, which, in turn, may lead to substrate promiscuity.
57
 Thus, the 
glycine/asparagine to serine/threonine substitution may simply reduce substrate 
promiscuity and increase the selectivity to ACO. Inspection of the differences between 
the GABA and Asp active sites reveals the addition of a Tyr side chain in the active site 
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of the Asp transaminase (Figures 6b, d). The hydroxyl group on the Tyr side chain is 
known to stabilize the internal aldimine between the PLP cofactor and the catalytic lysine 
at physiological pH and to increase the kcat for the reaction in Asp transaminases.
61
 
Binding pocket hydrophobicity is also increased by the presence of the Tyr side chain, 
which may explain the moderate affinity of Asp transaminases for aromatic amino 
acids.
62
 Importantly, ACO and GABA transaminases substitute a smaller glutamine 
residue to hydrogen bond with the cofactor.
59, 63
 A MSA of several Asp transaminases 
from functional clusters 4a and 4b shows that the Tyr residue is highly conserved (Figure 
7c).  Lastly, the progression from an Asp to Tyr transaminase follows a spatial 
substitution of Asn to Tyr as opposed to a sequence substitution. The Tyr at the entrance 
of the binding pocket fulfills the same role as the Asn by forming hydrogen bonds with 
the PLP phosphate group. However, the effects of the spatial rearrangement are twofold. 
Mutation of the Asn in Asp transaminases removes a coordinated water molecule from 
the binding pocket to make room for aromatic substrates,
64
 and the presence of the Tyr 
side chain increases the hydrophobicity of the active site.
62
 Therefore, a single spatial 
substitution can greatly change the affinity for certain substrates in Type-I enzymes. An 
MSA of five Tyr transaminases confirms the conservation of the Tyr residue in the active 
site (Figure 7d) 
CPASS recognized these subtle, sequential changes that occurred between these four, 
nearest-neighbor active sites while also acknowledging the overall active site similarity. 
This enabled the close grouping of the ACO transaminase, GABA transaminase, L-
tyrosine decarboxylase, and aspartate aminotransferase within the same functional 
cluster; and, importantly, the identification of a clear evolutionary path to achieve the 
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observed substrate and functional divergence.  
 
2.5 Conclusion 
PLP-dependent enzymes have been a common target of molecular evolution studies, but 
prior efforts have been limited to small subgroups due to the low sequence identity within 
each fold-type and across all PLP-dependent enzymes.
24, 31, 32
 Instead, we have 
demonstrated the first phylogenetic network based on functional evolution to model all 
PLP-dependent fold-types together on a single network. We were able to correctly cluster 
all the PLP enzymes into their previously assigned fold-type simply based on the 
sequence and structure similarity of the PLP-binding site. Furthermore, the enzymes 
clustered based on their EC numbers within each fold-type cluster. Our CPASS-derived 
functional network allowed us to follow the step-wise evolution of substrate specificity 
and catalytic activity. Effectively, nearest neighbors in the CPASS-derived functional 
network were related by single-amino-acid changes for highly-conserved active site 
residues. It was not possible to achieve a similar network using either global sequence or 
structure similarity. Thus, the study herein successfully determined an evolutionary 
relationship based on function between many diverse and highly divergent PLP-
dependent enzymes using the available active site structures. Also, our results clearly 
verifies that CPASS is an effective approach for identifying an evolutionary relationship 
based on function using similarities in active site structure and sequence. 
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2.7 Supplemental Figures and Tables 
 
Supplemental Figure 1: Sequence based network analysis of PLP-dependent 
enzymes. A phylogenetic network of 204 PLP-dependent enzymes with ligand defined 
active sites in the PDB. The red, yellow, green, and blue markers indicate enzymes 
belonging to fold-types I, II, III, and IV, respectively. The network was built using a 
MSA from Clustal Omega and the Neighbor-net algorithm.  
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Supplemental Figure 2: Structure based network analysis of PLP-dependent 
enzymes. A phylogenetic network of 139 PLP-dependent enzymes with ligand defined 
active sites in the PDB. The network was built using pairwise TMalign scores and the 
Neighbor-net algorithm. Red, yellow, green, and blue regions correspond to fold-types I, 
II, III, and IV, respectively. 
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Fold-type Cluster PDB EC Organism Domain 
I 1 2JJG 2.6.1.36 M. tuberculosis Bacteria 
  
1OHW 2.6.1.19 S. scrofa Eukaryota 
  
1SZS 2.6.1.19 E. coli Bacteria 
  
4ATP 2.6.1.19 A. aurescens Bacteria 
  
2PB0 2.6.1.11 S. typhimurium Bacteria 
  
2ORD 2.6.1.11 T. maritima Bacteria 
  
4ADB 2.6.1.81 E. coli Bacteria 
  
2EH6 2.6.1.11 A. aeolicus Bacteria 
  
1VEF 2.6.1.11 T. thermophilus Bacteria 
  
4NOG 2.6.1.13 T. gondii Eukaryota 
  
1OAT 2.6.1.13 H. sapiens Eukaryota 
  
2YKY 2.6.1 Mesorhizobium sp. Bacteria 
  
4AO9 2.6.1 V. paradoxus Bacteria 
  
4GSA 5.4.3.8 Synechococcus sp. Bacteria 
  
3K28 5.4.3.8 B. anthracis Bacteria 
  
3DXV 5.1 A. obae Bacteria 
  
4A6T 2.6.1.62 C. violaceum Bacteria 
  
3I5T 2.6.1 R. sphaeroides Bacteria 
  
3TFT 2.6.1.62 M. tuberculosis Bacteria 
  
1MLY 2.6.1.62 E. coli Bacteria 
  
4A0R 2.6.1.62 A. thaliana Eukaryota 
  
3DU4 2.6.1.62 B. subtilis Bacteria 
  
3A8U 2.6.1.18 P. putida Bacteria 
  
2EO5 2.6.1.19 S. tokodaii Archaea 
  
1Z3Z 4.1.1.64 B. cepacia Bacteria 
      I 2 1BJO 2.6.1.52 E. coli Bacteria 
  
3E77 2.6.1.52 H. sapiens Eukaryota 
  
3QBO 2.6.1.52 Y. pestis Bacteria 
  
2BI3 2.6.1.52 B. alcalophilus Bacteria 
  
1W3U 2.6.1.52 B. alcalophilus Bacteria 
  
3VOM 2.6.1.52 M. tuberculosis Bacteria 
  
3IMZ 2.6.1.44 H. sapiens Eukaryota 
  
2YOB 2.6.1.44 H. sapiens Eukaryota 
  
2YRR 2.6.1 T. thermophilus Bacteria 
  
2DR1 2.6.1.51 P. horikoshii Bacteria 
  
3ZRP 2.6.1.51 S. solfataricus Archaea 
  
1VJO 2.6.1.44 Nostoc sp. Bacteria 
  
3ISL 2.6.1.44 B. subtilis Bacteria 
  
1M32 2.6.1.37 S. typhimurium Bacteria 
      I 3 1C7G 4.1.99.2 E. herbicola Bacteria 
  
1N8P 4.4.1.1 S. cerevisiae Eukaryota 
  
3COG 4.4.1.1 H. sapiens Eukaryota 
  
1IBJ 4.4.1.8 A. thaliana Eukaryota 
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1I43 2.5.1.48 N. tabacum Eukaryota 
  
1PG8 4.4.1.11 P. putida Bacteria 
  
1E5F 4.4.1.11 T. vaginalis Eukaryota 
  
3NMY 4.4.1.1 X. oryzae Bacteria 
  
3NNP 4.4.1.1 X. oryzae Bacteria 
  
4L0O 2.5.1.48 H. pylori Bacteria 
  
2CTZ 2.5.1 T. thermophilus Bacteria 
      I 4a 2X5F 2.6.1 S. aureus Bacteria 
  
1LK9 4.4.1.4 A. sativum Eukaryota 
  
1XI9 2.6.1 P. furiosus Archaea 
  
1V2E 2.6.1.15 T. thermophilus Bacteria 
  
1U08 2.6.1.88 E. coli Bacteria 
  
1O4S 2.6.1.1 T. maritima Bacteria 
  
1DJU 2.6.1.57 P. horikoshii Archaea 
  
3EI8 2.6.1.83 A. thaliana Eukaryota 
  
4FL0 2.6.1 A. thaliana Eukaryota 
  
3IF2 2.6.1 P. arcticus Bacteria 
  
2O1B 2.6.1.1 S. aureus Bacteria 
  
2X5D 2.6.1 P. aeruginosa Bacteria 
  
2ZY2 2.6.1.1 Pseudomonas sp. Bacteria 
  
2ZY4 2.6.1.1 A. faecalis Bacteria 
  
3DYD 2.6.1.5 H. sapiens Eukaryota 
  
1B5P 2.6.1.1 T. thermophilus Bacteria 
  
1J32 2.6.1.1 P. lapideum Bacteria 
  
3ELE 2.6.1 E. rectale Bacteria 
  
1WST 2.6.1 T. profundus Archaea 
  
1VP4 2.6.1 T. maritima Bacteria 
  
2ZP7 2.6.1.39 T. thermophilus Bacteria 
  
4JE5 2.6.1.39 S. cerevisiae Eukaryota 
  
3PPL 2.6.1.1 C. glutamicum Bacteria 
  
3IHJ 2.6.1.2 H. sapiens Eukaryota 
  
1IAX 4.4.1.14 S. lycopersicum Eukaryota 
  
1LKC 4.1.1.81 S. enterica Bacteria 
  
1GEW 2.6.1.9 E. coli Bacteria 
  
1H1C 2.6.1.10 T. maritima Bacteria 
  
3LY1 2.6.1.9 P. atrosepticum Bacteria 
  
1B8G 4.4.1.14 M. domestica Eukaryota 
  
1D2F 4.4.1.8 E. coli Bacteria 
  
3B1C 4.4.1.8 S. anginosus Bacteria 
  
3L8A 4.4.1.8 S. mutans Bacteria 
  
1C7N 4.4.1.8 T. denticola Bacteria 
  
4DQ6 2.6.1 C. difficile Bacteria 
  
3KAX 4.4.1 B. anthracis Bacteria 
      I 4b 1ASF 2.6.1.1 E. coli Bacteria 
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1AY5 2.6.1.57 P. denitrificans Bacteria 
  
3TAT 2.6.1.57 E. coli Bacteria 
  
2CST 2.6.1.1 G. gallus Eukaryota 
  
3II0 2.6.1.1 H. sapiens Eukaryota 
  
3MEB 2.6.1.1 G. lamblia Eukaryota 
  
1YAA 2.6.1.1 S. cerevisiae Eukaryota 
  
8AAT 2.6.1.1 G. gallus Eukaryota 
  
4EMY 2.6.1 A. prevotii Bacteria 
      I 5 2Z67 2.9.1.2 M. maripauldis Archaea 
  
2E7J 2.5.1.73 A. fulgidus Archaea 
  
1WYU 1.4.4.2 T. thermophilus Bacteria 
  
3RBF 4.1.1.28 H. sapiens Eukaryota 
  
1JS3 4.1.1.28 S. scrofa Eukaryota 
  
4E1O 4.1.1.22 H. sapiens Eukaryota 
  
1C4K 4.1.1.17 Lactobacillus sp. Bacteria 
  
2JIS 4.1.1.29 H. sapiens Eukaryota 
  
2DGK 4.1.1.15 E. coli Bacteria 
  
1KMJ 4.4.1.16 E. coli Bacteria 
  
4LW4 4.4.1.16 E. coli Bacteria 
  
1T3I 2.8.1.7 Synechocystis sp. Bacteria 
  
1EG5 2.8.1.7 T. maritima Bacteria 
  
3LVM 2.8.1.7 E. coli Bacteria 
  
3VAX 2.8.1.7 S. lividans Bacteria 
  
3A9X 4.4.1.16 R. norvegicus Eukaryota 
  
3F9T 4.1.1.25 M. jannaschii Archaea 
  
4EB5 2.8.1.7 A. fulgidus Archaea 
      I 6 2WK8 2.3 V. cholerae El Tor Bacteria 
  
2BWO 2.3.1.37 R. capsulatus Bacteria 
  
3TQX 2.3.1.29 C. burnetii Bacteria 
  
1DJE 2.3.1.47 E. coli Bacteria 
  
3A2B 2.3.1.50 S. multivorum Bacteria 
  
3G8M 2.1.2.1 E. coli Bacteria 
  
1BJ4 2.1.2.1 H. sapiens Eukaryota 
  
1RVU 2.1.2.1 O. cuniculus Eukaryota 
  
2DKJ 2.1.2.1 T. thermophilus Bacteria 
  
4OTL 2.1.2.1 B. cenocepacia Bacteria 
  
2VMO 2.1.2.1 
G. 
stearothermophilus Bacteria 
  
4BHE 2.1.2.1 M. jannaschii Archaea 
      I 7 3NYS 2.6.1.98 P. aeruginosa Bacteria 
  
1B9H 2.6.1 A. mediterranei Bacteria 
  
2C7T 2.6.1 B. circulans Bacteria 
  
3BB8 2.6.1 Y. pseudotuberculosis Bacteria 
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1MDX 2.6.1.87 S. typhimurium Bacteria 
  
2FNI 2.6.1.92 H. pylori Bacteria 
  
1O61 unknown C. jejuni Bacteria 
  
2HZP 3.7.1.3 H. sapiens Eukaryota 
  
1QZ9 3.7.1.3 P. fluorescens Bacteria 
      II 8 1J0E 3.5.99.7 C. saturnus Eukaryota 
  
1J0A 3.5.99.7 P. horikoshii Archaea 
      II 9 3DWI 2.5.1.65 M. tuberculosis Bacteria 
  
1WKV 2.5.1.47 A. pernix Archaea 
  
2JC3 2.5.1.47 S. typhimurium Bacteria 
  
3PC2 4.2.1.22 D. melanogaster Eukaryota 
  
4L28 4.2.1.22 H. sapiens Eukaryota 
  
3BM5 2.5.1.47 E. histolytica Eukaryota 
  
3VBE 2.5.1.47 G. max Eukaryota 
  
2ECO 2.5.1.47 T. thermophilus Bacteria 
  
1OAS 2.5.1.47 S. typhimurium Bacteria 
  
4AEC 2.5.1.47 A. thaliana Eukaryota 
  
2ISQ 2.5.1.47 A. thaliana Eukaryota 
  
3ZEI 2.5.1.47 M. tuberculosis Bacteria 
      II 10 1KFC 4.2.1.20 S. typhimurium Bacteria 
  
1WDW 4.2.1.20 P. furiosus Archaea 
  
3SS9 4.3.1.18 E. coli Bacteria 
  
1WTC 4.3.1.17 S. pombe Eukaryota 
  
3HMK 4.3.1.17 R. norvegicus Eukaryota 
  
2D1F 4.2.3.1 M. tuberculosis Bacteria 
  
1UIM 4.2.3.2 T. thermophilus Bacteria 
  
2ZSJ 4.2.3.1 A. aeolicus Bacteria 
  
1KL7 4.2.3.1 S. cerevisiae Eukaryota 
  
4F4F 4.2.3.1 B. melitensis Bacteria 
  
1VE5 4.3.1.19 T. thermophilus Bacteria 
  
1TDJ 4.3.1.19 E. coli Bacteria 
  
2RKB 4.3.1.17 H. sapiens Eukaryota 
  
1P5J 4.3.1.17 H. sapiens Eukaryota 
      III 11 3N29 4.1.1.96 C. jejuni Bacteria 
  
2J66 4.1.1.95 B. circulans Bacteria 
  
1KNW 4.1.1.20 E. coli Bacteria 
  
2YXX 4.1.1.20 T. maritima Bacteria 
  
3N2O 4.1.1.19 V. vulnificus Bacteria 
  
3NZP 4.1.1.19 C. jejuni Bacteria 
  
1TWI 4.1.1.20 M. jannaschii Archaea 
  
1HKV 4.1.1.20 M. tuberculosis Bacteria 
  
2NV9 4.1.1.19 P. bursaria Chlorella Virus 
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virus 
  
2OO0 4.1.1.17 H. sapiens Eukaryota 
  
1F3T 4.1.1.17 T. brucei Eukaryota 
  
2QGH 4.1.1.20 H. pylori Bacteria 
      III 12 1CT5 5.1.1.1 S. cerevisiae Bacteria 
  
1W8G 5.1.1.1 E. coli Bacteria 
  
3R79 unknown A. fabrum Bacteria 
  
3CO8 5.1.1.1 O. oeni Bacteria 
  
4BF5 5.1.1.1 A. hydrophilia Bacteria 
  
4BEQ 5.1.1.1 V. cholerae Bacteria 
  
1RCQ 5.1.1.1 P. aeruginosa Bacteria 
  
3B8W 5.1.1.1 E. coli Bacteria 
  
4A3Q 5.1.1.1 S. aureus Bacteria 
  
3E5P 5.1.1.1 E. faecalis Bacteria 
  
1SFT 5.1.1.1 
G. 
stearothermophilus Bacteria 
  
1XFC 5.1.1.1 M. tuberculosis Bacteria 
  
2DY3 5.1.1.1 C. glutamicum Bacteria 
  
1VFH 5.1.1.1 S. lavendulae Bacteria 
      IV 13 1I2K 4.1.3.38 E. coli Bacteria 
  
2XPF 4.1.3.38 P. aeruginosa Bacteria 
  
2Y4R 4.1.3.38 P. aeruginosa Bacteria 
  
4K6N 4.1.3.38 S. cerevisiae Bacteria 
  
2ZGI 4.1.3.38 T. thermophilus Bacteria 
  
3CSW 2.6.1.42 T. maritima Bacteria 
  
4DAA 2.6.1.21 Bacillus sp. Bacteria 
  
4CMD 2.6.1.42 N. haematococca Eukaryota 
  
4CHI 2.6.1.42 A. fumigatus Eukaryota 
  
2EJ3 2.6.1.42 T. thermophilus Bacteria 
  
1I1M 2.6.1.42 E. coli Bacteria 
  
3UZO 2.6.1.42 D. radiodurans Bacteria 
  
3DTH 2.6.1.42 M. smegmatis Bacteria 
  
3DTG 2.6.1.42 M. smegmatis Bacteria 
  
2HGX 2.6.1.42 H. sapiens Eukaryota 
  
2COG 2.6.1.42 H. sapiens Eukaryota 
 
Supplemental Table 1:  PLP-dependent enzymes selected for active site evolution 
analysis. A table of the 204 PLP-dependent enzymes used in this study annotated by 
PDB ID. Enzymes are grouped by fold-type and then by functional cluster in the network 
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analysis. The enzyme classification number, organism, and domain are also listed for 
each enzyme. 
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Chapter 3 
Functional Evolution of Proteins 
3.1 Introduction 
A functional clustering of ligand-defined active sites in the RCSB Protein Data Bank 
(RCSB PDB)
1
 was undertaken to infer an evolutionary lineage of enzymatic function. 
Sequence based phylogenetic methods are typically utilized to produce evolutionary tree 
structures.
2
 This is possible because molecular evolution occurs through random 
mutations at a constant rate.
3
 Nevertheless, the reliability of sequence-based evolutionary 
measurements becomes suspect when protein sequence homology enters the “twilight-
zone” and falls below 25% sequence identity.4 Simply, the accuracy of a phylogenetic 
tree is directly dependent on the accuracy of the sequence alignment, which becomes 
undependable at low sequence identity.
5, 6
 Therefore, due to the large sequential 
dissimilarity for the entirety of proteins deposited in the RCSB PDB, sequence-based 
evolutionary methods are not easily or reliably employed across an all-inclusive set of 
protein functional classes.  
Structure-based alignment is an alternative to sequence based alignments, especially 
considering the tremendous reduction in structure space relative to sequence space. 
Recent estimates suggest that only a few-thousand distinct protein folds exists,
7, 8
 which 
is consistent with the 1391 protein topologies currently identified by CATH.
9
 
Nevertheless, the alignment of protein structures is even more challenging than sequence 
alignment, and fails for completely dissimilar structures.
8
 Like sequence, the arrangement 
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of tertiary structures is extremely evolutionarily labile when considering the entirety of 
known protein functions. While global protein sequence and structure may drift without 
detrimental consequences, dramatic changes to an active site or functional epitope of a 
protein may negatively impact the survivability of an organism. Instead, functional 
evolution progresses slowly through gene duplication and functional drift to avoid 
negative influence on cellular fitness.
10, 11
 This occurs because even minor changes in the 
spatial orientation or amino acid composition within an active site may lead to dramatic 
changes in substrate and reaction specificity. Consequently, protein active sites mutate at 
a much slower rate relative to other structural elements and remain highly conserved over 
time.
12
 In effect, a similarity in protein active sites may remain even though the overall 
sequence or structure of a protein has completely diverged. Thus, it may be possible to 
infer an evolutionary relationship based on similarities in protein active sites in situations 
when global sequence or structure similarities no longer exist.  
 Several methods and databases have been previously published describing the clustering 
of proteins from the RCSB PDB. These include sequence,
13
 structure,
14
 ligand 
conformation,
15
 atomic properties,
16
 and putative cavity
17
 based approaches. However, a 
clustering and subsequent phylogenetic analysis based on ligand-defined active sites has 
not been done. The Comparison of Protein Active site Structures (CPASS) software and 
database compares the geometry and amino acid similarity between pairs of 
experimentally determined ligand-defined active sites. CPASS is distinctly different from 
protein cavity approaches because it focuses on known binding sites rather than putative 
pocket detection. Further, substrate conformation is only used in the determination of 
active site residues and not in the CPASS scoring function. Consequently, the 
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evolutionary analysis of proteins in the RCSB PDB based on active site similarity is a 
novel approach. 
We previously demonstrated the utility of CPASS to decipher the functional evolution of 
proteins by comparing the active sites of 204 PLP-dependent enzymes.
18
 We produced 
the first-ever phylogenetic tree that contained all four families or fold-types (I to IV) for 
PLP-dependent enzymes. The resulting phylogenetic tree correctly distinguished between 
the four individual folds and further sorted the enzymes by substrate specificity and 
function. Critically, no functional information was utilized to produce the phylogenetic 
tree of PLP-dependent enzymes, yet the enzymes were clustered perfectly based on EC 
number (i.e., branches were comprised of enzymes with the same EC number). 
Furthermore, examining individual branches of the phylogenetic tree illustrates the step-
wise evolution of function through a series of single amino-acid substitutions. In effect, 
nearest neighbors in the CPASS derived phylogenetic tree identified subtle differences in 
active site sequences and structures that led to changes in enzymatic activity and 
substrate specificity. Importantly, we were able to produce a phylogenetic tree for the 
PLP-dependent enzymes despite sequence identity well-below 20% and poor structural 
alignments between folds (TM-align
19
 score of ~ 0.3).    
Based on this prior success, we expanded upon the phylogenetic tree of PLP-dependent 
enzymes by using CPASS to functionally cluster all ligand-containing proteins present in 
the RCSB PDB. In essence, CPASS was used to produce a phylogenetic tree containing 
essentially all protein functional classes present in the RCSB PDB. CPASS was used to 
make a pair-wise comparison between all of the ligand-defined binding sites within the 
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RCSB PDB to produce an all-versus-all CPASS similarity score matrix. The proteins 
were then clustered by the identity of the bound ligand. Principal component analysis of 
the CPASS scores was employed to identify a representative structure for each functional 
class (i.e., same ligand and EC number) in order to reduce the overall size of the dataset. 
The representative structure for each functional class was then successfully modeled into 
a single phylogenetic tree based on the CPASS similarity score matrix. The resulting 
phylogenetic tree demonstrates the functional evolution across all of the protein 
functional classes within the RCSB PDB. To further illustrate the effectiveness of our 
approach, we also highlight two specific regions of the phylogenetic tree that demonstrate 
the stepwise substrate and enzymatic evolution of fructose-6-phosphate (F6P) bound 
active sites. 
 
3.2 Methods 
3.2.1 Active site Structure Comparison 
Protein structures with ligand defined active sites were collected from the Protein Data 
Bank
20
 and subjected to an all versus all comparison using CPASS.
21, 22
 CPASS scores 
were subsequently converted to relative distances by subtracting from 100% CPASS 
similarity. The distance matrix, due to size and computational constraints, was divided 
into smaller matrices based on bound ligand. Principal component analysis was applied to 
the smaller ligand defined matrices using MVAPACK
23
 where functional clusters were 
generated based on Enzyme Commission (EC) number.
24
 For each EC number cluster, a 
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95% confidence ellipse was calculated which was used to find the representative active 
site with the shortest Euclidean distance to its center. A total of 3996 representative 
active sites were found and utilized in the remainder of this study. 
 
3.2.2 Phylogenetic Analysis of Representative Active sites 
The CPASS distance matrix for the representative active sites was input into FastME for 
tree generation using the Neighbor-join algorithm.
25
 Briefly, the neighbor-join algorithm 
joins the two closest taxa or nodes in the distance matrix and creates a new node, which 
has recalculated distances to the remaining taxa and nodes. Multiple iterations of this 
process build the tree until only a pair of nodes remains. Identification and investigation 
of the resulting tree structure was accomplished through visual inspection using the 
Interactive Tree of Life online tool.
26
 
 
3.2.3 Active site Overlays 
From the CPASS representative dataset and tree, 8 enzymes were selected for additional 
investigation. Structural and sequential differences between the active sites of the 
enzymes (PDB IDs: 1DLJ, 1DLI, 2O2D, 1MV8, 2P3V, 1LBY, 1JP4, 1KA1) were 
elucidated by visual inspection using Chimera.
27
 In each case, residues were considered 
to be in the active site based on their relative proximity to the bound ligand in their 
respective crystal structure (6Å). The orientation of the active sites relative to one another 
was also determined by CPASS, as a standard 3D overlay of the tertiary structures would 
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result in misalignment of the active sites. 
 
3.3 Results 
3.3.1 Functional Clustering and Principal Component Analysis of Ligand Defined Active 
sites 
The Comparison of Protein Active site Structures (CPASS) software and database 
(http://cpass.unl.edu/) was used to compare all protein active sites from the RCSB PDB 
that contained a bound ligand. CPASS performs a pairwise comparison between two 
protein active sites, where active site residues were determined based on a defined 
distance to the bound ligand (6Å). CPASS similarity scores are determined by similarities 
in both amino acid composition and by the relative amino acid positions between the two 
compared active site. An “all versus all” distance matrix derived from CPASS similarity 
scores was initially calculated for all of the ligand defined active sites in the RCSB PDB.  
The protein structures were then clustered based on the identity of the bound ligand in 
order to create function specific protein groupings and to reduce the size of the dataset. A 
total of 169 protein function groups were created based on a shared identity of the bound 
ligand. Consequently, a total of 169 principal component analyses (PCA) were then 
performed using our MVAPACK
23
 software for each of these ligand defined protein 
groups. Group membership within the PCA scores plot was further defined by Enzyme 
Commission (EC)
24
 number and demarcated by a 95% confidence ellipse. A 
representative example of a PCA scores plot for the collection of fructose-6-phosphate 
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(F6P) bound active sites is shown in Figure 1. There are 7 different enzymatic 
functional classes (EC numbers: 2.7.1.105, 2.7.1.11, 3.1.3.11, 3.1.3.25, 3.5.1.25, 5.3.1.8, 
and 5.3.1.9) and one unannotated group in the PCA scores plot. 
 
 
Figure 1. The PCA scores plot of a CPASS distance matrix for fructose-6-phosphate 
bound proteins. Active sites are clustered by Enzyme Commission number, which refers 
to a specific function. Ellipses correspond to the 95% confidence intervals for each of the 
functional clusters (colored) and the dataset (black).  
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3.3.2 Structural Representatives of Functional Classes 
The PCA scores plots were leveraged to find a representative protein structure for each 
functional class based on EC number the type of bound ligand. For each functional class 
in the PCA scores plot, the protein active site with the shortest Euclidean distance to the 
center of the 95% confidence ellipse was chosen as a representative structure. Again, the 
95% confidence ellipse defines the membership for a given functional class. Accordingly, 
the selected protein active site should have a high CPASS similarity score or a small 
variance relative to the other protein active sites in the functional class. In effect, the 
selected protein active site is expected to serve as a structural “average” for the functional 
class. In total, the 169 PCA score plots identified a representative structure for 3996 EC 
functional classes. 
 
3.3.3 Phylogenetic Analysis 
A phylogenetic analysis was conducted using a distance matrix based on CPASS 
similarity scores for the 3996 protein active sites. The phylogenetic analysis used the 
neighbor-join algorithm and the resulting phylogenetic tree is shown in Figure 2. The 
phylogenetic tree is shown in a circular display with leaves colored according to the 
function defined by the first EC number [oxidoreductases (red), transferases (blue), 
hydrolases (yellow), lyases (green), isomerases (purple), ligases (orange), not annotated 
(black)]. Importantly, the functional classification was not used as part of the 
phylogenetic analysis. Instead, the resulting phylogenetic tree was simply annotated with 
the known functional classifications. 
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Figure 2. A phylogenetic tree of 3996 representative CPASS active sites from the RCSB 
PDB is presented. The phylogenetic tree highlights the functional evolutionary 
relationships between protein active site structures.  Leaves are colored according to the 
first EC number of the annotated active site (1: oxidoreductases, red; 2: transferases, 
blue; 3: hydrolases, yellow; 4: lyases, green; 5: isomerases, purple; 6: ligases, orange; not 
annotated: black). 
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3.4 Discussion 
Herein, we report the first functional clustering and evolutionary analysis of the entirety 
of proteins deposited in the RCSB PDB with a bound ligand. A functional evolution was 
based on active site similarities determined by our CPASS software and database. Protein 
active sites were first divided into functional classes based on the type of bound ligand. 
PCA of the CPASS similarity scores was then used to visualize the relative similarities of 
the functional class membership. The resulting PCA scores plot was then annotated with 
EC numbers and the 95% confidence ellipses (Figure 1) were used to define the 
membership of each functional class within the scores plot.  
PCA has been extensively used in chemometrics and various ‘omics’ fields for 
fingerprint analysis.
28
 In this study, PCA was used to reduce the variance within each 
functional class while also reducing the size of the dataset used for the phylogenetic 
analysis. The PCA scores plot for the collection of F6P bound active sites (Figure 1) 
yielded several important observations. First, a number of the 95% confidence ellipses 
partially overlap in the PCA scores plot. This suggests that there are structural elements 
that remain consistent within the active site even though the enzymatic functions vary 
considerably. Second, a complete separation of two functional classes would indicate that 
the active sites have either diverged significantly over time or have converged to act upon 
the same substrate. An evolutionary drift is also apparent when considering the shape and 
positions of the ellipses in the scores plot. The various clusters appear to drift away from 
the center of the scores plot. Assuming the center of the PCA scores plot is the structural 
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average of all active sites bound to a ligand, the movement of an ellipse or active site 
toward or away from the center would indicate convergent or divergent evolution, 
respectively. In effect, the substrate specificity and/or enzymatic activity is diverging as 
the enzyme moves away from the center of the scores plot or converging as it moves 
towards its center.  
The resulting scores plot also suggests that a combination of CPASS and PCA may be a 
useful approach for annotating functionally unclassified or hypothetical proteins. For 
example, the PCA scores plot of the active sites bound to F6P contained a functionally 
unannotated class of proteins. While the 95% confidence ellipse for this unannotated 
class was understandably broad (presumably because it contains different functions), 
individual proteins were found to be near or within other functional classes suggesting 
possible annotation(s) (Table 1). Furthermore, proteins found within the intersection of 
two or more ellipses may suggest a bi-functionality or a functionally promiscuous active 
site.  
 
Table 1. 
PDB ID: Nearest EC Cluster
a
 
1UXR 3.5.1.25 
2R66 3.5.1.25 
3BXH 5.3.1.8 
3PR3 5.3.1.9 
3PT1 5.3.1.8 
a
Shortest Euclidean distance to the center  
of the 95% confidence ellipse  
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In this study, PCA was primarily utilized to identify a representative protein structure 
for each functional class. Simply, the protein structure closest to the center of each ellipse 
was identified as the representative active site for the functional class. For example, a 
total of eight protein structures were identified from the PCA scores plot of the F6P 
bound active sites shown in Figure 1. This corresponds to one protein representative for 
each of the seven EC functional classes and one protein for the single unannotated class. 
In this manner, PCA allowed for a drastic reduction in the size of the dataset to about 
10% of its initial size. Consequently, a distance matrix was generated from an all-vs-all 
comparison of the 3996 representative protein active sites from each functional class. The 
matrix of CPASS similarity scores were then subjected to the neighbor-join algorithm for 
a phylogenetic analysis (Figure 2). The resulting phylogenetic tree captures the stepwise 
functional evolution of essentially all of the protein functional classes present in the 
RCSB PDB. 
Protein active sites are paired together in the tree according to enzymatic function, which 
was also seen in our previous study of PLP-dependent enzymes.
18
 The structure and 
amino-acid composition of a protein active site is typically highly conserved in order to 
maintain function and retain cellular fitness. Thus, functional evolution of a protein 
progresses slowly and likely follows a step-wise process of single-amino substitutions 
that also involves gene duplication. The process proceeds until a new function or 
substrate specificity is achieved. Importantly, this step-wise evolution of function is 
clearly evident in our phylogenetic tree of protein active sites. Nearest-neighbors, even 
those from different organisms, have very subtle differences in active site structures 
and/or sequence. Simply, as an active site progresses towards the next node, a change in 
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substrate specificity or enzymatic activity may result from a few amino-acid 
substitutions and/or minor conformational change (Figures 4, 5). Interestingly, while 
nearest neighbors share similar function, an overall view of the functional distribution 
throughout the entire phylogenetic tree is much more complex and diverse. This is 
apparent from the relatively random distribution of color throughout the phylogenetic 
tree, where leaves are colored according to the first EC number for each representative 
protein. The phylogenetic tree is not uniformly divided or colored into six contiguous 
functional classes. Instead, there are many small pairings and subgroupings of similar 
functional classes that are evenly distributed throughout the tree. This mixing of function 
is likely due to multiple ancestral active site scaffolds that have evolutionarily diverged 
and then expanded their biological roles. The organization of the phylogenetic tree is also 
consistent with convergent evolution where distant active site architectures have slowly 
mutated toward the same enzymatic function. In essence, the dramatic dispersion of color 
throughout the phylogenetic tree is further evidence of the multitude of divergent and 
convergent events that have occurred in the evolution of protein functions. 
Two representative regions of the phylogenetic tree have been highlighted to further 
illustrate the effectiveness of an evolutionary clustering of function based on CPASS 
similarity scores (Figure 3). It is important to note that two branches highlighted in 
Figure 3 come from distinct regions of the phylogenetic tree. Nevertheless, both branches 
contain a protein active site bound to fructose-6-phosphate (F6P), where two proteins 
(1LBY
29
 3.1.3.25, 3M5P 5.3.1.9) were representative structures identified from the PCA 
scores plot displayed in Figure 1. Using these two proteins as arbitrary evolutionary 
starting points, a step-wise evolution of substrate specificity and enzymatic activity is 
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easily observed. The active site of 1LBY has inositol-phosphate phosphatase activity 
and was found to be most similar to 2P3V,
30
 which shares the same function as 1LBY 
(Figure 3A). An overlay of the 1LBY and 2P3V CPASS determined active sites reveals 
an almost identical match in terms of both amino acid identity and geometry (Figure 4A). 
This is to be expected as nearest neighbors have the closest distance (highest CPASS 
similarity). Furthermore, the primary difference between the two active sites is the 
identity of the bound ligand. 2P3V is bound to S,R meso-tartaric acid instead of F6P, 
which was simply a result of the crystallization conditions. This outcome also 
demonstrates an important feature, the robustness of CPASS to identify highly similar 
active sites independent of the identity of the bound ligand.  
 
 
Figure 3. Two regions of the phylogenetic tree from Figure 2 were selected for further 
detailed analysis. (A) The protein active sites in this branch of the phylogenetic tree 
illustrate protein functional evolution that results in changes in substrate specificity. (B) 
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The protein active sites in this branch of the phylogenetic tree illustrate protein 
functional evolution that results in changes in both enzymatic activity and substrate 
specificity.  Proteins are listed by their PDB IDs and EC functions (3.1.3.25: inositol-
phosphate phosphatase; 3.1.3.7: 3'(2'), 3’ phosphoadenosine-5’-phosphate phosphatase; 
5.3.1.9: glucose-6-phosphate isomerase; 1.1.1.132: GDP-mannose 6-dehydrogenase; 
1.1.1.22: UDP-glucose 6-dehydrogenase). 
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Figure 4. Structural overlays of the active sites for (A) 1LBY (black) and 2P3V (yellow), 
and (B) 1LBY (black) and 1JP4 (green). Residues are labeled by type and sequence 
position with those from 1LBY in black and those from 2P3V and 1JP4 in red. Overlays 
are oriented relative to the bound F6P in 1LBY with the coordinated magnesium ions 
displayed in purple. Residues were chosen for the comparative analysis if they were 
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within 6Å of the bound ligand and were used in the CPASS similarity scoring. 
 
The next nearest node to 1LBY in Figure 3A includes two protein active sites (1JP4
31
 and 
1KA1
32
) with a similar function (identical for the first three EC numbers), but that act on 
different substrates. The CPASS determined active sites for 1JP4 and 1KA1 are quite 
similar (not shown), where the primary difference is the identity of the bound ligand 
(adenosine monophosphate vs. adenosine-3'-5'-diphosphate). In effect, these two nearest-
neighbor nodes (Figure 3A) contain a pair of proteins with similar functional 
classification (3.1.3.25 or 3.1.3.7), but with different bound ligands in the experimental 
structures deposited in the RCSB PDB. A comparison of the 1LBY active site, an 
inositol-phosphate phosphatase, with 1JP4, a 3’ phosphoadenosine-5’-phosphate 
phosphatase, reveals minor structural and amino acid differences between the two active 
sites (Figure 4B). Since the active sites have a similar function but different substrate 
specificity, the observed changes in amino acid composition and active site geometry are 
most likely related to substrate binding.  
The four proteins (1LBY, 2P3V, 1JP4, 1KA1) comprising this node are magnesium 
dependent phosphatases, which have an evolutionarily conserved active site and 
coordinate 2 to 3 metal ions.
32
 The metal ions specifically enable the catalytic 
dephosphorylation of bound substrates and are essential to enzyme activity. Interestingly, 
the metal coordination sites are strictly conserved even though the metal ions do not 
participate in substrate binding. Critical to our study, the sequence identity for members 
of the Mg
2+
-dependent superfamily is below 25%,
31
 which makes sequence-based 
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evolutionary analysis extremely challenging and further highlights the benefits of our 
CPASS approach. In fact, the CPASS analysis further confirms the high conservation of 
the metal coordination site. This is apparent in the structural overlays in Figure 4. The 
active site residues identified by CPASS around the coordination sites deviate very little 
in position while sequence identity is absolutely maintained. Conversely, the residues 
opposite the metal coordination sites, which do change between Figures 4A to 4B, are 
involved in substrate recognition.  
Since the active sites for 1LBY and 2P3V have the same function and act upon the same 
substrate, the tyrosine (1LBY:Tyr155, 2P3V:Tyr153) and arginine (1LBY:Arg165, 
Arg167, 2P3V: Arg170, Arg172) residues on the distal side of the active site relative to 
the metal ions are conserved. These residues assist in the coordination of the substrate 
sugar and phosphate moieties, respectively. For 1JP4, the substrate is changed to 3’-
phosphoadenosine 5’-phosphate (PAP), which induces spatial changes and amino-acid 
substitutions in the active site (Figure 4B). Specifically a tyrosine is replaced by a 
histidine (1JP4: His198) and an arginine is replaced by a threonine (1JP4: Thr195). These 
amino-acid substitutions form a new hydrogen bond network around the PAP 5’-
phosphate moiety.
31
 A reorientation of the side chain of the remaining arginine creates 
space to accommodate the increase in size of the PAP ligand. Interestingly, the PAP 
phosphatase maintains some of its inositol 1-phosphate/fructose-1,6-bisphosphate 
phosphatase activity.
31
 Considering how close the active sites are to one another in the 
phylogenetic tree and the similarity of the active site structures, the residual enzymatic 
activity is understandable. 
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A similar comparative analysis of protein evolution is illustrated by examining another 
branch from the phylogenetic tree (Figure 3B). Unlike the first illustrated example that 
lead to an evolution of substrate specificity (Figure 3A), this branch leads to the proteins 
adopting new functions in addition to changes to substrate specificities. The evolutionary 
focus of this branch is the active site of 3M5P, which is a glucose-6-phosphate (G6P) 
isomerase and was identified as a representative structure from the PCA scores plot in 
Figure 1.  
The active site of 3M5P was found to be most similar to 2O2D,
33
 which has the same 
function as 3M5P (EC 5.3.1.9, G6P isomerases). An overlay of the two CPASS active 
site structures in Figure 5A indicates near identity in regards to both amino-acid 
composition and structure. Again, the only difference in these two active site structures is 
the nature of the bound ligand. 3M5P is bound to F6P; whereas, 2O2D is bound to citrate. 
This difference is likely just a result of differences in the crystallization buffers. Critical 
residues in the active sites of 3M5P and 2O2D that are directly responsible for enzymatic 
activity are a lysine (3M5P: Lys505, 2O2D: Lys571), a glutamate (3M5P: Glu346, 
2O2D: Glu411), and an arginine (3M5P: Arg261, 2O2D: Arg326). These residues are 
positioned directly around the substrate sugar moiety,
33
 facilitate proton transfer (Lysine, 
Glutamate), and stabilize the intermediate structure. 
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Figure 5. Structural overlays of the active sites for (A) 3M5P (black) and 2O2D (pink), 
and (B) 3M5P (black) and 1DLI (cyan). Residues are labeled by type and sequence 
position with those from 3M5P in black and those from 2O2D and 1DLI in red. Overlays 
are oriented relative to the bound F6P in 3M5P. Residues were chosen for the 
comparative analysis if they were within 6Å of the bound ligand and were used in the 
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CPASS similarity scoring. 
 
The next nearest node to 3M5P includes three protein active sites (1MV8, 1DLJ, 1DLI)
34, 
35
 with a similar function (Identical for the first three EC numbers), but act on different 
substrates. The CPASS determined active sites for 1DLJ and 1DLI are essentially 
identical (not shown), where once again the primary difference is the identity of the 
bound ligand [nicotinamide-adenine-dinucleotide (NAD) vs. 1,4-dihydronicotinamide 
adenine dinucleotide (NADH)]. However, the active sites are no longer conserved when 
comparing 3M5P, a G6P isomerase, to 1DLI (or 1DLJ), a UDP-glucose 6-dehydrogenase 
(U6DH) (Figure 5B). The lysine and glutamate residues, which are important to 
enzymatic activity remain in 3M5P, but now occupy different positions within the active 
site. Of particularly note, the importance of these residues to the enzymatic activity of 
1DLI has been diminished. Now, the residues only assist in hydrogen bonding to the 
substrate rather than serving a more integral role in the enzymatic activity of the 
protein.
35
 Moreover, the critical arginine in the G6P isomerase active site is not in the 
CPASS determined active site for U6DH. Simply, there is no longer a reaction 
intermediate in U6DH that requires stabilization by an arginine. As a result, the arginine 
is not conserved in U6DH and the space it occupied has been better utilized. In essence, 
the overlay of active sites in Figure 5 demonstrates the stepwise evolution from a 
glucose-6-phosphate isomerase to a UDP-glucose 6-dehydrogenase A similar result is 
obtained when 3M5P is compared to 1MV8, in which a G6P isomerase is converted into 
a GDP-mannose dehydrogenase instead of UDP-glucose 6-dehydrogenase (not shown). 
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Comparing these active site structures provides a clear understanding of the slow, step-
wise evolution of protein function that is essential to the survivability and adaptability of 
a cell or organism.  
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Chapter 4 
Analysis of the Mechanism of Action of Helical Antimicrobial Peptides 
4.1 Introduction 
The emergence of drug resistant bacteria has made the development of novel antibacterial 
agents a pressing issue.
1
 In fact, most experts consider bacterial infections as one of the 
greatest threats to human health, and may result in upwards of 10 million deaths 
worldwide by 2050.
2
 Bacterial resistance to common antibiotics occurs through a variety 
of mechanisms.
3, 4
 For example, the gram-positive pathogen methicillin resistant 
Staphylococcus aureus (MRSA) copes with antibiotics by increasing membrane thickness 
or altering penicillin binding proteins (PBP).
5
 Alternatively, gram-negative bacteria such 
as Enterobacter spp., K. pneumoniae, and P. aeruginosa acquire resistance by developing 
efflux pumps, producing degrading enzymes, or by altering drug binding targets.
6-8
 
An interesting alternative to combat resistant bacteria are antimicrobial peptides 
(AMPs).
9
 AMPs are a class of molecules capable of killing a wide range of 
microorganisms by membrane pore formation, membrane disruption, or through a “multi-
hit” mechanism. AMPs can act on the cell membrane or on cytoplasmic targets such as 
the inhibition of protein synthesis, enzymatic activity, or cell wall synthesis.
10-12
 Perhaps 
the most attractive feature of AMPs as a source for new antimicrobials is the observation 
that bacteria are less likely to develop resistance to AMPs as compared to non-peptide 
antibiotics.
13
 This occurs because the fundamental structure of the membrane is not easily 
altered by mutations. Thus, determining the precise mechanisms of action and the 
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structural features that give rise to AMP antimicrobial activities is key to improving 
and evolving their efficacy. 
Citropin 1.1 (Cit 1.1) is an AMP derived from the skin of an Australian tree frog of the 
Litora genus. Cit 1.1 has shown promising activity against a large number of gram-
positive and gram-negative species that includes: S. aureus, S. epidermis, S. uberis, E. 
fecalis, E. coli, and K. pneumonia.
14
 Truncation studies have shown that deletion of Gly1, 
Leu2, or Phe3 completely ablated Cit 1.1 activity. Conversely, deleting Gly14, Gly15, or 
Leu6 had no impact on Cit 1.1 activity.
15
 Tyler and co-workers suggested that the -
helical conformation of Cit 1.1 was critical to antimicrobial activity.
16
 In fact, a similar 
biological activity was achieved when the secondary structure was maintained, but the L-
amino acids were replaced with D-amino acids.  However, reversing the peptide sequence 
did yield a less potent antibacterial compound.
17
 In a follow up study, the same group 
found that if an amide bond is formed between the amine of Leu5 and the carboxylic acid 
side chain of Asp4 (an isoAsp bond, which alters the linear conformation of Cit 1.1) the 
biological activity is effectively abolished while the metabolic stability of the peptide is 
greatly enhanced. This conformational change does not affect the total charge of the 
peptide, and only marginally changes the isoelectric point and hydrophobicity, but the 
isoAsp bond significantly alters its secondary structure.
18
 In addition, it has recently been 
proposed that two -helices are formed upon contact of Cit 1.1 with bacterial 
membranes.
15
 
 Taken together, the -helical structure of Cit 1.1 appears to play an important role in the 
peptide’s antimicrobial activity. Of particular note, these prior studies relied on the 
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introduction of relatively large structural changes to investigate a relationship between 
amino acid composition and peptide conformation on biological activity. In this report, 
we expand upon these initial investigations by further characterizing the structure and 
biological activity the Cit 1.1 peptide in a membrane mimetic environment. The synthesis 
and antimicrobial evaluation of new Cit 1.1 AMP analogs are also reported. The 
membrane-bound solution structures of the Cit 1.1 peptides were determined using 
circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopy. The mode 
of membrane disruption was visualized using microscopy techniques and validated by 
NMR. The toxicity of the most potent AMP was studied in vitro, and the in vivo efficacy 
was studied using a well-establish wax-moth larva assay. The resulting structural and 
biological data has enabled us to define a mechanism of action for Cit 1.1, to describe the 
structural arrangement of the peptide when in contact with membranes, and to understand 
the impact of subtle conformational changes on peptide activity. 
 
4.2 Materials and Methods 
4.2.1 Peptide synthesis and purification 
AMPs were synthesized using solid phase peptide synthesis (SPPS) on a AAPPTec Focus 
XC automated peptide synthesizer (Louisville, KY) on a 0.25 mmol scale. All peptides 
were synthesized using Fmoc-Rink Amide AM resin support (AAPPTec, Louisville, 
KY). The resin was wetted in dichloromechane (DCM) for 30 min to maximize swelling. 
The Fmoc- group was then deprotected twice using 20% 4-methyl piperidine (10 mL) 
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each time. The resin was thoroughly washed twice for 10 mins each time using a 1:1 
mixture of DCM and dimethylformamide (DMF). The desired amino acids were then 
added to obtain a predetermined sequence in the peptide synthesizer. Molecular weight of 
the AMPs was confirmed by MALDI using a SCIEX 4800 MALDI TOF/TOF analyzer 
(Ontario, Canada). The AMPs were purified using a preparative reverse-phase high 
performance liquid chromatography (HPLC) using a water (0.1% Trifluoroacetic acid 
(TFA)) and acetonitrile (0.1% TFA) gradient on an Agilent HPLC system (Santa Clara, 
CA) using a reverse phase column (Kinetex 5u XB-C18 100 A, 150 × 30.0 mm column). 
Purity for each AMP was confirmed to be >95% with an Agilent analytical HPLC (Santa 
Clara, CA). To determine the relative hydrophobicity, all AMPs were run through 
analytical HPLC using the same column, on the same day, using the same solvent 
reservoir. 
 
4.2.2 Minimum inhibitory concentration assay (MIC)  
Bacteria strains used in this experiment were Staphylococcus aureus JE2, Escherichia 
coli K12, and Klebsiella pneumoniae ATCC 13883. The MICs of the amphiphilic 
peptides was determined using a broth microdilution method as described in the third 
edition of the ASM Clinical Microbiology Procedures Handbook.
19
 A stock solution of 
each peptide was prepared in deionized water and then serial 2-fold dilutions were made 
in Muller Hinton broth (Difco
TM
, BD Diagnostics, Becton Drive, NJ), containing 5% 
DMSO in Cellstar 96-well microtiter plates (Greiner Bio-One, Austria). Bacterial cultures 
were prepared using the direct colony suspension method to 1.5 X 10
8
 colony forming 
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unit (CFU)/ml (0.5 McFarland) and diluted for 2 mL into 40 mL of MHB. Each well 
was inoculated with 10 μl of bacterial cultures. Plates were statically incubated at 37°C 
for 16-24 hr. MIC values were taken at the lowest concentration at which no growth was 
observed with the unaided eye or the microplate reader. The optical density (O.D.) value 
at 600 nm was recorded using a Thermo Fisher Scientific AccuSkan, MultiSkan FC 
(Waltham, MA). Vancomycin (Sigma, St. Louis, MO) and Gentamicin (Alfa Aesar, 
Ward Hill, MA) was used as positive control and blank media was used as negative 
control. All assays were performed in triplicates. 
 
4.2.3 Circular dichroism (CD) and secondary structure analyses 
The AMPs were fully dissolved in Milli-Q water + 20% trifluoroethanol (TFE) to a final 
concentration of 2 mM. CD spectroscopy was performed at 25 °C using a J-815 Jasco 
Circular Dichroism Spectrometer (Easton, MD) in a 0.1 mm quartz cuvette. The solvent 
system (H2O + TFE) was kept as the reference, which was then subtracted from the AMP 
spectra. The wavelengths for CD analysis were ranged from 190 - 300 nm with a scan 
speed of 100 nm/min. The response time was set at 2 s and the bandwidth was set to 1 
nm. The spectra were analyzed for their relative proportions of secondary structure using 
the Dichroweb online server for protein secondary structure analysis employing the K2D 
analytical program.
20
 CD experiments in presence of E. Coli were done following a 
previously published method.
21
 Briefly, E. Coli K12 was cultured in Muller Hinton Broth 
and incubated at 37°C. The resultant mid-log phase cultures were diluted to a final 
concentration of 1.5x10
8 
CFU/ml using phosphate buffer saline (0.5 McFarland). The 
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spectrum of the bacterial suspension was subtracted from the spectrum collected after 
addition of the AMP (2 mM) to yield the final spectrum. Helical wheel projections were 
calculated using the Heliquest online interface.
22
   
 
4.2.4 NMR Structure Determination 
Unlabeled peptide samples were prepared similarly to previous studies.
23
 Briefly, 2 mM 
of peptide was dissolved in 90% H2O and 10% D2O with 120 mM of SDS-d25 
(Cambridge Isotope), 50 mM trimethylsilylpropanoic acid (TMSP), and phosphate 
buffered saline (PBS) buffer at pH 7 (uncorrected). NMR experiments were collected at 
25
o
C on a 700 MHz Bruker Avance III spectrometer equipped with a 5 mm QCI-P probe 
with cryogenically cooled carbon and proton channels. Proton assignments and NOEs 
were accomplished with TOCSY, DQF-COSY, and NOESY experiments with shifts 
referenced to TMSP. NMR spectra were collected with 32 transients and 512 points in 
the indirect dimension. NOESY spectra were collected with mixing times of 100 ms and 
200 ms. Interstrand NOEs were identified using a 3D X-filtered experiment with a 
mixing time of 120 ms and a 50/50 mixture of unlabeled peptide and a peptide uniformly 
13
C, 
15
N labeled at Leu2.
24
 Initial models of the peptides were generated from Hα 
chemical shifts using the CS-Rosetta webserver at the BMRB.
25
 Structural refinement 
was carried out with XPLOR-NIH with dimer symmetry enforced.
26
 400 refined 
structures were generated for each peptide and the lowest 20 energy structures were 
subsequently subjected to water refinement in XPLOR-NIH. Validation of the peptide 
ensembles was done using the Protein Structure Validation Software (PSVS) suite from 
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the Northeast Structural Genomics Consortium.
27
 
  
4.2.5 One-Dimensional NMR Temperature Titration 
The unlabeled NMR peptide samples used for structure determination were also 
subjected to a temperature titration to monitor structure stability. 1D 
1
H NMR spectra 
were recorded at temperatures of 25, 30, 40, 50, 60, and 70
o
C with 64 transients, 128K 
data points, and a spectral width of 12.87ppm. Between each experiment, the samples 
were allowed to rest at the target temperature for 5 min before data collection. Following 
the titration, the 25
o
C spectrum was recollected to ensure that the sample did not undergo 
irreversible degradation upon heating. 
 
4.2.6 Paramagnetic Relaxation Enhancement Titration 
The unlabeled NMR peptide samples used for structure determination were also used to 
observe the effects of a diethylenetriaminepentaacetic acid gadolinium (III) dihydrogen 
salt hydrate (Gd-DTPA) titration. Gd-DTPA was titrated into the samples to 
concentrations of 0, 2, 4, 8, 16, and 24 mM. 1D 
1
H NMR spectra were recorded with 128 
transients, 64K data points, and a spectral width of 12.87 ppm. Effects resulting from 
sample dilution were accounted for by normalizing peak intensities to TMSP. 
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4.2.7 Transmission electron microscopy 
E. coli K12 and S. aureus JE2 were cultured in Muller Hinton Broth and incubated at 37 
°C. The resultant mid-log phase cultures were diluted to a final concentration of 1.5x108 
CFU/ml (0.5 McFarland). The bacteria cells were treated with the AMP at 2x the MIC 
value and incubated for 1 h at 37°C. A control was prepared by adding the media only. 
After AMP treatment, the cells were immediately washed thrice with HyClone™ 
Dulbecco's Phosphate Buffered Saline solution (GE Healthcare Life Science, 
Marlborough, MA) and fixed with 2.0% (v/v) glutaraldehyde
28
 Imaging was done on a 
FEI Tecnai G2 Spirit transmission electron microscope (Japan). 10 µL of the AMP-
treated or control bacterial suspension was placed on a copper grid and was allowed to 
dry for 5 min. The excess suspension was blotted off of the grid and it was dried for 5 
mins to remove the residual moisture.  
 
4.2.8 Scanning electron microscopy 
Bacterial suspensions for SEM were prepared identically as they were for TEM. The 
suspension was then placed on 0.1% Poly-L Lysine coated glass slide and allowed to 
adhere for 30 minutes. The slides were then washed thrice with PBS to remove excess 
fixative. Samples were post-fixed in a 1% solution of OsO4 for 30 mins to facilitate 
conductivity. They were then dehydrated in a graded ethanol series (50, 70, 90, 95, and 
100%). Ethanol was removed by washing the slides thrice with hexamethyldisilazane 
(HMDS). The HMDS was allowed to evaporate overnight to dry the samples. The glass 
slides were attached to aluminum SEM stubs with double-sided carbon tape. Silver paste 
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was applied to enhance conductivity, which was allowed to dry overnight. Samples 
then were coated with ≈ 50nm gold-palladium alloy in a Hummer VI Sputter Coater 
(Anatech, Battle Creek, MI) and imaged at 30kV in a FEI Quanta 200 SEM (Japan) 
operating in high vacuum mode.    
 
4.2.9 Atomic force microscopy and nano-indentation 
Escherichia coli K12 and Staphylococcus aureus JE2 were cultured in Muller Hinton 
Broth and incubated at 37°C. The resultant mid-log phase cultures were adjusted to a 
final concentration of 1.6x109 CFU/ml (5.0 McFarland). Cells were treated with AMP at 
10 times the MIC (30µM) and incubated for 30 minutes at 37°C. An untreated control 
was prepared in the same way by adding blank media. Cells were then washed thrice in 
HyClone™ Dulbecco's Phosphate Buffered Saline solution, and centrifuged at 8000 rpm 
for 10 mins. AFM imaging of the cells and nano-indentation measurements were 
performed at ambient conditions with relative humidity of 75% using the MFP 3D system 
(Oxford Instruments Asylum Research, Santa Barbara, CA). A silicon nitride cantilever 
MSNL-F (MSNL, Bruker) with nominal value of spring constant in the range of 0.6 N/m 
was used for both imaging and indentation. The spring constant of the cantilever was 
obtained using a thermal method prior to each experiment. Indentation was performed in 
the “Go There” mode after the image of the cells was obtained on various specified 
points on the cell surface. Collected force-distance curves were analyzed with the Igor 
Pro 6.23 software package (Wavemetrics, Portland, OR). Mechanical properties were 
obtained by fitting of the force curves to a cone geometry model of the tip. Fitting was 
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done with calibrated parameters of the tip geometry, which were obtained before the 
experiment by indentation of the probe against the PDMS Gel reference sample (PDMS-
SOFT-1-12M, Bruker) with a known Young’s modulus of 2.5 MPa. 
 
4.2.10 FITC uptake kinetics 
E. coli K12 and S. aureus JE2 were cultured in Muller Hinton Broth and incubated at 37 
°C. The resultant mid-log phase cultures were diluted to a final concentration of 1.5x108 
CFU/ml (0.5 McFarland). The bacteria cells were treated with the AMP at 2x the MIC 
value and incubated for 1 h at 37°C. A control was prepared with solvent used to dissolve 
the AMP. 100 μL of the bacterial suspension was loaded onto a 96-well plate and 
fluorescein isothiocyanate (FITC) (6 μg/ml) was added and thoroughly mixed with the 
bacterial cells. The initial fluorescence immediately after FITC addition was recorded and 
subsequent fluorescence intensities were recorded at 30, 60, 120 and 240 min intervals. 
The decrease in fluorescence intensity were expressed as % of initial fluorescence and 
recorded as the means ± SD.  
 
4.2.11 Membrane Internalization Kinetics 
E. coli K12 and S. aureus JE2 were cultured in Muller Hinton Broth and incubated at 37 
°C. The resultant mid-log phase cultures were diluted to a final concentration of 1.5x108 
CFU/ml (0.5 McFarland). The bacteria cells were treated with the AMP at 2x the MIC 
value and the fluorescence value was immediately determined. A control was prepared by 
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adding only the solvent. The initial fluorescence immediately after AMP addition was 
recorded and subsequent fluorescence intensities were recorded at 30, 60, 120 and 240 
min intervals. The decrease in fluorescence intensity were expressed as % of initial 
fluorescence and recorded as the means ± SD. 
 
4.2.12 In vivo assay on G. mellonella model of Staphylococcal infection 
500 µL of the bacterial suspension was prepared and adjusted to 2.5×10
8
 CFU/10 µL in 
PBS buffer. 10µL of the bacterial suspension was injected to the last left pro-leg of the G. 
mellonella larva. Following injection, the infected larva was incubated in top-side 
perforated petri dishes for 2 hours. All larvae were found to be alive 2 hours post 
infection (n=15). Following this the AMP-treated group and Vancomycin-treated groups 
were treated with AMP-016 (15mg/kg) and Vancomycin (15mg/kg) respectively. The 
larvae were observed every 24 hr for 5 days. A survival graph was plotted representing % 
survival over time. The survival data were plotted using the Kaplan Meyer method and 
comparisons were made between groups using the log rank test.  
 
4.2.13 In vitro toxicity studies 
AMPs were dissolved in Dulbecco's Modified Eagle Medium (DMEM) containing 10% 
FBS and 1% penicillin streptomycin to a final concentration of 4 mM. An aliquot of this 
stock solution was taken and serial dilutions were performed using DMEM buffer to 
obtain the desired concentration. Cytotoxicity was performed using a celltiter blue assay 
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and following the manufacturer’s protocols. Cell death was determined by observing 
the change of absorbance of resazurin using a spectrophotometer. The results were 
plotted as Absorbance vs AMP concentration and the IC50 (concentration that kills 50% 
of the cell population) was calculated. 
 
4.3 Results  
4.3.1 Peptide Synthesis and Characterization 
The crude AMPs were identified by Matrix Assisted Laser Desorption Ionization-Time of 
Flight (MALDI-TOF) spectrometry (Supporting information). The purities of the AMPs 
were determined to be >95% and the relative hydrophobicities of the AMPs were 
determined using analytical High-Performance Liquid Chromatography (HPLC) (Table 
1).  
 
  
HaCat (uM) 
Retention  
Time (mins) 
MW 
AMP-001 50 17.48 1615 
AMP-002 120 17.78 1629.03 
AMP-003 >310 20.09 1657.04 
AMP-004 >310 17.35 1658.09 
AMP-005 >310 19.52 1615.99 
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AMP-006 45 16.86 1586.94 
AMP-007 140 16.63 1558.89 
AMP-008 >310 16.44 1530.84 
AMP-009  >310 18.89 1644 
AMP-010 >310 21.76 1724.26 
AMP-011 >310 17.88 1700.17 
AMP-012 >40 17.83 1671.03 
AMP-013 60 17.91 1643.01 
AMP-014 >310 16.05 1673 
AMP-015  >310 18.18 1629.03 
AMP-016 45 18.22 1654.04 
 
Table 1. Cytotoxicity against HaCat cell lines, relative retention times and calculated 
molecular weights of the antimicrobial peptides. 
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Table 2. Antimicrobial activities of Citropin and its analogues against S. aureus, E. coli, 
P. aeruginosa and K. pneumoniae. Activities are listed by concentration (µM). 
 
4.3.2 Minimum Inhibitory Concentration (MIC Assay)  
Cit 1.1 showed high activity against S. aureus (10 μM), E. coli (25 μM), and K. 
pneumoniae (30 μM) corroborating findings from previous studies (Table 2).16, 29-31 The 
AMP-002 analog was synthesized by substituting a methyl glycine (Sar1) for Gly1. 
AMP-002 retained activity against S. aureus and E. coli, but exhibited diminished 
activity against K. pneumoniae (>50 μM). The N-terminus acetylation of Cit 1.1 yielded 
the AMP-003 analog, which resulted in completely diminished activity against S. aureus, 
E. coli and K. pneumoniae. Methylation of the N-terminus amine of Cit 1.1 yielded the 
AMP-004 analog, which also resulted in full ablation of activity across all of the tested 
bacterial strains. The AMP-005 analog was synthesized by substituting Gly1 with a 
hydrazine group, which resulted in complete loss of antibacterial activity.  
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Replacing two Lys residues (Lys7, Lys8) with ornithine (Orn, AMP-006) resulted in a 
2.5-fold decrease in the MIC value against S. aureus (25 µM) and a 1.7-fold decrease 
against E. coli (15 µM). The activity of AMP-006 against K. pneumoniae remained 
unchanged (30 µM) relative to Cit 1.1. Replacement of the lysine residues with 2,4-
diaminobutyric acid (Dab) or 2,3-diaminopropionic acid (Dpr) yielded analogs AMP-007 
and AMP-008, respectively. Both Dab and Dpr substitutions resulted in a complete loss 
of antibacterial activity (> 50 µM). An AMP-009 analog was constructed in which Lys7 
was replaced with a citrulline, which is a structural mimic of arginine and contains a urea 
functional group instead of the charged guanidium group. The citrulline substitution 
resulted in a complete lack of antibacterial activity for AMP-009. AMP-010 was 
synthesized by methylating all of the available Cit 1.1 amine groups. AMP-011 was 
generated by methylating only the Lys amine moieties to produce a peptide analog that 
still contains a positive charge. Nevertheless, both AMP-010 and AMP-011 exhibited a 
complete lack of antibacterial activity. AMP-012 was constructed by replacing Lys7 and 
Lys8 with an arginine. Similarly, an AMP-013 analog was generated by substituting Lys7 
for an arginine. The MICs for both AMP-012 and AMP-013 decreased 2-fold against S. 
aureus (5 µM). However, the potency of AMP-012 and AMP-013 against gram-negative 
organisms was mixed. AMP-013 exhibited a 1.7-fold higher activity against E. coli (15 
µM) compared to both Cit 1.1 and AMP-012. Conversely, all three peptides exhibited the 
same activity against K. pneumoniae (30 µM). A glycine residue was inserted into the Cit 
1.1 sequence following Lys 8 to create the AMP-014 analog. The AMP-014 analog was 
observed to be inactive against all of the bacterial strains tested. The remaining Cit 1.1 
analog (AMP-015) was constructed with a modest substitution of Asp4 for a Glu. As 
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expected, this substitution retained activity comparable to Cit 1.1 against S. aureus 
and E. coli, but the activity against K. pneumoniae was completely lost. An AMP-016 
analog was constructed where Phe3 was replaced with a Trp. The AMP-016 analog 
exhibited the best antibacterial activity against both S. aureus (3 µM) and E. coli (3 µM) 
relative to Cit 1.1 and the other analogs. This corresponded to 3-fold and 8-fold increase 
in activity, respectively. The activity against K. pneumoniae was the same as Cit 1.1 (30 
µM).  
 
Figure 1. A) Representative CD spectra of Cit 1.1 (red), AMP-003 (green) and AMP-016 
(blue) in a solution of 20% TFE+H2O at a concentration of 2 mM. B) Subtracted CD 
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Spectrum of Cit 1.1 (red), AMP-003 (green) and AMP-016 (blue), incubated with live 
E.coli cells. Cells (0.1 OD) were suspended in 10 mM phosphate buffer (pH 7) and AMP-
016 (25µM) was added to the cuvette, and the spectrum was immediately collected. The 
background spectrum of the E. coli cells was subtracted from the E. coli AMP spectrum 
to derive the final spectrum. (C) Plot showing the Hα deviations (ppm) from statistical-
coil chemical shifts. Amino acids are numbered according to their sequence in Cit 1.1 
(red), AMP-003 (green), AMP-016 (blue). (D) TOCSY Hα region of Cit 1.1 (red), AMP-
003 (green), and AMP-016 (blue). Peaks are labeled according to their respective amino 
acid position. 
 
4.3.3 Circular Dichroism (CD) Spectroscopy 
CD Spectroscopy is routinely employed to determine the secondary structure of proteins 
and peptides.
32
 Accordingly, the antimicrobial activity of the Cit 1.1 analogs was 
compared to α-helical content using CD spectroscopy (Figure 1A, B). The most active 
peptides Cit 1.1, AMP-002, -012, -013, and -016 had the highest α-helical content 
corresponding to ≥ 45% (Table 3). Conversely, the moderately active (AMP-006 and -
015) or inactive peptides (AMP-003, -004, -008, -009, -010, -011, and -014) contained a 
lower α-helical content of ≤ 31%. The inactive AMP-005 and -007 analogs were 
exceptions and exhibited an α-helical content of approximately 40%. In general, a high α-
helical content appears to be a prerequisite for Cit 1.1 activity. The secondary structures 
for the Cit 1.1 analogs were also analyzed in the presence of bacteria to mimic a native 
environment (Figure 1B). The Cit 1.1, AMP-003 and -016 were all observed to adopt α-
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helical structures upon incubation with E. coli despite differences in antimicrobial 
activity. It has been previously demonstrated that the minima of a CD spectrum is an 
indicator of the proportion of the peptides that have folded into an ordered secondary 
structure.
21
 Accordingly, an observed difference in the minimum depth of CD spectra 
may identify relative differences in the proportion of Cit 1.1 analogs that adopt α-helical 
conformations. Comparing the CD spectra of Cit 1.1, AMP-003 and -016 in the presence 
of E. coli cells indicates that AMP-016 has the lowest minima and, consequently, the 
highest proportion of α-helical peptides. Cit 1.1 was the next lowest and AMP-003 
exhibited the least α-helical content. Importantly, this trend correlates with the relative 
activity of the Cit 1.1 analogs. 
 
Table 3. Relative content of α-helix, β-sheet and random coil in the structure of Cit 1.1 
and its analogs. The relative proportion of secondary structures was calculated using the 
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Dichroweb online interface using K2D analytical algorithm.
20
  
 
4.3.4 NMR Spectroscopy 
Negatively charged sodium dodecyl sulfate (SDS) micelles closely mimic a bacterial 
membrane and were therefore chosen as a model for the structural elucidation of Cit 1.1, 
AMP-003, and AMP-016 by NMR.
33
 Standard two-dimensional (2D) TOCSY and 
NOESY datasets were collected for backbone and side-chain resonance assignments.
34
 
NMR assignments for Cit 1.1, AMP-003, and AMP-016 were nearly complete with 94% 
HN, 100% Hα, 100% Hβ, 88% Hγ, 90-100% Hδ, 60-100% Hε, 0-33% Hζ, and 100% Hη 
of the assignments made. Figure 1C shows the Hα chemical shift deviations from 
statistical-coil values for the three peptides bound to SDS micelles.
35, 36
 The three 
peptides show negative chemical shift differences across the entirety of the sequence, 
which is strongly suggestive of an α-helical conformation along the SDS micelle. 
Chemical shift differences between the Cit 1.1, AMP-003, and AMP-016 peptides are 
more apparent when the HN chemical shifts are included. This is illustrated by an overlay 
of the Hα region of the 2D TOCSY spectra for the three peptides as shown in Figure 1D. 
Major chemical shifts changes are observed for residues 3 to 7, which are consistent with 
the Hα chemical shift changes plotted in Figure 1C.  
The NMR structures for the Cit 1.1, AMP-003, and AMP-0016 peptides in SDS micelles 
were determined to further elucidate the role that structure plays in antimicrobial activity. 
An initial dimer model was generated for each peptide using CS-ROSETTA.
37
 The three 
peptide dimer structures were then refined with XPLOR-NIH
38
 based on 536 to 622 
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intramolecular NOE restraints, and 16 intermolecular (peptide-peptide) NOE 
restraints. A total of 400 models were calculated per peptide of which the 20 lowest 
energy structures were further water refined. The structural statistics for the three 
peptides (Table 4) indicates that the experimental data agrees well with the calculated 
structures. Backbone RMSDs for each of the peptides was 0.3Å, 0.7Å, and 0.4Å for Cit 
1.1, AMP-003, and AMP-016, respectively. The structures did not contain any NOE 
violations >0.5Å or dihedral angle violations >5°. The high quality of the NMR structures 
is also evident by the PROCHECK z-scores of -0.3, -0.95, and -0.47 for Cit 1.1, AMP-
003, and AMP-016, respectively.
39
 Further, 92-94% of all residues are located in the most 
favored region of the Ramachandran plot. An overlay of the water refined 20 lowest 
energy NMR structures for the Cit 1.1, AMP-003, and AMP-016 peptides are shown in 
Figure 2A-C. 
 
Structure statistics for: Cit 1.1 AMP-003 AMP-016 
NOE Restraints 622 552 536 
Short Range (|i-j|<=1) 414 390 362 
Medium Range (1<|i-j|<5) 208 162 174 
Long Range (peptide-peptide) 16 16 16 
ϕ/ψ in most favored region 91.70% 94.20% 92.9 
ϕ/ψ in additionally allowed 
region 
8.30% 5.80% 7.1 
ϕ/ψ in generously allowed 0% 0% 0 
ϕ/ψ in disallowed region 0% 0% 0 
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Backbone atoms rmsd (Å) 0.3 0.7 0.4 
Heavy atoms rmsd (Å) 0.5 0.7 0.6 
NOE violations (>0.5Å) 0 0 0 
PROCHECK (all) Z-score -0.3 -0.95 -0.47 
 
Table 4. Structure statistics for Cit 1.1, AMP-003, and AMP-016. 
 
 
Figure 2. The ensemble of the lowest energy, water refined structures of (A) Cit 1.1, (B) 
AMP-003, and (C) AMP-016. Peptide ribbon structures for (D) Cit 1.1, (E) AMP-003, 
and (F) AMP-016 with binned amide proton temperature titration data according to 
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the ΔH ranges 0  to -0.05 (minor chemical shift, yellow), -0.05 to -0.25 (intermediate 
chemical shift, orange), and -0.25 to -0.45 (major chemical shift, red). NOE connectivity 
plots for (G) Cit 1.1, (H) AMP-003, and (I) AMP-016. Weights of the connectivities are 
normalized to the NOE intensities.  
   
The resulting NMR structures indicate that the Cit 1.1, AMP-003, and AMP-016 peptides 
adopt a head to tail helical dimer (Figure 2D-F). The head-to-tail orientation of the 
peptides was confirmed by the presence of NOEs from Leu2 of strand A to Ile13/Leu16 
of strand B. These long-range structural restraints are only possible for a head to tail 
dimer. Of particular note, a significant number of NOEs exist at the N-terminus (Figure 
2G, I), which is consistent with the presence of both an α- and 310-helix for the 
biologically active peptides (Cit 1.1 and AMP-016). It is possible that the peptides adopt 
both conformations (or are in equilibrium) when bound to a SDS micelle. In this case, the 
NMR structure would simply represent an overall average of the conformational 
exchange. Importantly, the inactive AMP-003 lacks a similar NOE pattern (and number 
of NOEs) at the N-terminus and, thus, it exclusively adopts an α-helical structure (Figure 
2H). Since the only difference between Cit 1.1 and AMP-003 is the N-terminal 
acetylation, this clear difference in helix composition between the peptides is due to the 
acetylation.  
Amide proton temperature titrations up to 70
o
C were performed on the three peptides to 
characterize helical stability (Figures S1-3). The titration data was binned according to 
the relative magnitude of the HN chemical shift changes (ΔHN): minor (0 to -0.05, 
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yellow), intermediate (-0.05 to -0.25, orange), and major (-0.25 to -0.45, red). The 
peptide ribbon diagrams in Figure 2D-F are colored based on these HN chemical shift 
changes in order to qualitatively assess the thermal stability of the helices. Amino acid 
residues exhibiting major chemical shift changes upon heating are transitioning from a 
stable and structurally-ordered state to a disordered and unstructured state. Conversely, 
residues with relatively unchanged chemical shifts are likely already in a transiently 
disordered state at room temperature. 
 The peptides were titrated with gadolinium-diethylenetriamine pentaacetic acid (Gd-
DTPA) and monitored by NMR to identify the solvent exposed residues while the peptide 
was bound to SDS micelles (Figure S4-6). The addition of a paramagnetic species will 
reduce the NMR signal intensity for residues in contact with the solvent proportionally to 
the amount of the added paramagnetic species. Upon the addition of Gd-DTPA, the 
majority of the amino acids exhibited an approximate linear decrease in peak intensity 
regardless of location in the dimer structure. This is most likely due to multiple binding 
sites for Gd-DTPA on each peptide, an aggregation of the peptides along the surfaces of 
the micelles, and a dynamic association/dissociation of the dimer.
40
 Leu2 in Cit 1.1 and 
AMP-016 was an exception to this general observation. The NMR peak intensity for 
Leu2 increased, at first, with the addition of Gd-DTPA. Of note, the peak intensity for 
Leu2 was relatively weak compared to the other residues (Figure 1D), which is 
suggestive of a high exchange rate and/or a transiently disordered structure.  
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4.3.5 Transmission Electron Microscopy (TEM), Scanning Electron Microscopy 
(SEM) and Atomic Force Microscope (AFM) imaging 
Treatment of S. aureus and E. coli with AMP-016 lead to membrane disruption 
accompanied by the formation of distinct vesicle-like structures budding as seen by SEM, 
TEM, and AFM (Figures 3, 4A-D).  
 
 
Figure 3. SEM Micrograph of (A) E. coli (control) (B) E. coli (treated) (C) S. aureus 
(control) (D) S. aureus (treated). TEM Micrograph of (E) E. coli (control) (F) E. coli 
(treated) (G) S. aureus (control) (H) S. aureus (treated). For both TEM and SEM, bacteria 
(10
6
 CFU) were treated with AMP-016 (6uM) for 30 mins.  
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Figure 4. AFM Micrograph of (A) E. coli (control) (B) E. coli (treated) (C) S. aureus 
(control) (D) S. aureus (treated). Young’s Modulus of (E) E. coli (F) S. aureus. Adhesion 
forces of (G) E. coli (H) S. aureus. Young’s modulus and adhesion forces are presented 
as mean±SD and were collected over 50 randomly selected points. Statistical significance 
was determined by Student’s t-test. P < 0.05 was considered to be statistically significant. 
The bacterial cells were first imaged and the mechanical properties were subsequently 
determined from the same samples. Bacteria at 10
6
 CFU were treated with AMP-016 
(6uM) for 30 mins.  
 
4.3.6 Stiffness of Bacterial Membrane by AFM Nano-Indentation 
Untreated E. coli membrane was found to have a Young’s modulus of about 17.6 GPa, 
which reduced to only 4.7 GPa upon AMP-016 treatment, a 3.7-fold reduction in stiffness 
(Figure 4E, G). Young’s modulus of S. aureus reduced from 700 MPa to 160 MPa, a 4.4-
fold reduction in membrane stiffness (Figure 4F, H). Previous AFM nano-indentation 
studies on E. coli have yielded stiffness values ranging between 200 MPa and 3.700 
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GPa.
41, 42
 Although our reported values are higher, these variations might result from 
differences in bacterial strains, sample processing, or the state of the cells at the time of 
the study (vegetative vs spore).
43, 44
 
 
4.3.7 Fluorescein Isothiocyanate (FITC) Uptake Kinetics 
Membrane disruption causes cellular internalization of FITC and an associated decrease 
of fluorescence intensity outside the bacterial cells.
45
 Thus, a correlation between an 
increase in antimicrobial activity and the rate and extent of FITC uptake is expected for 
active Cit 1.1 analogs.  AMP-012, -013, and -016 peptides exhibited a greater rate and 
extent of FITC uptake when compared to Cit 1.1 (Figure 5A).  
 
 
Figure 5. A) FITC uptake kinetics of AMPs. E. coli (10
6
 CFU) was treated with AMPs 
(2X MIC) for 240 mins and the percent decrease in fluorescence was determined. The 
data are presented as mean percent of the initial fluorescence. B) Membrane 
internalization kinetics of AMPs. E. coli (10
6
 CFU) was treated with the AMPs and 
incubated for 240 mins. Data are presented as mean percent of initial fluorescence. 
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Untreated control (black), Cit 1.1 (red), AMP-003 (green) AMP-012 (turquoise), 
AMP-013 (purple), AMP-016 (blue). 
 
4.3.8 AMP Internalization Kinetics 
Treatment of E. coli with AMP-012, -013, or -016 resulted in a significant decrease in 
fluorescence when compared to Cit 1.1 (Figure 5B). This is consistent with the 
observation that AMP-012, -013, and -016 displayed a similar or higher antimicrobial 
activity relative to Cit 1.1 (Table 2). Minimal internalization was observed with AMP-
003, which corresponds with its lower antibacterial activity. Introduction of tryptophan or 
arginine residues into Cit 1.1 appears to increase the rate of membrane binding or the 
affinity of the peptide dimer to the membrane.  
 
4.3.9 In-vivo Efficacy Study 
In vivo efficacy of the most active compound, AMP-016, was determined in a wax moth 
model for staphylococcal infection due to its maximum activity. The AMP-016 treated 
group displayed a comparable survivability to the vancomycin treated group at a dose of 
15 mg/kg (Figure 6).  
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Figure 6: In-vivo survival analyses of G. mellonella larva following S. aureus infection 
and drug treatment. Larvae were infected with a S. aureus suspension (1.5×10
7
 CFU). 
The larvae were then treated with AMP-016 (15 mg/kg) and vancomycin (15 mg/kg), 2 
hr post-infection. A log rank test for trend was performed to determine the statistical 
difference of the curve (p = 0.017). 
 
4.4 Discussion 
4.4.1 Antimicrobial Activity 
Helical AMPs have been extensively studied as potential antimicrobial candidates for 
topical and systemic uses; and utilized as the antimicrobial component of anti-biofouling 
surfaces. However, little attention has been given towards the structural determinants of 
AMP activity beyond properties such as charge, helicity and hydrophobicity. To this end, 
we have rationally designed analogs of the Cit 1.1 AMP to look beyond conventional 
factors thought to be major determinants of antibacterial activity. The N-terminus of 
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AMPs tend to be polar or ironic, which is likely to play a key role in membrane 
interactions.
13
 For example, a number of helical AMPs contain either a glycine, a 
positively charged residue (Arg, Lys) or a polar residue (Ser, Asp, Gln) at the N-terminus 
(e.g., magainin-2, pexiganan, thanatin, esculetin). In effect, all of these helical peptides 
have an exposed N-terminal amine which are capable of forming hydrogen bonds and are 
known to participate in electrostatic interactions with negatively charged bacterial 
membranes. However, the actual role of the N-terminus in AMP activity or the nature of 
its potential interaction with the membrane remains unclear. To understand the potential 
importance of electrostatic interactions with the N-terminus of AMPs, several Cit 1.1 
analogs were synthesized with various modifications at the N-terminus. The AMP-002 
analog, in which Gly1
 
was replaced with a methyl glycine, exhibited comparable activity 
to Cit 1.1 against S. aureus and E. coli. However, the activity of AMP-002 against K. 
pneumoniae was completely abolished. The methylation of a primary amine changes the 
lipophilicity at the N-terminus. Thus, the reduction of activity due to the Sar substitution 
also suggests multiple H-bond donors may be needed at the N-terminus of AMPs for full 
activity. This is also consistent with the observation that the AMP-003 analog, which is 
acetylated at the N-terminus, was completely inactive. Acetylation of amines alters the 
pKa and the isoelectric point of a peptide while also reducing the net charge of the 
peptide.
46
 In effect, the acetylation eliminated the ability of the N-terminus of the AMP-
003 to hydrogen bond with the membrane.  
 To further investigate the importance of the primary amine on Cit 1.1 activity, the N-
terminus was converted into a quaternary amine (AMP-004). This modification was 
expected to have two distinct and positive impacts on Cit 1.1 activity. First, a permanent 
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positive charge was incorporated into the Cit 1.1 structure that cannot form a 
hydrogen bond. The role of a resident positive charge in the activity of many 
antibacterials is well established.
47-49
 Second, the quaternary amine makes AMP more 
resistant to proteolysis.
50
 Improved antimicrobial activity would be expected if the 
peptide is stabilized and has a longer bioavailability. Thus, based on previous 
observations, AMP-004 was expected to exhibit a better activity than Cit 1.1. 
Unexpectedly, AMP-004 was observed to be inactive against all tested bacterial strains. 
This indicates that a positive charge on the N-terminal amine is not sufficient to interact 
with the negatively charged bacterial membrane. Similarly, replacing Gly1 with a 
hydrazine group resulted in the complete loss of antibacterial activity for the AMP-005 
analog. Hydrazines have a lower pKa (~8.3) than amines (~9.6), which is further lowered 
when near an electron-withdrawing group.
51, 52
 As a result, the alkylated hydrazine 
nitrogen is likely not protonated (note that the alkylated nitrogen is the most likely site of 
protonation
53
) under the conditions of the MIC assay. Furthermore, an internal hydrogen 
bond may form between the hydrogen on the hydrazine and the amide carbonyl. In 
addition to preventing a hydrogen bond with the bacterial membrane, this internal 
hydrogen bond may also affect the overall peptide structure and alter its biological 
activity. The inactive AMP-003, AMP-004 and AMP-005 analogs clearly emphasize the 
importance of the N-terminus in AMP activity and the potential critical role that 
hydrogen bonds play in the interaction with the bacterial membrane.  
In addition to the N-terminal amine, most AMPs contain two or more ionizable amino 
acids such as Lys and Arg. It is widely recognized that Lys and Arg side-chains are 
positively charged at biological pH (6.9 to 7.4), which allows for a potential electrostatic 
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interact with the bacterial membrane. This important structural feature has also led to 
the alternative common name for AMPs of cationic antibacterial peptides, which 
emphasizes the peptides charge over other properties essential to activity. Accordingly, 
several modifications to Cit 1.1 were made to evaluate the role of these charged residues 
to antibacterial activity. Lys7 and Lys8 were replaced with progressively shorter amine 
bearing sidechains: ornithine (Orn), 2,4-diaminobutyric acid (Dab), and 2,3-
diaminopropionic acid (Dpr). Orn, Dab, and Dpr are successively one methylene shorter. 
Replacing the two Lys with Orn (AMP-006) resulted in a peptide with a 2.5-fold decrease 
in the MIC value against S. aureus (25 µM), and a 1.7-fold decrease against E. coli (15 
µM). The activity against K. pneumoniae remained unchanged (30 µM) relative to Cit 
1.1. The Dab (AMP-007) and Dpr (AMP-008) substitutions
 
resulted in complete loss of 
antibacterial activity (>50 µM). These findings suggest the –NH3
+
 moiety or the longer 
side-chain of Lys is necessary for membrane interaction and the antibacterial activity of 
Cit 1.1.  Another possibility is that the decrease in –CH2 units results in a lower 
hydrophobicity. This is supported by the shorter HPLC retention times for Orn, Dap and 
Dpr (16.44 to 16.86 mins.) compared to Cit 1.1 (17.48 min). This finding suggests that 
the incorporation of lysine analogs with longer side-chains may enhance the antibacterial 
activity of AMPs. 
To further explore the relative contribution of the electrostatic interaction and hydrogen-
bond formation by the Lys side chain to Cit 1.1 activity, the Lys residues were 
methylated (AMP-010 and AMP-011) to produce analogs that still contain a positive 
charge. Unexpectedly, and despite having a permanent +3 charge, both AMP-010 and 
AMP-011 were found to be inactive. Increasing the methyl substitution of the lysine side 
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chain amine has been found to produce a less favorable cation-π stacking interactions 
in terms of energy and geometry.
54
 This observation raises the possibility that a crucial 
cation-π stacking interaction exists between a lysine side chain and the phenylalanine at 
position 3. Additionally, it is possible that the inability of the lysine -NH2 to form a 
hydrogen bond with the bacterial membrane might be the cause of the peptide’s 
inactivity.  
Arginine-rich peptides have been previously shown to exhibit potent antibacterial 
activity.
55-57
 In fact, a number of studies have indicated that an increase in arginine versus 
lysine content has resulted in enhanced antimicrobial activity.
58-64
 Nevertheless, others 
have observed a deviation from this arginine-to-lysine enrichment rule.
65-68
 It appears that 
a “sweet spot” exists in the choice of arginine or lysine based on hydrophobicity, 
hydrophobic ratio, secondary structure, and isoelectric point. To investigate this issue, a 
Cit 1.1 analog (AMP-012) was constructed where Lys7 and Lys8 were replaced with an 
arginine. An AMP-013 analog was also constructed that only replaced Lys7 with an 
arginine. The MICs for both AMP-012 and AMP-013 decreased 2-fold against S. aureus 
(5 µM). The increase in antimicrobial activity may be explained by an enhanced 
translocation of peptides within the microbial cells.
58, 60, 69-71
 However, the potency of 
AMP-012 and AMP-013 against gram-negative organisms was mixed. AMP-013 
exhibited a 1.7-fold higher activity against E. coli (15 µM) compared to both Cit 1.1 and 
AMP-012. Conversely, all three peptides exhibited the same activity against K. 
pneumoniae (30 µM). To further explore the importance of Lys or Arg to Cit 1.1 activity, 
an AMP-009 analog was constructed in which Lys7 was replaced with a citrulline, which 
is a structural mimic of arginine, but contains a urea functional group instead of the 
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charged guanidium group. The citrulline substitution resulted in a complete lack of 
antibacterial activity for AMP-009, further establishing the importance of a Lys at 
position 7 in the activity of Cit 1.1. Although the citrulline urea group is capable of 
hydrogen bond formation, its side chain is uncharged. Accordingly, the citrulline 
substitution reduces the net charge of AMP-009 to only +1. This suggests that the overall 
net charge of the peptide may also contribute to the antimicrobial activity of AMPs.  
Previous studies have shown that Cit 1.1 adopts an α-helical conformation, but there has 
also been some debate about the exact details of the Cit 1.1 structure. Instead of a single 
-helical chain, two helices separated by a β-turn has been suggested for the Cit 1.1 
structure.
15
 To address this possibility, a glycine residue was inserted into the Cit 1.1 
sequence following Lys8 to create the AMP-014 analog. The insertion of Gly9
 
was 
expected to provide added flexibility to the peptide
72
 and potentially enhance its activity 
if the two  helix model was correct. AMP-014 was observed to be inactive against all of 
the bacterial strains tested and suggests the two helix model for Cit 1.1 may be incorrect. 
Nevertheless, it is important to note that the Gly insertion does lengthen the peptide and 
shifts the sequence beyond Lys8. The sequence shift does affect the amino acids found on 
each Cit 1.1 surface (Figure 7). Thus, the loss in activity may also be explained by an 
interruption in the hydrophilic α-helix surface, which leads to a disruption in membrane 
binding. Of course, if the Cit 1.1 structure is comprised of two -helices separated by a 
flexible link, then the added flexibility of the inserted Gly would allow enough mobility 
for the correct surface of the -helices to interact with the membrane.  
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Figure 7. Alpha helical properties and position of the amino acid residues were predicted 
using the Heliquest online analysis tool.
22
 
 
Tryptophan-rich peptides have also been shown to enhance the activity of AMPs.
55, 56, 73
 
Thus, the potential impact of incorporating a tryptophan into the Cit 1.1 peptide was also 
investigated. The AMP-016 analog was constructed where Phe3 was replaced with a Trp. 
The AMP-016 analog exhibited the best antibacterial activity against both S. aureus (3 
µM) and E. coli (3 µM) relative to Cit 1.1 and the other analogs. This corresponded to 3-
fold and 8-fold increase in activity, respectively. The activity against K. pneumoniae was 
the same as Cit 1.1 (30 µM). The indole ring in tryptophan is likely acting as a better 
anchor to the bacterial membranes than the smaller phenyl ring.
73
 Biologically active 
AMP-001 AMP-012 AMP-013 
AMP-014 AMP-015 AMP-016 
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tryptophan-rich peptides typically have multiple tryptophan residues. Therefore, the 
dramatic increase in antimicrobial activity following such a modest change was 
remarkable and unexpected.  
The remaining Cit 1.1 analog AMP-015 was constructed with a modest substitution of a 
Glu for Asp4. As expected, this substitution retained an activity comparable to Cit 1.1 
against S. aureus and E. coli, but the activity against K. pneumoniae was completely lost. 
Given the similarities between the peptides, an explanation for this observation is not 
apparent at this time.  
 
4.4.2 NMR Spectroscopy 
Cit 1.1, AMP-003, and -016 were analyzed by NMR to elucidate the relationship between 
structure and antimicrobial activity. Interestingly, Figure 1C indicates that the largest Hα 
chemical shift difference between the three peptides occurs at the N-terminus between 
residues Asp3 and Lys7. Although the dissimilarity between AMP-016 and Cit 1.1/AMP-
003 can be attributed to the tryptophan substitution at position 3, the minor deviation of 
Asp4 is likely a result of the acetylation of the N-terminus. In the case of AMP-016, the 
steric and electronic effects from the indole side chain are likely to increase the local 
flexibility at position 3 and potentially lead to a significant decrease in helicity. N-
terminal acetylation does not induce any significant effect on the overall helicity of 
AMP-003 except for a slight decrease at Asp4. The removal of the charged N-terminus 
may slightly change the polarity or the hydrogen-bond network around Asp4 that may 
contribute to a decrease in helicity. Figure 1D shows the overlay of the Hα region of the 
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2D TOCSY for the three peptides. The significant chemical shift differences of the N-
terminal residues highlight a changing local environment for residues 3 to 7 that is likely 
a result of minor alterations in the structure of the three peptides. Accordingly, these 
subtle changes in the peptide’s structure may be directly related to differences in 
antimicrobial activity. 
Our NMR derived structures for Cit 1.1, AMP-003, and -016 differ significantly from the 
previous results of Sikorska et al. that describe the presence of two helices separated by a 
β-turn.23 Experimentally determined NOEs were found along the full length of each of 
the peptides and (Figure 2G-I) and between the helices in a dimer orientation. Although 
the Cit 1.1, AMP-003, and AMP-016 dimers are not completely superimposable, there 
are no major structural differences between the three peptide structures that appear to 
explain the difference in activity. In all cases, the dimers pack together along a 
hydrophobic face, which then exposes charged residues to the solvent. Consequently, the 
peptides’ NMR structures are consistent with the prior observation that the number and 
distribution of hydrophobic residues is crucial for antimicrobial activity.
74
 Increasing 
peptide hydrophobicity increases antimicrobial activity, but only if the overall 
hydrophobicity remains below an optimal upper threshold. If too many hydrophobic 
residues are inserted into the peptide sequence then unintended peptide aggregation 
occurs, which leads to a loss in activity. Therefore, the Cit 1.1 peptide must maintain a 
hydrophobic surface to allow for a stable dimer in order to carpet a bacterial cell 
membrane, but to also avoid the formation of inactive aggregates. This, however, does 
not explain the differences in activity between the active (Cit 1.1/AMP-016) and inactive 
(AMP-003) peptides since all the peptides form a similar head-to-tail dimer. Instead, the 
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primary difference between the active and inactive peptide dimers is the N-terminal 
acetylation. 
Acetylation of the N-terminus in Cit 1.1 most likely changes the polarity and hydrogen 
bond network near the modification site, which appears to have a profound effect on 
antimicrobial activity. It has been previously observed that N-terminal acetylation 
increases the propensity of α-helix formation in peptides regardless of the amino acid 
sequence.
75
 N-terminal acetylation also increases the overall stability of an α-helix. In the 
case of Cit 1.1, the apparent increase in helical stability due to acetylation resulted in a 
loss of activity. Consequently, antimicrobial activity may be correlated with a certain 
amount of structural disorder or mobility within the peptide. This is consistent with a 
mechanism previously observed for α-synuclein. N-terminal acetylation increased the 
helical propensity of α-synuclein and substantially decreased protein aggregation.76, 77 
Thus, the antimicrobial activity of Cit 1.1 may likely depend on an equilibrium between a 
disordered monomer in solution and helical dimers coating the membrane surface. In the 
presence of bacteria, the equilibrium shifts from disordered monomer to the helical 
dimer. The dimer is then able to associate with other dimers on the membrane surface and 
promote antimicrobial activity through a proposed carpet mechanism. However, if the 
peptide is stabilized in solution than the equilibrium is shifted away from interacting with 
the bacterial membrane and the antimicrobial activity is abolished. We hypothesize that 
Cit 1.1 exists as a disordered monomer in solution and dimerizes and aggregates along 
the anionic surface of the bacterial membrane. In the inactive form, the N-terminal 
acetylation stabilizes the transiently formed monomer α-helix in solution and the 
aggregation on the membrane surface, which promotes antimicrobial activity, is greatly 
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diminished. Again, the observation that the inactive AMP-003 dimer is exclusively α-
helical and the Cit 1.1/AMP-016 dimers are a mixture of α- and 310-helix is supportive of 
the proposal that helix stability affects antimicrobial activity.  To further investigate the 
role of α-helical stability in regards to antimicrobial activity, NMR was used to measure 
the thermal stability and solvent accessibility of the Cit 1.1, AMP-003, and AMP-016 
peptides. 
The temperature-dependent chemical shift changes clearly define the dimer interface as 
the residues with the largest ΔHN values (Figures 2D-F, S1-3). The residues in the dimer 
interface correspond to: Ile6, Val9, Ala10, Ile13, and Gly14. Importantly, the inactive 
AMP-003 peptide exhibited the smallest HN chemical shift changes for these residues. 
This suggests the inactive AMP-003 is relatively less stable as a dimer in the SDS micelle 
compared to the active peptides. Interestingly, there are additional AMP-003 residues 
outside of the dimer interface that also exhibit a temperature-dependent chemical shift 
change. This was not observed for the Cit 1.1 or AMP-016 peptides. One possible 
explanation for this difference is that the AMP-003 peptide still maintains an α-helical 
structure as a monomer, which undergoes further temperature-dependent denaturation. 
This does not appear to occur for Cit 1.1 or AMP-016. In fact, more residues in the Cit 
1.1 peptide compared to AMP-003 are disordered based on the lack of a temperature-
dependent chemical shift change. This further suggests that a certain amount of structural 
disorder or dynamics is necessary for antimicrobial activity. 
The presence of a helical dimer is also suggested by the Gd-DTPA titration experiments. 
At low concentrations of Gd-DTPA, the amide peak intensity for Leu2 was found to 
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increase, which indicates a reduction in the chemical exchange with the solvent. It is 
plausible that the coordination of Gd-DTPA by the active peptides stabilizes the dimer 
structure and reduces the amide chemical exchange of Leu2 causing an initial sharpening 
of the peak. Only at higher Gd-DTPA concentrations does the Leu2 NMR resonance 
broaden like the other amino acid residues. This effect is not seen in the inactive peptide 
(AMP-003), suggestive of a more stable α-helix along the entirety of the peptide 
monomer. 
 
4.4.3 Transmission Electron Microscopy (TEM), Scanning Electron Microscopy (SEM) 
and Atomic Force Microscope (AFM) 
Bacterial membrane disruption can be described either by the worm-hole, the barrel-
stave, or the carpet model.
78, 79
 Previously reported data on the Cit 1.1 interaction with 
negatively charged lipid vesicles hinted towards involvement of the carpet mechanism.
14
 
In the carpet-model of membrane disruption, the AMPs bind parallel to the membrane 
and cover the entire surface. This causes cell membrane permeation and eventually 
release of small vesicles from the membrane.
78, 79
 A separate study involving giant 
unilamellar vesicles (GUVs) corroborated the carpet mechanism shown in the previous 
studies.
72
 However, these prior studies relied on negatively charged phospholipid model 
membranes, which are structurally simple compared to bacterial membranes. These 
model membranes do not accurately represent the complexity of single or double-
membraned gram-negative organisms. Furthermore, these studies relied on indirect 
fluorometric observations instead of direct microscopic imaging.
14, 78
 Treatment of S. 
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aureus and E. coli with AMP-016 lead to membrane disruption accompanied by the 
formation of protruding blebs as visualized by SEM, TEM, and AFM (Figures 3, 4A-D). 
Previous electron micrographs of S. aureus showed discontinuous membrane surfaces 
that did not conform to any of the prevailing modes of membrane disruption,
31, 78
 The 
absence of blebs in the prior studies is most likely due to damaged membrane architecture 
caused during cell-sectioning. 
The carpet mechanism of membrane disruption is commonly associated with detergent-
like antibacterials displaying indiscriminant cell lytic properties. It has been also 
suggested that peptides acting by this mechanism do not require a specific peptide 
structure.
11
 Contrary to these beliefs, we have shown that even those AMPs that disrupt 
membranes in a detergent like fashion are highly sensitive to subtle structural 
modifications. A human host defense peptide, LL-37, has also been shown to disrupt 
membranes following the “carpet model”.80 However, their innocuous presence within 
human bodies illustrates a high selectivity between prokaryotic and eukaryotic cells.  
 
4.4.4 Stiffness of Bacterial Membrane by AFM Nano-Indentation 
Although AMPs are widely thought to disrupt bacterial membranes, few studies exist that 
have investigated their influence on bacterial membrane stiffness. Consequently, little is 
known about the mechanical properties of the disrupted membrane. AMP-006 treatment 
lowered the membrane stiffness by four-fold in both gram-positive and gram-negative 
bacteria. Based on the electron micrographs from this study and those from others, 
membrane disruption appears to be a strictly localized phenomenon occurring at specific 
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points of the membrane. However, the highly narrow standard deviation of the 
Young’s modulus indicates the uniformity with which membranes were disrupted over 
the entire cell. Thus, we conclude cell membrane softening occurred globally in the 
bacterial membrane. As previously stated, Cit 1.1 appears to disrupt membranes by the 
carpet model, requiring peptide molecules to bind parallel to the bacterial membrane and 
then inserting a hydrophobic face into the membrane to cause a disruption.
31
 This would 
require the AMPs to cover the entire bacterial surface, which most likely explains the 
global reduction in membrane stiffness on AMP treatment even though we observe only 
localized features of disruption in the form of blebs and leakage. 
AMP mediated membrane softening however, has greater implications in augmenting 
bacterial chemotherapy and overcoming drug resistance. It has been recently shown that 
disruption of the outer membrane of E. coli by pentamidine facilitates overcoming drug 
resistance in gram-negative bacteria.
81
 Pentamidine, however, requires a much higher 
concentration (25 μM) of drug to disrupt the outer membrane. AMP-016 on the other 
hand, not only disrupts both the outer and inner membrane at a concentration 5 times 
lower than pentamidine, it also lowers the membrane stiffness about four-fold on average 
in both gram-positive and gram-negative bacteria (Figure 4E-H). Depletion of factors 
which are responsible for maintaining membrane fluidity have been shown to reduce 
membrane stiffness.
82
 Others have shown that altered membrane stiffness has a profound 
influence on cell channel functions.
83
 Reduced membrane fluidity has been a prime 
mechanism for acquiring drug resistance.
84, 85
 Therefore, AMP mediated lowering of 
membrane rigidity may be an attractive means of facilitating drug penetration and 
overcoming resistance. 
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4.4.5 AMP Internalization Kinetics 
The rate of membrane internalization was used to measure the relative interaction of Cit 
1.1 analogs with bacterial membranes by monitoring changes in peptide fluorescence. 
Aromatic groups like phenylalanine and tryptophan may anchor a peptide into the 
bacterial membrane,
73
 where the insertion of the side chain is expected to lead to 
fluorescence quenching. Treatment of E. coli with AMP-012, -013, or -016 resulted in a 
significant decrease in fluorescence when compared to Cit 1.1 (Figure 5B). This is 
consistent with the observation that AMP-012, -013, and -016 displayed a similar or 
higher antimicrobial activity relative to Cit 1.1 (Table 2). Introduction of tryptophan or 
arginine residues into Cit 1.1 appears to increase the rate of membrane binding or the 
affinity of the peptide dimer to the membrane. These findings may be explained by the 
ability of arginine and tryptophan to allow the Cit 1.1 analogs to penetrate deeper into the 
bacterial membrane.
86
  
 
4.4.6 FITC Uptake kinetics 
Membrane disruption caused cellular internalization of FITC and an associated decrease 
of fluorescence intensity outside the bacterial cells.
45
 Thus, a correlation between an 
increase in antimicrobial activity and the rate and extent of FITC uptake is expected for 
active Cit 1.1 analogs.  AMP-012, -013, and -016 peptides exhibited a greater rate and 
extent of FITC uptake when compared to Cit 1.1 (Figure 5A). Again, this is consistent 
with the increased rate of membrane internalization (Figure 5B) and the relative increase 
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in antimicrobial activity (Table 2) of these peptides. Thus, the arginine and 
tryptophan modifications to Cit 1.1 appear to induce greater membrane damage compared 
to the wild-type peptide. These results are consistent with prior observations that arginine 
and tryptophan-rich peptides enhance antibacterial activity by imparting greater amount 
of damage to the cell membrane.
55-57
  
 
4.4.7 In-vivo efficacy study 
In vivo efficacy of the most active compound, AMP-016, was determined in a wax moth 
model for staphylococcal infection. Cit 1.1 has been shown to have a protective effect 
against both gram-negative and gram-positive bacteria in in-vivo models of sepsis.
87, 88
 
The AMP-016 treated group displayed comparable survivability to the vancomycin 
treated group at a dose of 15 mg/kg. AMP activity is often diminished in the presence of 
salts and serum, which are major obstacles to successful translation to a clinical trial.
89, 90
 
Our results (Figure 6) indicate that AMP-016 activity is not sensitive to physiological salt 
or serum proteins and holds significant potential as a new antimicrobial treatment.  
 
4.5 Conclusion 
Using finely tuned Cit 1.1 analogs, we have probed the various interactions essential for 
membrane disruption and antibacterial activity of helical AMPs. Cationic N-terminal 
residues form crucial hydrogen bonds that were found to be indispensable for 
antibacterial action. Ablation of either the hydrogen bond donors or the positive charge 
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resulted in inactivity, which suggests hydrogen bonding and electrostatic interactions 
synergistically cooperate in membrane disruption. We further discovered that the 
projection of lysine side chains were essential to antibacterial activity. A shortening of 
the side chain and corresponding reduction of the amine projection led to decreased 
activity against all tested bacterial strains. Increased bulk of the hydrophobic anchor was 
found to have the most pronounced influence on the AMPs. Mutation of Phe3 to a Trp 
produced a peptide with significantly increase antimicrobial activity. NMR studies 
revealed the propensity of AMPs to form head to tail dimers on the surface of anionic 
membranes and bacterial surfaces. Both NMR and CD spectroscopy show a positive 
correlation between a-helicity of the AMPs and their antibacterial activity. Further, 
equilibrium between a disordered monomer and the helical dimer structures was 
proposed that supports the carpet model of membrane disruption. This was subsequently 
confirmed by electron microscopy in both gram-positive and gram-negative bacteria. 
Fluorometric studies revealed increased internalization of the AMPs and FITC, which 
further supports membrane disruption. AFM nano-indentation showed a four-fold global 
reduction membrane rigidity upon AMP treatment. Reduction in membrane rigidity has 
far-reaching implications for augmenting antibacterial therapeutics and in overcoming 
drug resistance by using AMPs as part of multidrug therapy. 
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4.7 Supplemental Figures 
 
Figure S1. Temperature titration data for Cit 1.1. The change in the amide proton 
chemical shift (ΔH) was monitored as a function of temperature. Labels are found right of 
the graph and follow the peptide sequence in order. The largest changes in chemical 
shifts correspond to stable amino acids becoming disordered at elevated temperature. 
Coloring corresponds to binned amide proton temperature titration data according to 
the ΔH ranges 0  to -0.05 (minor chemical shift, yellow), -0.05 to -0.25 (intermediate 
chemical shift, orange), and -0.25 to -0.45 (major chemical shift, red). 
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Figure S2. Temperature titration data for AMP-003. The change in the amide proton 
chemical shift (ΔH) was monitored as a function of temperature. Labels are found right of 
the graph and follow the peptide sequence in order. The largest changes in chemical 
shifts correspond to stable amino acids becoming disordered at elevated temperature. 
Coloring corresponds to binned amide proton temperature titration data according to 
the ΔH ranges 0  to -0.05 (minor chemical shift, yellow), -0.05 to -0.25 (intermediate 
chemical shift, orange), and -0.25 to -0.45 (major chemical shift, red). 
 
  
147 
 
Figure S3: Temperature titration data for AMP-016. The change in the amide proton 
chemical shift (ΔH) was monitored as a function of temperature. Labels are found right of 
the graph and follow the peptide sequence in order. The largest changes in chemical 
shifts correspond to stable amino acids becoming disordered at elevated temperature. 
Coloring corresponds to binned amide proton temperature titration data according to 
the ΔH ranges 0  to -0.05 (minor chemical shift, yellow), -0.05 to -0.25 (intermediate 
chemical shift, orange), and -0.25 to -0.45 (major chemical shift, red). 
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Figure S4: Gd-DTPA titration of Cit 1.1. The intensities of the amide proton peaks for 
each amino acid were monitored upon titration with Gd-DTPA at the listed 
concentrations. Intensities for each peak (I(x)) are normalized to the corresponding peak in 
the initial spectrum (I(0)). 
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Figure S5: Gd-DTPA titration of AMP-003. The intensities of the amide proton peaks 
for each amino acid were monitored upon titration with Gd-DTPA at the listed 
concentrations. Intensities for each peak (I(x)) are normalized to the corresponding peak in 
the initial spectrum (I(0)). 
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Figure S6: Gd-DTPA titration of AMP-016. The intensities of the amide proton peaks 
for each amino acid were monitored upon titration with Gd-DTPA at the listed 
concentrations. Intensities for each peak (I(x)) are normalized to the corresponding peak in 
the initial spectrum (I(0)). 
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Chapter 5 
The NMR Solution Structure and Function of RPA3313: A Putative 
Ribosomal Transport Protein from Rhodopseudomonas palustris 
5.1 Introduction 
Rhodopseudomonas palustris is a unique organism known for its metabolic diversity and 
extensive distribution throughout the environment.
1
  It has the ability to grow under four 
distinct modes of metabolism (photoautotrophic, photoheterotrophic, chemoautotrophic, 
and chemoheterotrophic) on a wide assortment of carbon sources. R. palustris is typically 
found in soil and freshwater sources, but has also been discovered  in swine waste and 
coastal sediments.
2
 As a purple non-sulfur photosynthetic bacterium, it belongs to the 
alphaproteobacterium order.
3
  Within this order exists many species which are similarly 
metabolically versatile, yet there are clear phylogenetic differences. In fact, based on 16S 
rRNA sequencing the inherent divergence in the order is not based on phototrophic 
ability but rather demonstrates a mixing of phototrophs and non-phototrophs.
3
 R. 
palustris is of particular biotechnological interest because it utilizes aromatic 
hydrocarbons as a carbon source under both aerobic and anaerobic growth conditions. 
Also, R. palustris fixes more nitrogen when grown on aromatic hydrocarbons relative to 
aliphatic substrates.
4
 Furthermore, growth of the organism can occur on aromatic 
substrates containing a range of functional moieties. The combination of all of these 
factors makes R. palustris a model organism for bioremediation, energy production, and 
other biotechnological applications.
5-9
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In 2004, the genome of R. palustris was sequenced and published along with a 
prediction of general gene functional classes.
2
 Approximately 15% of the genome is 
believed to be devoted solely to transport, which is surprising since prokaryotes usually 
commit only a third of this amount (5-10%) to transport.
10
 Nevertheless, this greater 
commitment of R. palustris to transport is consistent with its observed metabolic 
diversity. A larger assortment of transport proteins would be necessary for R. palustris to 
readily adapt to various carbon and energy sources; or to proliferate under changing 
respiration or environmental states.  Conversely, 29% of the genome has been tentatively 
labeled as hypothetical or of unknown function. An additional 8% of the genome is only 
annotated with a general function. A follow-up LC-ES-MS/MS proteomics analysis of R. 
palustris included a more detailed functional annotation based on protein sequence 
analysis.
11
 But, the percentage of functionally uncharacterized or partially annotated 
proteins remained unchanged. Of particular note, the proteome of R. palustris was 
analyzed for each metabolic mode of growth. Thus, the relative expression rates of R. 
palustris proteins under each metabolic mode of growth are known.
11
 The large fraction 
of unannotated or partially annotated R. palustris genes presents a significant obstacle for 
the further development of biotechnological applications and hinders additional 
biochemical studies. 
The R. palustris protein RPA3313 (7.45 kDa, 70 amino acids) is a hypothetical protein 
targeted for structural elucidation by the Structural Genomics Consortium at the 
University of Toronto (http://www.thesgc.org/). RPA3313 is currently classified by 
UniProtKB
12
 (Q6N4M4) as an uncharacterized protein. A BLAST search of the 
RPA3313 sequence reveals a group of 93 hypothetical yet conserved proteins (> 32% 
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identity) from only the alphaproteobacterium order (Figure 1). Unfortunately, 
minimal structural or functional information was obtained from the sequence analysis 
since no structures of homologous proteins are present in the Protein Data Bank 
(http://www.rcsb.org/).
14
  
 
 
Figure 1. (A) A neighbor-join tree of the protein BLAST results of RPA3313 against 
non-redundant protein sequences. All of the sequence hits belong the 
alphaproteobacteria order and have identities >32%. The three colored groups are 
dominated by species belonging to the genera listed next to them. The tree highlights the 
fact that this protein is a member of an unannotated and a structurally uncharacterized 
class of proteins. (B) The BLAST sequence alignment of RPA3313 with the nine other 
Rhodopseudomonas proteins. The secondary structure is indicated above the sequence 
alignment and was generated with Polyview-2D.
13
 RPA3313 is indicated in the 
phylogenetic tree and sequence alignment with a dot. 
 
RPA3313 was identified in the previously reported R. palustris proteomics study
11
 and 
was only observed to be expressed during photoautotrophic growth. Photoautotrophic 
  
154 
organisms, such as R. palustris, sequester atmospheric CO2 and convert it to energy 
rich carbon sources. Ribulose 1,5-bisphosphate carboxylase/oxygenase (RubisCO) are 
found in photoautotrophic organisms and are responsible for most of the organic carbon 
in the environment. As the most abundant protein in nature, RubisCO is found in plants, 
bacteria, and archaea in at least four molecular forms.
15
 The genome of R. palustris 
contains multiple forms of RubisCO, which further contributes to its adaptability to 
diverse environmental conditions.
16
 The combined adaptability and RubisCO activity of 
R. palustris may be beneficial to biotechnological applications involving bulk removal of 
CO2 from the atmosphere. However, the photoautotrophic mode of metabolism in R. 
palustris and other alphaproteobacteria remains relatively unknown.
17
  
Although the hypothetical protein RPA3313 has been experimentally verified as an 
expressed protein during photoautotrophic growth; the function and structure of 
RPA3313 still remains elusive. Structural approaches are a valuable alternative to 
obtaining a functional annotation when sequence similarity techniques fail and leaves a 
large class of functionally uncharacterized proteins.
18,19
 Thus, obtaining an NMR solution 
structure for R. palustris protein RPA3313 is expected to provide a better understanding 
of its general biological role and also provide a putative structure and function for the 93 
homologous proteins (Figure 1). RPA3313 forms a novel split ββαβ fold with a 
conserved ligand binding pocket. The NMR structure combined with a bioinformatics 
analysis and mass spectrometry proteomics suggest RPA3313 may assist in the 
transportation of substrates to or from the ribosome for further processing.   
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5.2 Methods 
5.2.1 Protein expression and purification 
Uniformly 
15
N and 
13
C labeled RPA3313 samples were prepared for NMR structural 
studies as follows. The target sequence for RPA3313 (70 amino acids with a 21 amino 
acid histidine tag for purification, MGSSHHHHHHSSGRENLYFQG) was expressed 
from a pRI952 with glyT construct transformed into BL21(DE3) cells.
20
 Cells were 
grown in Luria-Bertani (LB) media at 37°C until an approximate optical density (OD600) 
of 0.6 and then spun down and transferred to M9 minimal media at 37°C containing 4% 
U-
13
C glucose and 1% U-
15
N NH4Cl. Expression of RPA3313 was induced after one hour 
of equilibration in the M9 media with isopropyl β-D-1-thiogalactopyranoside (IPTG). 
Cell lysates were collected 4 hours after induction with IPTG and purified with a Co
2+ 
affinity column (HisPur Cobalt Resin, Thermo Scientific). Sample homogeneity was 
assessed by SDS-PAGE. ESI-MS and size exclusion chromatography was used to 
confirm the monomeric solution state and exact mass of RPA3313 (Supplemental Figure 
S1). The protein sample was stored in an NMR sample tube in 18 mM 2-(4-
morpholino)ethanesulfonic acid (MES) buffer with 0.01% sodium azide, 80 mM sodium 
chloride and 10% D2O at a pH of 5.6 (uncorrected).  
 
5.2.2 NMR structure determination 
All NMR experiments were collected with non-uniform sampling at 20% sparsity using a 
Poisson-gap schedule
21
 at 298K on a 700 MHz Bruker Avance III spectrometer equipped 
  
156 
with a 5 mm QCI-P probe with cryogenically cooled carbon and proton channels. 
Backbone and side-chain assignments were completed using the standard triple resonance 
approach consisting of the following experiments: 
1
H-
15
N HSQC, 
1
H-
13
C HSQC, HNCO, 
HN(CA)CO, HNCA, HN(CO)CA, CCANH, CBCA(CO)NH, HNHA, HBHA(CO)NH, 
CC(CO)NH, HCC(CO)NH, HCCH-COSY, and HCCH-TOCSY.
22,23
 Identification of 
nuclear Overhauser effects (NOEs) was accomplished with 
15
N-edited NOESY-HSQC 
and 
13
C-edited NOESY-HSQC experiments using a mixing time of 150 ms. The resulting 
data was reconstructed using multidimensional decomposition (MDD) and processed in 
TopSpin 3.2 followed by evaluation in CCPNMR Analysis.
24
 Initial model generation 
according to backbone chemical shifts was undertaken using CS-ROSETTA
25-27
 on the 
open webserver at the BMRB (https://csrosetta.bmrb.wisc.edu/).  The CS-ROSETTA 
software was only used for the creation of an initial model for RPA3313. CS-ROSETTA 
was not used to further refine the RPA3313 ensemble.  
XPLOR-NIH version 2.37 was used to refine the initial model of target RPA3313.
28,29
 
Briefly, the refinement involved 912 manually assigned NOE distance restraints, 66 
hydrogen bond distance restraints, 30 
3
JNHα coupling constants, 128 
13Cα/13Cβ chemical 
shifts, and 102 predicted dihedral angle restraints from TALOS+.
30
 1000 total structures 
were generated during the XPLOR-NIH structure refinement and the 20 lowest energy 
structures were subsequently subjected to water refinement according to the RECOORD 
conventions. The coordinate average structure for the water-refined models was further 
subjected to the same explicit water refinement method for energy minimization. The 
water-refined ensemble and average structure for target RPA3313 was analyzed with the 
PSVS software suite, which is comprised of commonly used structural validation 
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packages.
31-35
 UCSF Chimera was used for the structural visualization and surface 
representation of RPA3313.
36
  
 
5.2.3 Chemical crosslinking and in-gel digestion 
Approximately 3 hours following the induction of RPA3313 in Lysogeny broth (LB) 
media, the E. coli culture was pelleted and resuspended in crosslinking buffer (1% 
paraformaldehyde, 1X PBS, pH 8, 37°C). Crosslinking was allowed to proceed for 15 
minutes before quenching with 1.25 M glycine. The E. coli cells were lysed by sonication 
and RPA3313 with crosslinked binding partners was purified using the RPA3313 
histidine tag and a Co
2+ 
affinity column as described above in the protein purification 
section. The sample preparation procedure also efficiently removes the formaldehyde 
crosslinking. The purified proteins were then visualized by SDS-PAGE. Protein bands 
were excised before submission to the Nebraska Center for Mass Spectrometry for 
MS/MS analysis. 
Rhodopseudomonas palustris (ATCC) was propagated in a filled flask of 500 mL of 112 
medium at 30°C for several days until reaching stationary growth. Bacterial growth was 
red in color indicating that photoautotrophic had occurred. The culture was pelleted by 
centrifugation and resuspended in water prior to lysis by sonication. Extracted proteins 
were frozen and lyophilized overnight. Approximately 2 mg of pure RPA3313 was added 
to the R. palustris protein extract before the addition of crosslinking buffer. The 
crosslinking was performed similar to the E. coli crosslinking above. RPA3313 with 
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crosslinked binding partners was purified using the RPA3313 histidine tag and a Co
2+ 
affinity column as described above in the protein purification section. 
 
5.2.4 MS proteomics 
Protein bands separated with SDS–PAGE were digested in situ using a slightly modified 
version of a published method.
37
 Briefly, the samples were washed with 
100 mM ammonium bicarbonate, reduced with 10 mM DTT, alkylated with 
55 mM iodoacetamide, washed twice with 100 mM ammonium bicarbonate, and digested 
in situ with 10 ng/µL trypsin (Promega, Madison, WI, USA). Peptides were extracted 
with two 60 µL aliquots of 1:1 acetonitrile:water containing 1% formic acid. The extracts 
were dried down using a SpeedVac and then reconstituted into 15 uL of water + 0.1% 
formic acid.  Four microliters of the extract solution was injected onto a trapping column 
(300 µm × 1 mm) in line with a 75 µm × 15 cm C18 reversed phase LC column (Waters, 
Milford, MA, USA). Peptides were eluted from the column using a water + 0.1% formic 
acid (A)/ acetonitrile + 0.1% formic acid (B) gradient with a flow rate of 500 nL/min. 
The gradient was developed with the following time profile: 0 min, 5% B; 5 min, 5% B; 
35 min, 35% B; 40 min, 45% B; 42 min, 60% B; 45 min, 90% B; 48 min, 90% B; and 
50 min, 5% B. 
The eluting peptides were analyzed using a Synapt G2S Q-TOF tandem mass 
spectrometer (Waters, Milford, MA, USA) with electrospray ionization. Analyses were 
performed using data-dependent acquisition (DDA) with the following parameters: 0.7 
sec. survey scan (380–200 Da) followed by up to four MS/MS acquisitions (50-2000 Da). 
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The instrument was operated at a mass resolution of 18000. The instrument was 
calibrated using a solution of NaI in 1:1 water:acetonitrile. The MS/MS data were 
processed using Masslynx software (Micromass, Milford, MA, USA) to produce peak 
lists for database searching. Mascot (Matrix Science Ltd, London, UK) was used as the 
search engine. Data were searched against the National Centre for Biotechnology 
Information (NCBI) non-redundant database. The following search parameters were 
used: mass accuracy 20 ppm, enzyme specificity trypsin, fixed modification 
carboxyamidomethylcysteine (CAM), variable modification oxidized methionine. Protein 
identifications were based on random probability scores with a minimum value of 25. 
 
5.2.5 Bioinformatics Analyses 
The RPA3313 sequence (excluding the 21 residue histidine tag) and the NMR structure 
were submitted to the ConSurf webserver to identify evolutionary conserved residues.
38-41
 
Structural comparison was done with PDBeFold
42
 and protein-protein interaction 
residues were predicted with cons-PPISP.
43,44
 Results from the ConSurf and cons-PPISP 
analyses were mapped onto the surface of the protein with UCSF Chimera.
45
 Surface 
hydrophobicity was also calculated within Chimera. The BLAST hits were visualized 
with the neighbor-join algorithm using Dendroscope.
46
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5.3 Results and Discussion 
5.3.1 Solution Structure of R. palustris protein RPA3313 
Backbone and side-chain resonance assignments for RPA3313 were made for the 68 
assignable residues excluding the N-terminus histidine tag (Figure 2). The NMR 
assignments are nearly complete with 68 of 68 N, 68 of 68 HN, 68 of 68 Cα, 76 of 76 Hα, 
60 of 60 Cβ, 93 of 97 Hβ, 33 of 55 Cγ, 57 of 60 Hγ, 13 of 28 Cδ, 32 of 39 Hδ, 3 of 12 Cε, 
16 of 21 Hε, 0 of 9 Cζ, and 4 of 7 Hζ. The monomeric solution structure of RPA3313 was 
calculated using 912 distance restraints, 102 angle restraints, 30 
3
JNHα coupling constants, 
128 
13Cα/13Cβ chemical shifts, and an initial model generated using CS-ROSETTA.25-27 
During structure generation, 1000 structures were initially created and the 20 lowest 
energy models were selected for further water refinement. A coordinate average of the 20 
water-refined structures was subjected to water refinement for additional minimization. 
The water refined ensemble structures did not contain any distance violations >0.5 Å or 
dihedral angle violations >5°. Also, the NMR data agrees well with the calculated 
structures since the RMSD of the backbone secondary structure residues is 0.70±0.07 Å 
and the RMSD for heavy atoms is 1.2±0.12 Å. Complete structural statistics for the 
RPA3313 NMR structures are listed in Table 1. Chemical shift assignments have been 
submitted to the BMRB as entry 30070 and coordinate files have been uploaded to the 
PDB as entry 5JN6. 
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Figure 2. A 2D 
1
H-
15
N HSQC NMR spectrum of RPA3313 with peaks labeled according 
to their respective residue numbers or side-chain identification. Unlabeled peaks 
correspond to the 6x His tag, which was not included in the structure generation or 
analysis. 
 
The overall quality of the RPA3313 NMR structure was assessed with the PSVS software 
suite (Table 2). All but one residue was located in the most favored region (98.3%) of the 
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Ramachandran plot with the remaining residue in the allowed region (1.7%). 
PROCHECK further supported the dihedral angle quality of the RPA3313 NMR structure 
with Z-scores of 0.12 and -0.71 for ϕ, ψ angles and all angles, respectively. Overall 
model quality was further assessed with ProsaII that produced a good Z-score of -0.58. 
An excellent quality score of -0.45 was also obtained from a MolProbity analysis, which 
evaluates atom clashes in the 3D structure. The ProsaII, PROCHECK and MolProbity 
scores are consistent with other high-quality NMR structures deposited in the PDB. 
Conversely, the Verify3D structure assessment yielded only a modest score of -1.93, but 
the analysis is still within an acceptable range compared to other NMR structures. 
Verify3D measures agreement between the 3D structure and the primary sequence. The 
novel fold for the RPA3313 structure may be a factor in the relatively low Verify3D 
score. 
 
Table 1. Structure Calculation Statistics
α
 
rmsd for distance restraints (experimental) (Å) <SA> ( SA  )r 
        all (912) 0.048±0.004 0.039 
        inter-residue sequential (|i-j| = 1) (269) 0.019±0.009 0.002 
        inter-residue short-range (1 < |i-j| < 5) 
(238) 
0.075±0.006 0.067 
        inter-residue long-range (|i-j| ≥ 5) (83) 0.070±0.019 0.054 
        intraresidue (256) 0.007±0.003 0.005 
        H-bonds (66) 0.022±0.007 0.024 
rmsd for dihedral angle restraints (deg) (102) 0.654±0.032 0.626 
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rmsd for 
3
JHNα restraints (Hz) (30) 0.515±0.050 0.569 
rmsd (covalent geometry)   
        bonds (Å) 0.007±0.000 0.008 
        angles (deg) 0.716±0.027 0.461 
        impropers (deg) 1.075±0.090 0.977 
energy (kcal/mol)   
        total -
1900.73±89.02 
-2161.44 
        bond 29.05±3.24 30.99 
        angle 87.92±8.88 96.49 
        dihedral 3.58±1.76 2.43 
        impropers 49.58±8.67 39.10 
        van der Waals -184.53±10.91 -191.49 
        NOE 63.30±10.65 41.50 
        
3
JHNα 8.03±1.51 9.73 
        Cα and Cβ shifts 77.89±10.00 65.75 
RMSD from mean (residues 2-21, 27-55) (Å)   
        Backbone 0.70±0.07  
        Heavy Atoms 1.20±0.12  
α 
<SA> represents the ensemble of the 20 water-refined simulated annealing 
structures. ( SA  )r represents the water refined average of the ensemble. 
 
Table 2. Structure Evaluation 
PSVS Z-score (residues 6-54) 
 
        Verify3D -1.93 
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        ProsaII (-ve) -0.58 
        Procheck (ϕ and ψ) 0.12 
        Procheck (all) -0.71 
        MolProbity -0.45 
Ramachandran Space (all residues) 
 
        most favored regions 98.30% 
        allowed regions 1.70% 
        disallowed regions 0.00% 
 
The structure of RPA3313 adopts a split ββαβ motif formed by 3 β-strands (β1-3) packed 
against an α-helix (Figure 3). There are no known structures of homologs to RPA3313 
and a search against the PDB using PDBeFold did not yield any significant results. 
Although the ββαβ motif is ubiquitous, when the RPA3313 structure is compared to 
proteins with similar motifs there is either a different handedness, or the orientation of the 
sheet along the α-helix is askew. This is not uncommon for this type of fold, as the 
sheet typically curls or flexes to cover the hydrophobic core of the protein.47  
Starting at the N-terminus, the first 2 β-strands are formed antiparallel to one another and 
are connected by a β-hairpin turn. The initial residues at this terminus do not contribute to 
β1 and are disordered. At the beginning of β2, Trp15 creates significant bulk in the core 
of the protein near the β-hairpin. The indole side chain reaches from β2 toward the 
surface of the protein, which forces Gly10 to accommodate this structural perturbation. 
Both β1 and β2 have branched side chains forming the center of the protein. Connecting 
β2 to the α-helix is an extended loop region comprised mostly of negatively charged, 
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polar residues. This loop outlines the top of a cavity formed with β1 and the N-
terminus of the α-helix. An additional Tyr residue in the loop has its side chain in close 
proximity to Lys30, which marks the beginning of the α-helix. The length of the α-helix 
is approximately 17 residues and is terminated by Gly48. Alanine residues line the inside 
of the helix and polar residues, including one cysteine, create the solvent exposed surface. 
A γ-turn links the α-helix to β3, which runs parallel to β2.  The side chain of Arg52 on β3 
is angled toward the center of the β-sheet and creates a stacking interaction with Arg14 
on β2 (Figure 4). This interaction is stabilized by Glu50, which may explain why the α-
helix to β3 turn contains only 2 residues. The bottom of β3 is hydrophobic and consists of 
branched chain amino acids.  
 
 
Figure 3. (A) An ensemble of the 20 best water-refined structures of RPA3313 for 
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residues 6-54 and (B) the coordinate average structure of the ensemble after water 
refinement. The structures are colored according to secondary structure: red for α-helix, 
blue for β-strand, and white for loops and disordered regions. The structural elements and 
the N- and C-terminus are labeled. The disordered C-terminus has been excluded for 
clarity. 
 
Following the last β-strand is the disordered C-terminus. At approximately 15 residues in 
length, this tail is mostly unstructured except for a small α-helical propensity centered on 
Val67. Seemingly uninteresting at first, the disordered C-terminus probably has a 
significant physiological function. Disordered termini are known to serve in a broad 
range of roles such as protein-protein interaction sites, chaperones, and signal 
processing.
48
 The proximity of the terminus to the large cavity on the surface of 
RPA3313 also suggests that it may potentially serve a role in activity (Figure 3b). Single-
stranded DNA (ssDNA) binding proteins in prokaryotes maintain evolutionary conserved 
disordered C-termini that compete with the DNA binding site in order to exclude 
unwanted binders.
49
 Although it is not known if RPA3313 binds ssDNA, the mechanism 
of the competition between the disordered tail and ligand remains a possibility. Also, 
many photosynthetic organisms possess globular proteins that have extended termini and 
are involved in a wide array of functions.
50
 These extensions are highly variable and 
show little conservation between homologous species. However, they are necessary for 
host protein regulation and function. Since RPA3313 is expressed during 
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photoautotrophic growth, it is possible that the disordered tail is involved in a light 
dependent mechanism.  
 
Figure 4. Arginine stacking interaction on the surface of RPA3313. Arginines 14 and 52 
interact across the top of the β-sheet and are stabilized by glutamate 50. Each of the 
residues is evolutionarily stable indicating the occurrence of a conserved interaction. 
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5.3.2 Conserved Residue Analysis 
The structure of RPA3313 was submitted to the ConSurf server for conserved residue 
analysis. ConSurf identifies and scores residue conservation based on a BLAST search 
and a subsequent multiple sequence alignment. Plotted on a surface representation of the 
RPA3313 NMR structure are the ConSurf scores, which range from 0 (blue) to 1 (red) 
with 1 signifying high conservation (Figure 5).  Clearly visible is a conserved pocket 
between the extended loop and the top of β1. The deepest region of the cavity is defined 
by the peptide backbone of the α-helix and Tyr6. Conserved residues with side chains 
pointing into the pocket are Asp20, Tyr27, Lys30, and Phe34 (Figure 6). The Asp, Tyr, 
and Lys residues have the ability to form hydrogen bonds with a ligand. Additionally, 
Lys and Asp are possible metal coordinators and Tyr and Phe may be involved in π-π 
interactions with a ligand. Also conserved are small flexible residues Gly2, Ala4, and 
Gly25. Each residue is either at the top or the bottom of the pocket and likely contributes 
to important structure flexibility. These small residues would enable the protein to bend 
in order to accommodate a larger ligand, or to change the size of the entrance to the 
pocket based on other structural perturbations or modifications. Gly2 is doubly important 
as it follows the N-terminal start methionine. Small flexible residues trailing methionine 
enable truncation by an aminopeptidase and it is anticipated that the physiological form 
of RPA3313 lacks this initial methionine residue.
51
 Distal to the pocket, the γ-turn 
between α-helix and β3 is also highly conserved. It is possible that this turn also acts like 
a hinge between the β-sheet and α-helix to allow the protein to adjust to a possible change 
in the hydrophobic core resulting from binding a ligand or a protein-protein interaction. 
The aforementioned stacked arginine residues (14, 52) are also moderately conserved. 
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The ConSurf score of approximately 0.5 indicate that this could be an evolutionary 
newer interaction or function. The stabilizing Glu50 residue has a higher conservation 
score (~0.7) than the arginines, but lower than the other residues in the γ-turn. This 
suggests that Glu50 may have a dual role in providing flexibility at the hinge in addition 
to stabilizing the arginine stacking interaction. Lastly, a highly conserved proline residue 
(56) exists at the end of β3. Proline is known to disrupt secondary structure formation and 
is most often found in disordered regions or turns. In this case, proline is acting as a 
terminator of a β-strand, which may assist in keeping the C-terminus residues in a 
disordered state. Furthermore, proline residues are associated with protein-protein 
interactions involving disordered protein regions.
52
 In these situations the disordered tail 
or region adopts an induced fit upon interaction or binding. 
 
 
Figure 5. ConSurf Analysis. (A) ConSurf per residue scores for the structure RPA3313. 
Conserved residues are red and non-conserved residues are blue. (B) ConSurf scores 
mapped onto the molecular surface representation of RPA3313. A conserved pocket is 
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formed between the N-terminus of the α-helix and the first β-strand. Residues found 
to be less conserved are mostly found in the loop regions and the disordered tail (C-
terminus, not shown). 
 
Figure 6. Surface pocket and possible ligand binding site on RPA3313. Shown are the 
residues with side chains that point into the pocket of the protein. The evolutionarily 
conserved residues are labeled. The remaining residues may also participate in the 
function of the pocket even though they are not highly conserved. 
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5.3.3 Protein-Protein Interaction Site Prediction 
A further bioinformatics analysis of the structure of RPA3313 was carried out with cons-
PPISP. The cons-PPISP server utilizes a neural network to predict position specific 
interaction sites on protein surfaces. Based on the output of cons-PPISP, it is possible to 
reliably identify clusters of residues that suggest a potential protein binding site. Two 
large sites were successfully identified that, when visualized on the surface of the 
RPA3313 NMR structure, lie opposite of one another (Figure 7). One potential protein 
binding site is between the β-sheet and α-helix on the bottom of RPA3313, while the 
other crosses the width of the β-sheet on the top of the protein. The bottom protein biding 
site consists of side chains from residues Tyr6, Trp15, Phe34, Cys38, Ser42, Ile45, 
Lys46, Glu50, Val51, Arg52, Ile53, and Thr54 (Figure 7a). Although mostly hydrophobic 
in composition (Figure 7c), these residues form a likely interaction hotspot due to their 
high abundance in other known protein-protein interactions.
53
 Furthermore, the surfaces 
of β-sheets are known to commonly participate in protein binding. A protein binding 
event at this bottom location on the RPA3313 surface could induce a significant 
reshuffling of the hydrophobic core as discussed earlier. The second predicted protein 
binding site runs perpendicular to the β-sheet and lies directly opposite the first predicted 
binding site (Figure 7b). Solvent exposed side chains from residues Val9, Tyr27, Ala32, 
Ala36, Ala39, and Asn43 populate the surface of the top protein binding site. This 
putative protein interaction site has both hydrophobic and hydrophilic regions (Figure 7d) 
indicating that multiple binding partners are possible. 
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.
 
Figure 7. cons-PPISP predictions and surface hydrophobicity. (A) Front and (B) back 
orientations of RPA3313 with predicted protein interaction sites colored red. (C) Front 
and (D) back surface hydrophobicity colored from blue (hydrophilic) to orange 
(hydrophobic). 
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5.3.4 Protein-Protein Crosslinking 
A simple crosslinking experiment was carried out in order to determine possible protein 
binders to RPA3313. The crosslinking experiment was performed both in vivo in E. coli 
and in vitro with a proteome extract from R. palustris. The replicate crosslinking 
experiments were performed to reliably identify physiologically-relevant interaction 
partners to RPA3313. RPA3313 was overexpressed in E. coli and prior to the two distinct 
crosslinking experiments the cell culture was split into two separate samples. A small 
aliquot of the total cell culture was removed for the in vivo crosslinking experiment, and 
the remaining cell culture was then used to extract and purify the overexpressed 
RPA3313 protein.  
Purified RPA3313 was spiked into a total protein extract from an R. palustris cell culture 
and the formaldehyde crosslinking was then performed in vitro. In contrast, the E. coli 
cell culture overexpressing RPA3313 was simply treated with formaldehyde for an in 
vivo crosslinking experiment. Formaldehyde was used to covalently link lysine side 
chains through amide bond formation and subsequently removed by heating the sample 
after purification. Following purification, the crosslinked proteins were resolved by SDS-
PAGE and identified by MS/MS analysis. Proteins found to be crosslinked to RPA3313 
belonged to ribosomal subunits in both E. coli and R. palustris (Table 3). Moreover, most 
of the protein component of the ribosome from both organisms was identified to bind 
RPA3313. Thus, RPA3313 appears likely to bind to the ribosome at one or multiple 
points. Since it is also possible that the ribosome remained intact during the crosslinking 
and purification process, the number of binding sites for RPA3313 on the ribosome 
remains undetermined. It is important to note that RPA3313 was only overexpressed in E. 
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coli and not in R. palustris. This insures that the results are physiologically relevant 
and not a simple artifact of an overexpressed protein being crosslinked to equally 
abundant ribosomal proteins. In fact, an additional in vivo crosslinking experiment with a 
second overexpressed protein (human DJ-1) served as a negative control and verified that 
the RPA3313 results were not an artifact of a protein overexpression system. Despite 
identical experimental conditions and unlike RPA3313, human protein DJ-1 did not 
crosslink with any (as expected) E. coli proteins in vivo.  
A previous study successfully sequenced and identified the ribosomal subunits from R. 
palustris.
54
 During the study, other uncharacterized proteins were purified with the 
ribosome, but none of them were identified as RPA3313. Like many ribosomal subunits 
from other organisms, some of the subunits from R. palustris contained disordered C-
termini. The disordered C-terminus acts as an anchor and buries itself into the RNA core 
and also promotes proper assembly of the ribosome.
55,56
 Globular portions of the proteins 
are then exposed to the solvent to interact with other proteins. While RPA3313 is not part 
of the ribosome, its tertiary structure mimics a ribosomal subunit with the multiple 
protein-protein binding sites and a disordered C-terminus. RPA3313 may instead act as a 
chaperone or transporter for substrates traveling to or from the ribosome.  
Table 3. In vivo and in vitro Crosslinking Results 
Organism Identified Ribosomal Proteins 
E. coli S2-11, S13, S15, S16, S18, S19, S21, L2-6, L9-11, L13-22, L24, L27, 
L28, L32 
R. palustris S6-13, S15-17, S19-21, L1-3, L6, L7/12, L9, L10, L15, L17-19, L21, 
L23, L24, L30, L32, L33 
E. coli 
(DJ-1 control) 
NA 
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5.4 Conclusion 
RPA3313 is a conserved protein from R. palustris and a member of functionally 
unannotated class of proteins in alphaproteobacteria. The purpose of this study was to 
structurally characterize this class of proteins and provide an initial functional 
characterization. An NMR solution structure reveals that RPA3313 adopts a novel 
globular split ββαβ motif followed by a disordered C-terminus tail. PSVS evaluation of 
the ensemble of the 20 lowest energy structures of RPA3313 produced generally good 
quality scores consistent with other high-quality NMR structures deposited in the PDB. 
Bioinformatics analyses led to the identification of several possible protein-protein 
interaction sites on the surface of RPA3313 and a large conserved pocket sandwiched 
between the β-sheet and α-helix. Crosslinking analysis revealed that RPA3313 interacts 
with the ribosome both in vivo and in vitro. Multiple ribosomal subunits were pulled 
down with RPA3313 in E. coli and in R. palustris, so the exact nature of the interaction 
between the two is unknown. In silico dockings, 
15
N NMR titrations, and ligand 
screenings were done in an attempt to determine the physiological role of RPA3313 (data 
not shown). However, a binder with a sub-millimolar binding constant was not found. It 
is possible that the tertiary structure of RPA3313 changes the shape of its binding pocket 
when in contact with another protein or in a much larger complex. Also, the C-terminus 
tail could be blocking or competing for the binding site and the lack of an N-terminus 
methionine truncation could also impede the binding site. The expression conditions of 
RPA3313 also remain unknown. It is possible that the protein is only expressed during 
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certain metabolic modes of growth, as this protein is not found in evolutionary distant 
bacterial species with more limited metabolism. The combined structural and proteomic 
analyses in this study strongly suggests that RPA3313 by itself or in a larger complex 
may serve as a ribosomal transport protein. 
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5.6 Supplemental Figures 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure S1. Intact mass analysis using ESI-MS of RPA3313 from Figure 
1. ESI-MS confirms the major state of RPA3313 is a monomer. 
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Chapter 6 
Identification of a Ligand-Binding site on the Staphylococcus aureus 
DnaG Primase C-Terminal Domain 
6.1 Introduction 
The initiation of DNA synthesis in living organisms and many large viruses results from 
the coordinated interaction of two enzymes - primase and helicase.
1, 2
 In bacteria, DnaG 
primase is the specialized DNA-dependent RNA polymerase that synthesizes short 
oligoribonucleotide polymers called primers. DNA polymerase, an enzyme that lacks the 
ability to initiate chain synthesis, elongates the primers. DnaG primase is stimulated by 
the homohexameric DnaB helicase. (Note: The name DnaB helicase is used here for the 
protein that is actually named DnaC helicase in Staphylococcus aureus and Bacillus 
subtilis because, in all other bacteria, DnaB is the name of the replicative helicase and 
DnaC is the name of the helicase-loading enzyme). DnaB helicase dissociates the two 
strands of duplex DNA during DNA replication while hydrolyzing ATP, and travels 
processively in the 5’-3’ direction along the single-stranded lagging template toward the 
replication fork, communicating allosterically with the multi-subunit replicative DNA 
polymerase. This action keeps it in proximity of the replication fork and ensures the 
primers are synthesized on the exposed single-stranded DNA nearest to the replication 
fork. Since primase activity is weak, the stimulation by DnaB causes primase to 
synthesize primers only at the replication fork when and where they are needed.
3, 4
 
Finally, the DnaG-DnaB interaction is an attractive antibiotic target because it is 
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conserved in bacteria, essential for DNA replication, and is distinctly different from 
that of viruses, archaea, and eukaryotes.
5-7
  
DnaG primase is composed of three functional domains: the N-terminal zinc-binding 
domain (ZBD, Pfam: PF08275) responsible for DNA binding specificity; the RNA 
polymerase domain (RPD, Pfam: PF01751) responsible for enzymatic activity; and the C-
terminal domain (CTD, Pfam: PF10410) responsible for the interaction with the DnaB 
helicase.
8-10
 The 110-residue ZBD contains the highest percentage of conserved residues 
and structural conservation, whereas the 140-residue CTD has the least sequence 
conservation and the most structural diversity (Table S1). Of these domains, the ZBD is 
unique to bacterial primases, the magnesium-binding residues of the RPD shares some 
similarity to the magnesium-binding residues of topoisomerases and some DNA-
hydrolyzing enzymes, while the CTD is similar only to the N-terminal domain of DnaB 
helicases, the domain to which it binds.
11-14
 Currently, no high-resolution structure has 
been solved for a full, intact bacterial primase, but structures are available for all three 
individual domains. The primase CTD is the domain with the most experimental 
structures.
6, 15-18
 There are X-ray crystal structures and NMR solution structures (Table 1) 
from S. aureus (2LZN, current paper), E. coli (2HAJ, 1T3W), G. stearothermophilus 
(1Z8S, 2R6A), and H. pylori (4EHS). In addition, the ZBD-RPD domain pair from 
Aquifex aeolicus has been experimentally determined.
11
 It has been proposed that the 
conformations of the two E. coli structures in 1T3W may not be biologically relevant due 
to crystallization conditions and packing effects.
17
  
To develop the DnaG-DnaB interface as an antibiotic target, we determined the solution 
structure of the DnaG CTD from S. aureus. This organism was chosen because there is an 
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urgent need for new antibiotic targets due to the rapid rise in antibiotic resistance.
19
 A 
comparison to known structures from other bacteria indicated that the S. aureus CTD was 
composed of two subdomains. The CTD from Firmicutes and Proteobacteria may adopt 
similar conformations when bound to helicase, but may adopt different free 
conformations. A study of the structural dynamics of the free S. aureus CTD confirmed 
that the junction between the two subdomains is the focal point for the greatest 
movement. Also, one of the subdomains is significantly more ordered than the other. The 
structure was used to identify three small compounds that bound to the close 
conformation, which is likely to reduce the primase-helicase interaction.  
 
Table 1: Primase CTD structures used for analysis     
Species PDB ID – chain Reference  
S. aureus 2LZN – 14 Current paper 
G. stearothermophilus 1Z8S – 5 6 
E. coli 2HAJ – 19 17 
G. stearothermophilus 2R6A – C 16 
H. pylori 4EHS – A and 4EHS – B 20 
E.coli 1T3W – A and 1T3W – B 18   
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6.2 Experimental Procedures 
6.2.1 Chemicals 
The dimethyl sulfoxide-d6 (99.9% D) and deuterium oxide (99.9% D) were obtained from 
Aldrich (Milwaukee, WI). The 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium salt 
(98% D) was purchased from Cambridge Isotopes (Andover, MA). The potassium 
phosphate dibasic salt (anhydrous, 99.1% pure) and monobasic salt (crystal, 99.8% pure) 
were purchased from Mallinckrodt (Phillipsburg, NJ). All compounds used for screening 
were obtained as described earlier.
21
 Briefly, the compound library is composed of 437 
known biologically active compounds distributed across 113 mixtures with 3-4 
compounds in each mixture. 
 
6.2.2 Proteins 
Uniformly 
13
C,
15
N-labeled S. aureus DnaG primase CTD and uniformly 
15
N-labeled S. 
aureus DnaG primase CTD were designed and purified by Nature Technologies (Lincoln, 
NE). The details of protein expression and purification were previously described.
22
 The 
vector added 20 N-terminal residues: an HN metal affinity tag 
(MGHNHNHNHNHNHNGG) followed by a protease-sensitive DDDD sequence.
22
 
 
6.2.3 NMR data analysis, structure calculations and refinement 
The NMR spectra for obtaining the protein backbone assignments were collected at 298 
K on a five-channel 600-MHz Bruker Avance spectrometer equipped with a 5-mm TXI 
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probe. The NMR spectra for the protein side chain assignments were collected at the 
Rocky Mountain Regional 900-MHz NMR Facility on a four-channel 900-MHz Varian 
INOVA spectrometer equipped with a 5-mm HCN probe. The nearly complete S. aureus 
DnaG primase CTD NMR resonance assignments have been previously reported.
22
 
Distance constraints were obtained from 3D 
15
N-edited NOESY and 3D 
13
C-edited 
NOESY that were collected at 900 MHz.
23
 Hydrogen bond constraints were determined 
using the (CLEANEX-PM)-FHSQC experiment.
24
 All torsion angle constraints were 
obtained by chemical shift analysis using the TALOS
25
 software program, and measured 
coupling constants from an HNHA experiment.
26
  
For the backbone NMR assignment experiments, 
13
C,
15
N-labeled protein was 
concentrated to 1.2 mM in a 95% H2O/5% D2O buffered solution of 100 mM NaCl, 25 
mM potassium phosphate at pH 6.64 (uncorrected) using an Amicon ultra centricon (MW 
cutoff 10,000 Da). Long-term protein stability was enhanced by adding 50 mM arginine 
and 50 mM glutamine. For the side chain experiments, 
13
C,
15
N-labeled protein was 
concentrated to 1.4 mM in the same buffer. All multidimensional experiments were 
processed using NMRPipe
27
 and analyzed using PIPP
28
 and CCPNMR.
29
  
Nuclear Overhauser Effect (NOE) assignments were obtained by using 3D 
15
N-edited 
NOESY and 3D 
13
C-edited NOESY. NOE intensities were sorted visually into four 
classes: strong (1.8–2.5 Å), medium (1.8–3.0 Å), weak (1.8–4.0 Å), and very weak (3.0–
5.0 Å). Upper limits for distances involving methyl protons and non-stereospecifically 
assigned methylene protons were corrected appropriately for center averaging. Initial 
NOE assignments were completed by the program Autostructure.
30
 Despite the high 
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magnetic field of 900 MHz, the extent of cross-peak overlap was great enough to 
warrant manual refinement of the NOE assignments.  
Hydrogen bond constraints were determined using the (CLEANEX-PM)-FHSQC 
experiment, which identifies amide residues with fast water exchange rates.
24
 Hydrogen 
bond constraints were assigned to amides in secondary structure regions for any 2D 
1
H-
15
N HSQC peaks lacking a corresponding peak in the (CLEANEX-PM)-FHSQC 
spectrum. The carboxyl oxygen to amide nitrogen hydrogen bond distances were set at 
2.8 Å while the carbonyl oxygen to amide proton distances were set at 1.8 Å. All 
carboxyl groups within 2.5 Å of slowly exchanging amide groups were constrained to be 
involved in a hydrogen bond. 
The structures were refined using the hybrid distance geometry dynamic-simulated 
annealing method
31
 using the XPLOR-NIH program
32, 33
 adapted to incorporate 
pseudopotentials for 
3
J(HN-Hα) coupling constants, secondary 13Cα/13Cβ chemical shift 
constraints, and a conformational database potential.
34-38
 The force constant for the 
conformational database was kept relatively low (0.5–1.0 kcal/mol) throughout the 
simulation to allow the experimental distance and torsion angle constraints to 
predominately influence the resulting structures. The force constant for the NOE and 
dihedral constraints were 30 times and 10 times stronger than the force constants used for 
the conformational database.
39
 All peptide bonds were constrained to be planar and trans. 
There were no hydrogen-bonding or electrostatic empirical potential energy terms in the 
target function. A total of 1000 structures were calculated and the 20 lowest energy 
structures were selected to become the ensemble of S. aureus DnaG primase CTD 
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structures. Each of these twenty structures were subjected to further energy 
minimization using explicit water with Crystallography and NMR system (CNS) version 
1.2.
40
 Explicit water solvation was accounted for with Lennard-Jones and electrostatic 
potentials using a modification of the procedure and force field of Nilges.
41, 42
  
 
6.2.4 Protein backbone dynamics 
The NMR experiments for protein dynamics analysis were collected on a Bruker 500 
MHz Avance spectrometer (Billerica, MA) equipped with a triple resonance, Z-axis 
gradient cryoprobe. The sample was uniformly 
15
N-labeled S. aureus DnaG primase CTD 
concentrated to 1.2 mM in a 95% H2O/5% D2O buffered solution of 100 mM NaCl, 50 
mM arginine, 50 mM glutamine, 25 mM potassium phosphate, pH 6.64 (uncorrected) 
using an Amicon ultra centricon (MW cutoff 10 000 Da).  
The previously described
43-45
 experiments included a 2D 
15
N-
1
H HSQC experiment 
(hsqct1etf3gpsi) designed to measure T1 relaxation rates with delay times of 0.0 ms, 5.39 
ms, 53.92 ms, 134.80 ms, 269.60 ms, 404.40 ms, 539.20 ms, 674.00 ms and 1078.40 ms, 
a 2D 
15
N-
1
H HSQC experiment (hsqct2etf3gpsi) designed to measure T2 relaxation rates 
with delay times of 0.0 ms, 17.6 ms, 35.2 ms, 52.8 ms, 70.4 8 ms, 105.6 ms, 123.2 ms, 
140.8 ms, 158.4 ms, 176.0 ms, and a 2D 
15
N-
1
H HSQC experiment (hsqcnoef3gpsi) 
designed to measure NOE changes.  
The relaxation rates (T1, T2) for each amino acid within the structure were calculated by 
fitting the intensity of each peak to the intensity decay curve (eq 1) where It is the 
intensity of each peak at the delay time t, I0 is the initial steady state intensity. 
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𝐼𝑡 = 𝐼0exp⁡(−
𝑡
𝑇1,2
)     eq 1 
The NOE values were determined by the ratio of peak intensity between the saturated 
(Isat) and unsaturated (Iunsat) spectra. 
𝑁𝑂𝐸 = 𝐼𝑠𝑎𝑡/𝐼𝑢𝑛𝑠𝑎𝑡     eq 2 
The T1 rates, T2 rates, and NOE ratios were determined from their fits to their respective 
equations using Kaleidagraph (Synergy Software, Reading, PA) and exported to the 
FAST-MODEL FREE program
46
 to calculate an overall correlation time (τm); and per 
residue order parameters (S
2
), internal motion (τe), and chemical exchange (Rex) using the 
Lipari-Szabo model-free method.
47
 Some of the NOE ratios were above the theoretical 
maximum of 1.0 and were set to 1.0 to run the FAST-MODEL FREE program.  
 
6.2.5 Primase CTD and C1 subdomain similarity phylograms 
An all-versus-all root-mean-square deviation (RMSD) matrix table (Table S2) was 
generated using the MatchMaker tool in UCSF Chimera.
48
 All chains from X-ray 
structures were included in the structural comparison. Only the best representative 
structure from the NMR ensemble, identified by XPLOR as having the lowest RMSD 
relative to the mean, was included in the comparison (See Table S3). 
The computed RMSD matrices were then inserted into the Splitstree4
49
 program to 
generate the unrooted phylogenic trees depicted in Figure 3. The trees were generated 
using the Neighbor-join algorithm. The pairwise RMSDs were calculated between the 
complete C-terminal domains (Figure 3A) as well as between the aligned C1 subdomains 
(Figure 3C). 
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6.2.6 Primase CTD sequence similarity 
The sequences for the E. coli, G. stearothermophilus, H. pylori, and S. aureus primase C-
terminal domains were acquired from the Protein Data Bank.
50
 Three different sequence 
alignment programs, Muscle, T-Coffee, and Clustal Omega,
51-53
 were used to determine a 
sequence similarity between the four primase CTD proteins. The results obtained from 
the three sequence alignment programs were identical and were converted into the Phylip 
format for analysis using Splitstree4.
49
 The unrooted phylogenic tree (Figure 3B) was 
created using the Neighbor-join algorithm and equal angle method. 
 
6.2.7 NMR ligand affinity assays 
Sample preparation and experimental parameters for the NMR ligand affinity screen were 
performed as described previously.
54
 Briefly, each ligand mixture (113 total) was 
screened using a 1D 
1
H NMR spectrum with excitation sculpting.
55
 Each NMR sample 
2O buffered solution of 20 
mM d19-bis-Tris at pH 7.0 (uncorrected) with 2% DMSO-d6 to maintain ligand solubility 
and 11.1 µM 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium salt as a chemical shift 
reference. All 1D 
1
H NMR spectra were processed with the ACD/1D NMR manager v. 
12.0 (Advanced Chemistry Development, Inc., Toronto, Ontario). Each 1D 
1
H NMR 
spectrum was compared to the corresponding free ligand mixture reference spectrum and 
visually analyzed to identify binding ligands based on a decrease in the intensity of ligand 
NMR resonances. A 2D 
1
H-
15
N HSQC spectrum was collected for each ligand with a 
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positive response from the 1D 
1
H NMR line-
1
H NMR 
screen except for 95% H2O/5% D2O. A single ligand-free 2D 
1
H-
15
N HSQC spectrum 
was collected as a reference, where a binding event was confirmed based on a clustering 
of surface residues that incurred a chemical shift change one standard deviation above the 
average. 
 
6.2.8 Protein-ligand titration and docking 
DnaG primase CTD HSQC was collected at a protein concentration of 1 mM and was 
titrated with adenosine (0.9, 1.8, 2.6, 3.3, and 4.0 mM), acycloguanosine (0.7, 1.9, 3.5, 
and 5.2 mM), and myricetin (0.9, 1.8, 2.6, 3.3, and 4.0 mM). All NMR data was collected 
at 25 ˚C on a 700 MHz Bruker Avance III spectrometer equipped with a 5 mm QCI-P 
probe with cryogenically cooled carbon and proton channels. The 2D 
1
H-
15
N HSQC 
protein titration data was processed and analyzed in NMRPipe.
27
 Briefly, the spectral 
titration data for each ligand was automatically peak picked and adjusted manually within 
NMRDraw. The 
1
H-
15
N and 
15
N chemical shifts from the selected peaks were then fit to a 
Ka (1/Kd) according to a previously published method.
56
 Subsequently, the peaks that 
showed significant binding were manually assigned to residues. AutoDock was then used 
to individually dock the three ligands into a primase CTD binding site defined by the 
observed chemical shift perturbations. Chimera was used to visualize the lowest energy 
docked complexes.
48
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6.3 Results  
To fight antibiotic-resistant infections, there is a need to identify new antibiotic targets. 
The bacterial primase C-terminal domain is an especially promising target because 
eukaryotic primases do not have a cognate sequence or structure and because its critical 
function is to interact with DnaB helicase to limit DNA replication to the replication fork. 
Among a number of factors, evaluating the “drugability” of a protein target requires a 
fundamental understanding of its structure-function relationship.
57
 As a first step towards 
this goal, we determined the three-dimensional structure of the primase CTD from the 
pathogen S. aureus.  
 
6.3.1 S. aureus primase CTD structure determination 
Backbone and side chain resonance assignments were completed using standard triple 
resonance NMR experiments.
22
 In summary, the backbone resonance assignment was 
93% complete with 133 amino acids out of the 143 primase residues assigned 
unambiguously in the 2D 
1
H-
15
N HSQC spectrum. Nearly all the peaks were uniformly-
shaped and separated from the others, which indicates that each residue is in a unique 
environment and that S. aureus primase CTD exists in a single conformation. Unassigned 
residues include M1-H13, D19, E470, H479, L480, M481, T500, R536, E537, E543, 
P551, and Y552. Primase CTD residues are numbered relative to the complete DnaG 
primase sequence, while the N-terminal purification tag is simply numbered from residue 
1 to 20. Most of the unassigned residues were located in the purification tag or within 
highly solvent exposed regions. The structure consists of eight α-helices. Residues H479, 
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L480, and M481 were in a turn region between helix 1 and 2. Residue T500 was in an 
unstructured loop region between helix 2 and helix 3, whereas residues P551 and Y552 
were in an unstructured loop region between helix 5 and helix 6. The only unassigned 
residues that appear to be localized within a secondary structure were E470, R536, E537, 
and E543. E470 is the second residue of helix 1, while R536 and E537 are in the middle 
of helix 5, and E543 is near the end of helix 5. An exhaustive analysis of the NMR data 
set was unable to yield assignments for these residues, suggesting the end of helices 1 and 
5 may undergo partial unfolding leading to chemical shift exchange broadening for these 
residues. 
The solution structure of the S. aureus primase CTD was calculated using 1823 distance 
constraints, 280 dihedral constraints, 256 
13Cα and 13Cβ carbon chemical shift 
constraints, and 82 
3
JNHα coupling constant constraints, among others (Table 2). In the 
initial phase, 1000 structures were calculated from 10 individual sets of 100 structures 
each using XPLOR-NIH
32, 33
 as described previously.
58
 Each set of structures was started 
from a randomly generated seed. The lowest energy structures were consolidated to 
generate a set of 20 low energy structures that were further refined within a virtual water 
environment using the RECOORD recalculated coordinates
42
 as implemented in CNS.
40
  
The resulting S. aureus primase CTD structures (Figure 1) form a self-consistent set as 
determined by a range of statistical analyses (Table 2). The root mean square deviation 
(RMSD) for all 1823 experimental distance constraints is 0.040 (± 0.023) Å, which 
implies a good agreement between the structural ensemble and the constraints. None of 
the distance constraints have a violation that exceeds 0.247 Å. There are also low 
deviations from the constraints for the 
13Cα chemical shifts, 13Cβ chemical shifts, and the 
  
198 
3
J(HN-Hα) coupling constants, indicating consistent conformations for both the 
backbone and side chains. Similarly, the deviations from idealized covalent geometries 
are consistent with good quality structures. 
 
Table 2: Structure Statistics
a
 
Root mean square parameter <SA> σ (SA)r 
Distance restraints (Å) 
 All (1823) 0.040 0.023 0.022 
 Inter-residue sequential (|i-j| = 1) (460) 0.056 0.021 0.030 
 Inter-residue short range (1 < |i-j| ≤ 5) (444) 0.062 0.018 0.041 
 Inter-residue long-range (|i-j| > 5) (140) 0.247 0.093 0.374 
 Intra-residue (663) 0.001 0.001 0.003 
 Backbone hydrogen bonds (116) 0.014 0.005 0.008 
Dihedral restraints (deg) (280)  1.21 0.23 1.12  
 1.05 0.05 1.08 
 1.06 0.04 1.09 
3
J  coupling restraints (Hz) (82) 0.011 0.0005 0.011 
FNOE (kcal mol
-1
) 87 36 46 
Ftorsion (kcal mol
-1
) 28 20 21 
FVDW (kcal mol
-1
) -509 31 -510 
Idealized covalent geometry 
 Bond length (Å) (2400) 0.0114 0.0005 0.0108 
 All angles (deg) (4302) 1.44 0.06 1.43 
 Improper torsion angles (deg) (1287) 1.95 0.23 1.84 
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a
<SA> is the average value from an all-versus-all comparison of the set of 20 annealed structures;  is 
the standard deviation for the all-versus-all comparison; and (SA)r is the value for the restrained 
minimized mean structure. The number of restraints for each parameter is given in parentheses. For 
backbone NH-CO hydrogen bonds, the two restraints are r(NH-O) = 1.5 - 2.3 Å and r(N-O) = 2.5 - 3.3 Å. 
The values of the square-well NOE (FNOE) and torsion angle (Ftorsional) potentials
59
 are calculated with force 
constants of 50 kcal mol
-1
Å
-2
 and 200 kcal mol
-1
rad
-2
, respectively. The value of the Lennard-Jones van 
der Waals term (FVDW)
60
 is calculated with a force constant of 4 kcal mol
-1
Å
-4
 with the CHARMM
61
 
empirical energy function. The improper torsion angle restraints serve to maintain planarity and chirality. 
 
 
Figure 1: Primase CTD ensemble overlay. (A) A ribbon diagram of the average water 
refined structure. The C1 subdomain is composed of helices 1-6 and the C2 subdomain is 
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composed of helices 7-8. All structures were generated with Visual Molecular 
Dynamics (VMD-XPLOR) and are colored according to the secondary structure: red, α-
helix; green, loop. (B) An overlay of the backbone trace of the 20 lowest-energy, water-
refined structures aligned with residues 468-566 from the C1 subdomain. (C) An overlay 
of the backbone trace of the 20 lowest-energy structures aligned with residues 570-603 
from the C-terminal C2 subdomain.  
 
The quality of the S. aureus primase CTD NMR structure was assessed using two suites 
of programs (Table 3). PROCHECK
62
 indicates the average minimized structure has an 
overall G-Factor of -0.12 ± 0.04 with no bad contacts, consistent with a good quality 
structure. The Protein Structure Validation Software suite of programs (PSVS)
63
 gave a 
Verify3D score of -4.58 ± 0.71, which is within the typical range. The Molprobity 
module indicates that the S. aureus primase CTD structure has a very good Z-score (-
2.50) compared to the average Z-score (-10.74) for all NMR structures in the Protein 
Data Bank. Finally, a Ramachandran plot of backbone dihedral angles for all non-glycine 
residues indicates that 83.4 ± 3.2% lie within the “most favored” region and only 0.7 ± 
0.6% lie within “disallowed” regions. That is, one residue in 14 of the 20 structures is 
found in the disallowed region but never in a consistent location within the structure 
(Table S4). These residues tend to have a lower number of constraints, which results in a 
low penalty for unusual conformations during energy minimization. 
The final step in the analysis was to compare the 20 energy-minimized structures with the 
mean structure (Table 4). Within the C1 subdomain comprising the first two-thirds of the 
residues, the average root-mean square deviation (RMSD) of the 20 lowest energy 
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structures about the mean coordinate position is 1.54 ± 0.19 Å for backbone atoms 
and 2.37 ± 0.17 Å for all heavy atoms. When only secondary structure elements are used 
for alignment, the mean coordinate position deviation is 1.18 ± 0.14 Å for backbone 
atoms and 1.93 ± 0.16 Å for all heavy atoms. These deviations indicate the backbone 
structure is well defined. The side chain residues have fewer constraints and 
correspondingly higher structural disorder. 
 
 
Table 3: Ensemble self-consistency
a
  
Parameter <SA> σ (SA)r  
PROCHECK
b 
 Overall G-Factor -0.12 0.04 -0.09 
 H-bond energy 0.82 0.06 0.8 
 Number bad contacts/100 residues
 
0.0
  
0.0 
PSVS Z-scores
c
 
 Verify3D -4.58 0.71 -4.82 
 ProsaII (-ve) -1.14 0.34 -1.20 
 Procheck (phi-psi) -0.56 0.42 -0.28 
 Procheck (all) -1.92 0.32 -2.07 
 MolProbity clash score -2.50 0.97 -2.46 
Ramachandran space
d
 
 Most favored regions 83.4% 3.2 85.5% 
 Additional allowed regions 14.5% 3.0 13.0% 
 Generously allowed regions 1.43% 1.2 0.7% 
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 Disallowed regions 0.7% 0.56 0.7%  
a
<SA> is the average value from an all-versus-
standard deviation for the all-versus-all comparison; and (SA)r is the value for the restrained minimized 
mean structure.  
b
PROCHECK values are in comparison to the likelihood of finding each residue within the derived 
structure as compared to a database of residues found in similar environments within structures with 
resolution below 1.8 Å. 
c
PSVS (Protein Structure Validation Suite) provides an analysis of five separate structural analysis 
programs, each of which measures a different parameter. The PSVS reports Z-scores for each analysis, 
where a Z-score is the number of standard deviations from the mean. The authors of PSVS suggest that 
Z-scores lower than -5 should be reevaluated. 
d
Ramachandran space analysis from the PDB sum website uses a database of structures with resolution 
below 1.8 Å to decide whether a region is considered to be “most favored”, etc.  
 
Table 4: Ensemble self-consistency of the C1 subdomain
a
 
Comparison Backbone atoms All heavy atoms 
All residues  
<SA> vs. SAmean 1.54 ± 0.19 Å 2.37 ± 0.17 Å 
<SA> vs. (SA)r 1.98 ± 0.28 3.05 ± 0.32 
(SA)r vs. SAmean 1.26 1.94 
Secondary structures 
<SA> vs. SAmean 1.18 ± 0.14 1.93 ± 0.16 
<SA> vs. (SA)r 1.56 ± 0.22 2.55 ± 0.26 
(SA)r vs. SAmean 1.03  1.66 
a
<SA> is the average value from an all-versus-all comparison of the set of 20 annealed structures; (SA)r is 
the value for the restrained minimized mean structure; and SAmean is the Cartesian mean structure 
created from the geometric mean for each atom of all 20 structures. The SAmean structure does not 
adhere to any of the restraints for bond lengths, angles, etc. The secondary structure residues are: 469-
- - -52 - -
secondary structure rmsd values were measured by aligning all secondary structure elements and 
calculating an average and standard deviation. 
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6.3.2 S. aureus primase CTD structure 
The 20 energy-minimized S. aureus primase CTD structures (Figure 1) are deposited in 
the Protein Data Bank (PDB) with the identification code 2LZN. The structure is 
composed of 8 helices arranged into two subdomains as is the primase CTD NMR 
structure from G. stearothermophilus.
6
 In our S. aureus primase CTD structure, the first 
six helices create the C1 subdomain and encompass residues 467 to 565 (Figure 1A). The 
last two helices, 7 and 8, create the C2 subdomain encompassing residues 572 to 603. 
When the 20 structures are overlaid using the alignment of the C1 subdomain backbone 
residues as a guide (Figure 1B), the C2 subdomain structures do not superimpose well. 
The converse overlay based on the alignment of the C2 subdomain shows the same effect 
(Figure 1C). The poor superimposition arises because of the very low number of 
structural restraints between the subdomains. However, the linker between the 
subdomains is constrained by 11 NOEs from the C1 subdomain, 77 NOEs within the 
linker, and 17 NOEs from the C2 subdomain. On the other hand, the loop region between 
the subdomains lacks sequential NH-NH NOEs in the 
1
H-
15
N HSQC-edited NOESY and 
the loop residues G567, Q568 and E569 exhibit exchange peaks in the CLEANEX 
experiment.
24
 These residues are likely undergoing rapid exchange with the solvent, a 
feature indicative of exposed residues that lack protection from hydrogen bonds found in 
secondary structures. As we shall see below, the dynamics analysis indicates that the 
subdomains behave as two independent domains.  
  
204 
The surface charge distribution shows the exposed surface is uniformly but weakly 
electrically positive (Figure 2). The buried interface between the subdomains is 
electrically negative, as reflected in the moderately large Verify 3D Z-score. This 
repulsion may destabilize the interaction between the C1 and C2 subdomains, causing 
them to prefer a more extended conformation. In addition, there are some partially buried 
electrically negative residues in the C1 subdomain. The overall charge distribution is 
unlike the uniformly negative CTD from G. stearothermophilus,
6
 suggesting that it is not 
a universal feature of primase CTDs. 
 
 
Figure 2: Electrostatic surface potential. Surface charge distribution of the C-terminal 
domain showing (A) the face toward the RNA polymerase domain (F463 is the N-
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terminal residue of this domain) with space-filled C2 subdomain on the left and the 
ribbon diagrammed C1 subdomain on the right. (B) The solvent-exposed face (180° 
rotation around the x-axis relative to the structures in panel A) with space-filled C1 
subdomain and ribbon diagrammed C2 subdomain. 
 
6.3.3 Primase CTD conformations 
Every enzyme family has a distinct sequence/structure relationship linked to the 
evolutionary pressures on the sequence and structure within each organism.
64
 To 
determine how the S. aureus primase CTD structure relates to other known primase CTD 
structures (Table 1), the MatchMaker tool in UCSF Chimera
48
 was used to calculate 
pairwise RMSDs for the eight known primase CTD structures (Table S2). The resulting 
unrooted phylogram (Figure 3A) shows three main branches that correlate with distinct 
conformations (Figure 4). The first branch (conformation A) includes our NMR structure 
from S. aureus (2LZN-14) and the G. stearothermophilus NMR structure (1Z8S-5). The 
second branch (conformation B) includes the E. coli NMR structure (2HAJ-19), the G. 
stearothermophilus crystal structure (2R6A-C), and both H. pylori crystal structures 
(4EHS-A and B). The third branch (conformation C) includes both E. coli crystal 
structures (1T3W-A and B). Conformations A and B are more similar to each other than 
they are to conformation C. Furthermore, it has been proposed
17
 that conformation C may 
not be biologically relevant because the crystals were formed at low pH (4.6), which 
resulted in a packing effect of swapped dimer conformation. 
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Since the unrooted phylogram for the full length structure did not split according to 
sequence phylogeny, we created unrooted phylograms based on CTD sequence similarity 
(Figure 3B) and the primase CTD C1 subdomain structure (Figure 3C). From the 
sequence similarity phylogram, we observed two distinct branches corresponding to the 
expected phylogenetic split between the Firmicutes (G. stearothermophilus, S. aureus) 
and the Proteobacteria (E. coli, H. pylori). The same phylogenetic split was observed for 
the C1 subdomain structures, showing that there is a structure-sequence phylogenetic 
split for this protein.  
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Figure 3: Unrooted phylograms. Representation of the primase CTD structure (A), 
sequence similarity (B) and primase CTD C1 subdomain structure (C). All trees were 
generated with SplitsTree4 Each tree contains the following species: S. aureus primase 
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CTD (this study), G. stearothermophilus primase CTD, H. pylori primase CTD, and 
E. coli primase CTD.  
 
 
Figure 4: Primase CTD conformation classes. The species structures were categorized 
in three conformations from Figure 3A based on compactness: A compact, B 
intermediate, C extended. Conformation C may be biologically irrelevant.
17
  
 
6.3.4 Primase CTD flexibility 
An NMR dynamics analysis of the S. aureus primase CTD structure was conducted to 
complement the structural analysis. The NMR relaxation parameters T1 and T2, and the 
relative ratio of NOE enhancement were measured on a per residue basis and analyzed 
using the Fast-Model free program
46
 to calculate order parameters (S
2
) and chemical 
exchange (Rex) values (Figure 5). In general, the T1 values for the C1 subdomain residues 
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were higher than the T1 values for the C2 subdomain residues, indicating that the two 
subdomains exhibit different dynamics. A similar observation was made for the T2 
values, except that the T2 values for the C1 subdomain were lower than the T2 values for 
C2.  
It is important to note that Fast-Model free did not converge on a result when using the 
entire primase CTD structure. This is consistent with the observation that the C1 and C2 
subdomains behave as two separate domains and are dynamically independent. A 
convergent result was only obtained when the NMR dynamics data of the C1 and C2 
subdomains were modeled separately. The C1 subdomain included residues 463-572 and 
the C2 subdomain included residues 565-605. The linker region, corresponding to 
residues 565-572, was included in the dynamics analysis for both subdomains. 
The order parameters (S
2
) for the C1 subdomain residues covered a large range (0.240-
1.000) whereas the C2 subdomain residues were close to 1 (Figure 5D). The average S
2
 
values were 0.79 ± 0.02 and 0.97 ± 0.03 for the C1 and C2 domains, respectively. In 
general, an S
2
 value approaching 1.0 indicates a highly ordered residue with limited 
flexibility, while a lower S
2
 value indicates greater flexibility. This implies that the C1 
subdomain has a greater overall flexibility relative to C2. 
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Figure 5: Dynamics of S. aureus primase CTD. The NMR relaxation parameters T1 (A) 
and T2 (B), NOE enhancements (C), S
2
 order parameter (D), and Rex chemical exchange 
rate are plotted per residue. The C1 subdomain included residues 463-572 and the C2 
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subdomain included residues 565-605. The linker region corresponding to residues 
565-572 was included in the dynamics analysis for both subdomains.  
 
Within the primase CTD structure there are two stretches of three or more residues with 
S
2
 values less than 0.75: residues 488 to 498; residues 555 to 557 and residues 561 to 
563. Residues 488 to 498 lie in helix 2 and the linker between helix 2 and 3. Residues 
555 to 557 and 561 to 563 lie in helix 6 (Table S5). The flexibility of the linker between 
helix 2 and 3 is consistent with the variable lengths for helix 3 observed in the structures 
from other organisms. It is possible that the reduction in the flexibility of helix 3 is part of 
an allosteric system that provides an entropic energy change when helix 6 and 8 bind to 
the helicase NTD.
65
 The flexibility of the second half of helix 6 shows how the 
unstructured linker between helix 6 and 7 may act as a nucleus for unraveling helix 6. 
Surprisingly, the linker region corresponding to residues 565-572 was observed to be 
dynamic, indicating that the point of flexibility between the two domains is located at the 
end of helix 6. This finding further suggests that the dynamic, second half of helix 6 
(residues 561-564) compensates by either unraveling or bending for the increased motion 
between the two subdomains at the linker region. 
To identify the hinge between the two subdomains, we searched for a residue with a low 
order parameter and fast chemical exchange. N564 had one of the lowest order 
parameters (0.658) and the fastest chemical exchange (17.7 Hz), indicating a high degree 
of motion on both the ps-ns and ms timescales. It is the final residue of helix 6 and is 
located between a very rigid C2 subdomain and a flexible C1 domain, potentially 
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implicating N564 as a key residue for a conformational change.  
In addition to per-residue order parameters and chemical exchange rates, an overall 
correlation time (τm) was calculated for each subdomain. The correlation times for the C1 
and C2 subdomains were 7.2 ns and 6.4 ns, respectively. The predicted value for a 
hydrated protein with a molecular weight of 17.2 kDa, corresponding to the intact 
primase CTD structure, m ≈ MW/2400.
66
 The predicted tumbling times 
were 5.45 ns and 2.1 ns for C1 (13.1 kDa) and C2 (5.0 kDa). The observed τm values for 
both subdomains are substantially higher than predicted and share a greater degree of 
similarity than the predicted values. This indicates the C1 and C2 subdomains are both 
tumbling at approximately the same rate as the intact protein. The model that emerges is 
one in which the two subdomains can adopt a wide range of relative orientations, with 
N564 as a pivot point, but share an overall tumbling rate. 
 
6.3.5 Identification of ligands that bind to S. aureus primase CTD 
A high-throughput NMR ligand affinity screen of the S. aureus primase CTD was 
undertaken to identify potential binding compounds. Out of the 423 compounds tested, a 
total of 12 compounds were shown to bind S. aureus primase CTD using a 1D 
1
H NMR 
line-broadening screen: acycloguanosine, 3-aminopropionitrile fumarate, chelerythrine 
chloride, didecyldimethylammonium bromide, 5,5-diphenylhydantoin, L-histidine, (±)-α-
lipoamide, 1-methylimidazole, mitoxantrone dihydrochloride, myricetin, (±)-propranolol 
hydrochloride, sodium creatine phosphate, and sodium DL-lactate. Of these compounds, 
acycloguanosine and myricetin were further analyzed for binding with primase CTD 
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from S. aureus. Furthermore, adenosine was selected for binding studies due to its 
structural similarity to acycloguanosine. Quercetin, luteolin and kaempferol were also 
selected for their structural similarity to myricetin, but their low solubility prevented 
further study.  
A 2D 
15
N-
1
H HSQC spectrum was collected for free primase and for the primase-ligand 
complex using acycloguanosine, adenosine, or myricetin. All three compounds were 
shown to bind primase CTD based on protein chemical shift perturbations (CSPs) of 
Y552, N564, T570, L574, E580, I584, G585, L589, and Q590 (Figure 6A). Although 
initially unassigned, Y552 was discovered during the titration experiment and assigned 
based on spatial proximity to other perturbed residues. None of the three compounds 
reached CSP saturation at the highest concentration tested (≥ 4.0 mM), indicating that 
their KD’s were greater than 4 mM. Acycloguanosine, adenosine and myricetin exhibited 
CSPs above one standard deviation from the average of all non-binding site residues. 
Specifically, acycloguanosine, adenosine and myricetin caused CSPs of 0.35 ± 0.09 ppm, 
0.16 ± 0.29 ppm and 0.07 ± 0.02 ppm, respectively, for the binding site residues.  
When the nine residues incurring CSPs were mapped onto the structure of primase CTD, 
eight of the residues were located adjacent to one another on helix 6 or 7 (Figure 6B). 
The residue furthest from the other binding site residues was N564, which was previously 
identified as a key residue for a C1-C2 conformation change (Figure 5). When adenosine 
was docked into the groove between helices 6 and 7 (Figure 6B), the adenine moiety 
filled a hydrophobic pocket while its ribose was exposed to solvent and made specific 
interactions with three residues: Y552, I584, and G585 (Figure 6C). All three compounds 
docked into the same primase CTD pocket and adopted a uniform binding conformation. 
  
214 
The hydrophobic fused rings were buried deep into the pocket and the hydrophilic 
moieties interacted with the same three residues at the opening of the pocket (Figure 6D). 
Since these compounds bind to the closed conformation of primase CTD, they are likely 
to act as an inhibitor and reduce the helicase-primase interaction.  
 
Figure 6: Adenosine binding site identification. When S. aureus primase CTD (1 mM) 
was titrated with up to 4.0 mM adenosine, nine residues exhibited chemical shift 
perturbations in the 2D 
1
H-
13
C HSQC spectrum of primase CTD. A detail from the 
overlay of the 2D 
1
H-
13
C HSQC spectra is colored according to the addition of 0 mM 
(blue), 2.6 mM (purple) and 4.0 mM (red) of adenosine (A). Expanded view of a surface 
rendition of the primase CTD NMR structure is superimposed onto a ribbon structure to 
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highlight secondary structure elements. Adenosine (blue tessellated structure) was 
docked into the primase CTD region defined by the nine residues with significant 
chemical shift perturbations (colored purple), which are located between helices 6 and 7. 
The side chains for all the residues that interact with adenosine are drawn with licorice 
-helices 6 
and 7 are labeled (B). An expanded view of the ligand-binding pocket (flipped 180 
degree from panel B) represented as a ribbon structure with side chains interacting with 
adenosine shown as licorice bonds. The residues interacting with adenosine are labeled. 
The labels for residues with significant CSPs are colored purple (C). Superposition of the 
docked conformations of myricetin (green), adenosine (black), and acycloguanosine 
(orange) into the same expanded view of the primase CTD binding site from panel C (D).  
 
6.4 Discussion  
We report the first primase CTD structure from a medically relevant, mesophilic 
Firmicutes bacterium. Its structure shares many features with the known thermophilic 
Firmicutes and mesophilic proteobacterial primase CTD. It has an N-terminal 6-helix 
bundle called the C1 subdomain connected by linker residues to a C-terminal helix-turn-
helix called the C2 subdomain. The C1 subdomains from different species share the same 
overall fold, although there are differences in the lengths of several helices such that S. 
aureus and G. stearothermophilus are more similar to each other than to E. coli or H. 
pylori. The overall resolution of the S. aureus structure was low due to significant peak 
-helical 
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content of the CTD, coupled with a high degree of dynamic motion, led to peak 
broadening such that only 56% of side chain Hγ and 76% Hδ could be unambiguously 
assigned. The number of long range (>5 Å) NOEs was also lower than anticipated (140) 
for a protein of 19.6 kDa. Nevertheless, the overall rmsd of the 20 lowest energy 
structures was reasonable at 1.54 (± 0.19) Å and the ensemble of structures lies in 
acceptable ranges of common structure validation programs (all Z-scores above -5.0). 
When a representative structure for S. aureus primase CTD was compared to the x-ray 
and NMR CTD structures from other organisms, three conformational classes were 
observed (Figure 3A, 4). Two of the conformations are likely related to the function of 
primase. The conformation of the E. coli 1T3W structure is probably not biologically 
relevant given the low pH of its crystallization and some strong interface packing 
effects.
17
 Of all the structures, the G. stearothermophilus crystal structure 2R6A is the 
only one bound to helicase.
16
 This suggests that the structures of H. pylori (4EHS) and E. 
coli (2HAJ) are also helicase-bound forms. Since conformation B contains members from 
both Firmicutes and Proteobacteria, it indicates that the helicase-bound form of primase 
CTD is not phylum-dependent. Since the solution structures of G. stearothermophilus 
and S. aureus primase CTD are in conformation A, it appears to be the conformation 
adopted when primase dissociates from helicase. In the case of S. aureus, it has also been 
possible to use NMR dynamics to identify N564 as the key hinge residue that allows 
helix 6 to bend into helices 6 and 7.  
Three small molecules, acycloguanosine, adenosine, and myricetin, were discovered to 
bind a common site on the closed conformation of primase CTD. The ligand-binding 
pocket is only created when helices 6 and 7 are adjacent to one another. Among the nine 
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residues with CSPs that define this ligand-binding site, N564 exhibited the largest 
CSP and was also identified as a key residue in a conformational change between the 
open and closed form of primase CTD. As a result, this ligand-binding site is a potential 
target for the further development of small molecule inhibitors that may “lock” primase 
CTD in its closed form and prevent its interaction with the NTD of the helicase. In fact, 
two of the compounds shown to bind primase CTD have known inhibitory effects on 
DNA replication proteins, although their known mode of actions are different from the 
one identified here. Acycloguanosine is a known inhibitor of the primase-helicase 
interaction in herpes simplex virus and acts as a chain terminator.
67, 68
 Additionally, 
myricetin inhibits bacterial helicases with an IC50 
69
 by competing with the 
ATPase active sites. 
Since the S. aureus CTD structure shares many features with the G. stearothermophilus 
solution structure, we used the G. stearothermophilus DnaB/primase CTD co-crystal 
structure
16
 to identify potential interface residues. The co-crystal structure of the G. 
stearothermophilus primase CTD C2 subdomain (Figure 7A,C) contains five nonpolar 
residues (F577, L578, A581, A584, and I588) in the final helix that could make contact 
with DnaB NTD1 (L67, A72, A75, L80 and V86) (Table S6). Following this idea, we 
created a homology model of the S. aureus primase CTD and DnaB NTD (Figure 7B, D) 
and found there were conserved but not identical residues in the equivalent positions. The 
S. aureus CTD C2 subdomain residues were V598, L594, K591, E588 and V587, and the 
S. aureus DnaB NTD1 residues were V67, D72, S75, L80, and P86. It has been 
previously shown that a C-terminal fragment containing the last three helices of the G. 
stearothermophilus C2 subdomain
6
 exhibited sub-nanomolar binding affinity to DnaB, 
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but was not capable of stimulating the ATPase activity of DnaB. It could be that 
DnaG and DnaB from these two organisms interact using spatially similar, hydrophobic, 
but differently sized residues. The DnaG and DnaB structures may have coevolved to 
preserve the primase CTD interaction in a manner that led to species-specificity. 
The observation that the primase CTD-helicase structural interface is species-specific is 
consistent with previous studies showing that S. aureus helicase will only stimulate 
primer synthesis when incubated with the cognate primase.
6
 Stimulation of DnaB ATPase 
activity by primase binding has been shown to involve the C1 subdomain Y548 in G. 
stearothermophilus
70
 and F534 in the H. pylori
20
 C1 subdomain. Mutation of these 
residues to an alanine reduced binding affinity and ATPase stimulation. An examination 
of the G. stearothermophilus primase CTD structure shows that Y548 and the adjacent 
residue D547 in helix 6 of the C1 subdomain make contact with P97, T98, and N101 in 
the DnaB NTD2 (Figure 7C, Table S5). The structural equivalent residues in S. aureus 
C1 subdomain are D558 and Y559 and within the S. aureus DnaB NTD2 are also P97, 
T98, and N101 (Figure 7D). Since the residues are identical between G. 
stearothermophilus and S. aureus, it indicates the mechanism of ATPase stimulation is 
highly conserved. 
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Figure 7: Critical interface residues between primase and helicase. The co-crystal 
structure of the complex from G. stearothermophilus involves two DnaB NTDs, one of 
which interacts with the C1 subdomain of the primase and the other with the C2 
subdomain (A). The specific interface residues are shown in an expanded view (C). This 
was the template for the homology model of S. aureus primase CTD and DnaB NTDs 
(B), which is also shown in an expanded view (D). 
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6.6 Supplemental Figures and Tables 
Table S1: Bacterial primase sequence alignment 
According to the Clustal Omega FAQ page 
(http://www.ebi.ac.uk/Tools/msa/clustalo/help/faq.html#23)  
* indicates positions which have a single, fully conserved residues. 
: indicates conservation between groups of strongly similar properties – scoring > 0.5 in 
the Gonnet PAM 250 matrix. 
. indicates conservation between groups of weakly similar properties – scoring =< 0.5 in 
the Gonnet PAM 250 matrix 
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Blue – indicates S. aureus zinc binding domain 
Green – indicates S. aureus RNA polymerase domain 
Red – indicates S. aureus C-terminal domain 
 
CLUSTAL multiple sequence alignment by MUSCLE (3.8) 
 
Staphylococcus      --
MRIDQSIINEIKDKTDILDLVSEYVKLEKRGRNYIGLCPFHDEKTPSFTVSEDKQICH 
Bacillus            
MGNRIPEEVVEQIRTSSDIVEVIGEYVQLRKQGRNYFGLCPFHGENSPSFSVSSDKQIFH 
Geobacillus         
MGHRIPEETIEAIRRGVDIVDVIGEYVQLKRQGRNYFGLCPFHGEKTPSFSVSPEKQIFH 
Francisella         
MAKKVSNSFIKELVATADIVDVVSRYVNLKKTGKNYKGCCPFHNEKTPSFFVNPEKNFYH 
Aquifex             -----
MSSDIDELRREIDIVDVISEYLNLEKVGSNYRTNCPFHPDDTPSFYVSPSKQIFK 
Pseudomonas         
MAGLIPQSFIDDLLNRTDIVEVVSSRIQLKKTGKNYSACCPFHKEKTPSFTVSPDKQFYY 
E.coli              
MAGRIPRVFINDLLARTDIVDLIDARVKLKKQGKNFHACCPFHNEKTPSFTVNGEKQFYH 
Yersinia            
MAGRIPRVFINDLLARTDIIDLIDARVKLKKQGKNYHACCPFHHEKTPSFTVNGEKQFYH 
                             :. :    **::::.  ::* . * *:   **** :.:*** *. .*::   
 
Staphylococcus      CFGCKKGGNVFQFTQEIKDISFVEAVKELGDRVNVAVDIEATQSNSNVQIASDDLQ-
MIE 
Bacillus            CFGCGEGGNVFSFLMKMEGLAFTEAVQKLGERNGIAVA-
EYTSGQGQQEDISDDTVIMQQ 
Geobacillus         
CFGCGAGGNAFTFLMDIEGIPFVEAAKRLAAKAGVDLSVYELDVRGRDDGQTDEAKAMTE 
Francisella         CFGCQASGDALTFVKNINKLEFIDAVKNLAEIVGKPVEYENYS-QEDIQKEQLYNK-
CIS 
Aquifex             CFGCGVGGDAIKFVSLYEDISYFEAALELAKRYGKKL---------DLEKISKDEK-
VYV 
Pseudomonas         CFGCGAGGNALGFVMDHDQLEFPQAVEELAKRAGMDVPREERGGRGHTPRQPTDSP-
LYP 
E.coli              CFGCGAHGNAIDFLMNYDKLEFVETVEELAAMHNLEVPFEAGSGPSQIERHQRQT--
LYQ 
Yersinia            CFGCGAHGNAVDFLMNYDRLEFVESIEELATMHGLEVPYEAGSGTTQIERHQRQS--
LYQ 
                    ****   *:.. *    . : : ::   *.   .  :                        
 
Staphylococcus      
MHELIQEFYYYALTKTVEGEQALTYLQERGFTDALIKERGIGFAPDSSHFCHDFLQKKGY 
Bacillus            
AHELLKKYYHHLLVNTEEGNEALSYLLKRGITKEMIEKFEIGYASPAWDAATKILQKRGL 
Geobacillus         
AHALLKRFYHHLLVHTKEGQAALDYLQARGWTKETIDRFEIGYAPDAPDAAAKLLESHSF 
Francisella         
FLAAAQKYYRWNLGNSVTKDKAINYLKKRGIDSSLAKFFGIGYSSEGWNNITELAKSINI 
Aquifex             ALDRVCDFYRESLL---KNREASEYVKSRGIDPKVARKFDLGYAPSS-
EALVKVLKENDL 
Pseudomonas         
LLSAAAEFYKQALKSHPARKAAVNYLKGRGLTGEIARDFGLGFAPPGWDNLLKHLGGDNL 
  
233 
E.coli              LMDGLNTFYQQSLQ-
QPVATSARQYLEKRGLSHEVIARFAIGFAPPGWDNVLKRFGGNPE 
Yersinia            LMESLSAFYQQSLK-
GQNAKQAREYLKHRGLSEEIIQHFAIGFAPPGWDNALKRFGRDGE 
                           :*   *        *  *:  **          :*::. .     .        
 
Staphylococcus      DIELAYEAGLLSRNEENFSYYDRFRNRIMFPLKNAQGRIVGYSG-RTYTG-
QEPKYLNSP 
Bacillus            SLSSMEQAGLLIRSEKDGSHYDRFRGRVMFPIYTLQGKVIAFSG-RALGD-
DTPKYLNSP 
Geobacillus         SLPVMEKAGLLTKK-EDGRYVGRFRNRIMFPIHDHRGETVGFSG-RLLGE-
GHPKYVNSP 
Francisella         PEEILVDTGLAIKN-DKGNLYDRFRGRVMFPIRNIQGNVIAYGG-
RVTEDSDGVKYINSP 
Aquifex             LEAYLETKNLLSPT--KGVYRDLFLRRVVIPIKDPRGRVIGFGGRRIVED-
KSPKYINSP 
Pseudomonas         QLKAMLDAGLLVENSDTGKRYDRFRDRVMFPIRDSRGRIIAFGG-RVLGD-
DKPKYLNSP 
E.coli              NRQSLIDAGMLVTN-DQGRSYDRFRERVMFPIRDKRGRVIGFGG-RVLGN-
DTPKYLNSP 
Yersinia            SRTALNDAGMLVTN-DTGRTYDRFRERVMFPIRDKRGRVIAFGG-RILGD-
GVPKYLNSP 
                            .:   .       . *  *:::*:   .*  :.:.* *        
**:*** 
 
Staphylococcus      ETPIFQKRKLLYNLDKARKSIRK-----
LDEIVLLEGFMDVIKSDTAGLKNVVATMGTQL 
Bacillus            ETPIFHKSKLLYNFHQARPFIRK-----
RGQVVLFEGYADVLAAVKSGVEEAVATMGTAL 
Geobacillus         ETPVFRKGAILYHFHAARVPIRK-----
RQEALLVEGFADVISAAQAGIDYAIATMGTSL 
Francisella         
ETLVFQKNNILYGLYEYRERKKQYPDLINQSLVVVEGYMDVVGLAQHGFYAAVATLGTAF 
Aquifex             DSRVFKKGENLFGLYEAKEYIKE-----
EGFAILVEGYFDLLRLFSEGIRNVVAPLGTAL 
Pseudomonas         ETPVFHKGQELYGLYEARQKNRD-----
LDEIMVVEGYMDVIALAQQGIRNAVATLGTAT 
E.coli              ETDIFHKGRQLYGLYEAQQDNAE-----
PNRLLVVEGYMDVVALAQYGINYAVASLGTST 
Yersinia            ETEIFHKGRQLYGLYEAQVNHPN-----
PTRLLVVEGYMDVVALAQFGIDYAVASLGTAT 
                    :: :*.*   *: :   .    .         ::.**: *::     *.  .:*.:**   
 
Staphylococcus      SDEHITFIRKLTSNITLMFDGDFAGSEATLKTGQH----
LLQQGLNVFVIQLPSGMDPDE 
Bacillus            TEEQAKLLRRNVETVVLCYDGDKAGREATMKAGQL----
LLQVGCQVKVTSLPDKLDPDE 
Geobacillus         TEEQARIL-RPCDTITICYDGDRAGIEAAWAAAEQ----
LSALGCRVKVASLPNGLDPDE 
Francisella         SPNHAKILFRETSSVILCFDGDEAGQKAALRTIKILLP-
MLDGNKKLKILTLPDKDDPDD 
Aquifex             TQNQANLLSKFTKKVYILYDGDDAGR----
KAMKSAIPLLLSAGVEVYPVYLPEGYDPDE 
Pseudomonas         SEEHIKRLFRLVPSILFCFDGDQAGRKAAWRALESVLP-
NLQDGKRVRFLFLPEGEDPDS 
E.coli              TADHIQLLFRATNNVICCYDGDRAGRDAAWRALETALP-
YMTDGRQLRFMFLPDGEDPDT 
Yersinia            TAEHIQLLFRATDNVICCYDGDRAGRDAAWRALETALP-
YLNDGRQLRFMFLPDGEDPDT 
                    : ::   : .   .:   :*** **      : :         .  :    **.  ***  
 
  
234 
Staphylococcus      YIGKYGNDAFTTFVKNDKKSFAHYKVSILKDEIAHNDLS-
YERYLKELSHDISLMKSSIL 
Bacillus            YVQQYGTTAFENLVKS-
SISFVGFKINYLRLGKNLQDESGKEEYVKSVLKELSLLQDAMQ 
Geobacillus         YIRVYGGERFAGEAGC-
RRPLVAFKMAYLRRGKNLQHEGERLRYIDEALREIGKLSSPVE 
Francisella         YIKKYGLERFLTALDN-
SLAVADFVIDNLIQGKDLRKAEAKAEVLENLKNFLADVEDNIY 
Aquifex             FIKEFGKEELRRLINS-----SGELFETLIK----
TARENLEEKTREFRYYLGFISDGVR 
Pseudomonas         
LVRAEGEDAFRARITQQAQPLAEYFFQQLMLEADPATLEGKAHLATLAAPLLEKIPGNNL 
E.coli              LVRKEGKEAFEARMEQ-
AMPLSAFLFNSLMPQVDLSTPDGRARLSTLALPLISQVPGETL 
Yersinia            LVRKEGKDAFEQRMEA-
AQPLSTFLFETLMPQVDLSSPDGRAKLSTLALPLISQVPGEAL 
                     :   *   :               .  *                      :  : .    
 
Staphylococcus      QQKAINDVAPFFNVSPEQLAN--------------------------------------
- 
Bacillus            AESYLKSLSQEFSYSMETLLN--------------------------------------
- 
Geobacillus         QDYYLRQLAEEFSLSLSALHEQLSRSQRE------------------------------
- 
Francisella         SESITATIADKIGIKVEQFKN--------------------------------------
- 
Aquifex             RFALASEFHTKYKVPMEILLM--------------------------------------
- 
Pseudomonas         
RLLMRQRLSEITGLSGENIGQLAHHSPPPSSMDHGASGVLDGDDYFAASAYYENEPSHAP 
E.coli              RIYLRQELGNKLGILDDSQLE--------------------------------------
- 
Yersinia            RLYLRQQLGNKLGLLDDSQLD--------------------------------------
- 
                           .        .                                            
 
Staphylococcus      --------EIQFNQAPANYYPEDEYGGYDEYGGY-
IEPEPIGMAQFDNLSRREKAERAFL 
Bacillus            --------QLHQYRKEQKVQQKQVK---------
QVSKPSQIVQTKPKLTGFERAEREII 
Geobacillus         --------RTKPREAPDGETARPMLA-------------------
KKLLPAFQNAERLLL 
Francisella         --------LLKIRKQTTLNVNR-----------------------
QQNIQQKKLAKNLLL 
Aquifex             --------KIEKNSQEKEIK-------------------------------
LSFKEKIFL 
Pseudomonas         
FDAAPGYVEAQPRKSWNKDKKPWDGKKWDGKKKWDKGGRGDFKAPQRTPVSVESTTLNAL 
E.coli              --------RLMPKAAESGVS-------------------------
RPVPQLKRTTMRILI 
Yersinia            --------KLMPKQIDNANT-------------------------
YQPPQLKRTTMRILI 
                                                                               
: 
 
Staphylococcus      
KHLMRDKDTFLNYYESVDKDNFTNQHFKYVFEVLHDFYAENDQYNISDAVQYVNSNELRE 
Bacillus            YHMLQSPEVAVRMESHI--
EDFHTEEHKGILYELYAYYEKGNEPSVGTFLSWLSDEKLKN 
Geobacillus         AHMMRSRDVALVVQERIG-
GRFNIEEHRALAAYIYAFYEEGHEADPGALISRIPGELQPL 
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Francisella         EEFVLA-ELFVNIADFRILQHTND---------
FEIFATSKNLDILAKSLKILKEDSSNQ 
Aquifex             KGLI---ELKPKID-------------------LEVLNLSPELKELA------------
- 
Pseudomonas         
RTLLHHPQLALKVDDAGTLAREQDTYAQLLVSLLEALQKNPRQSSMQLIARWHGTPQGRL 
E.coli              
GLLVQNPELATLVPPLENLDENKLPGLGLFRELVNTCLSQPGLTTGQLLEHYRGTNNAAT 
Yersinia            
GLLVQNPQLATLIPSLQGLEQAKLAGLPLFIELVETCLAQPGLTTGQLLELYRDNKFSQQ 
                      ::   :                         .     .                     
 
Staphylococcus      -TLISLEQYNLNG---------EPYENEIDDYVNVINEK-
GQETIESLNHKLREATRIGD 
Bacillus            IITDISTDEFINP---------
EYTEEVLQSHLETLRRHQEKLEKMEIIFKIKQMEKTDP 
Geobacillus         ASDVSL--LLIAD---------DVSEQELEDYIRHVLNR--------
PKWLMLKVKEQEK 
Francisella         IEAVILIQLLAEDYPDYREYFFELLSYGIRNTQKKYAED----
KYQEQMFVMLKRVENSS 
Aquifex             VNALNGEEHLLPK---------EVLEYQV-DNLEKLFNN------------
ILRDLQKSG 
Pseudomonas         LQALGEKEWLIVQ---------ENLEKQFFDTITKLSES--------
QRFGEREERLRSV 
E.coli              LEKLSMWDDIADK---------NIAEQTFTDSLNHMFDS------------
LLELRQEEL 
Yersinia            LETLATWNHMIVE---------DMVEPTFVDTLASLYDS------------
ILEQRQETL 
                                          :  .  . .                              
 
Staphylococcus      VELQKYYLQQIVAKNKERM---------------- 
Bacillus            VEAAKYY-----VAYLQNQKARK------------ 
Geobacillus         TEAERRK----DFLTAAR-IAKEMIEMKKMLSSS- 
Francisella         VKKRLKYLGSLPFRSDVQEMERKYLVAKLGNSNII 
Aquifex             KKRKKRG-----LKNVNT----------------- 
Pseudomonas         MQKSYSE-----LTDEEKALLREHYSVAASSPSQS 
E.coli              IARERTH----GLSNEER---LELWTLNQELAKK- 
Yersinia            IARDRTH----GLNAEER---KELWSLNLALARKK 
 
Table S2:  Pairwise structure comparison matrices for all eight primase C-terminal 
domain structures:  (A) root mean square deviation (RMSD) and (B) number of aligned 
residues 
 
A. RMSD 
 E.coli 
1T3W_A 
E.coli 
1T3W_B 
E.coli 
2HAJ-19 
S.aureus 
2LZN-14 
G.stearo 
1Z8S-5 
G.stearo 
2R6A_C 
H.pylori 
4EHS_A 
H.pylori 
4EHS_B 
E.coli 
1T3W_A 
0 4.369 14.444 22.447 12.324 13.578 18.049 17.751 
E.coli 
1T3W_B 
4.369 0 15.897 14.734 12.675 14.268 19.743 19.735 
E.coli 
2HAJ-19 
14.444 15.897 0 12.162 11.226 5.870 13.047 12.891 
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S.aureus 
2LZN-14 
22.447 14.734 12.162 0 6.511 13.097 12.254 15.522 
G.stearo 
1Z8S-5 
12.324 12.675 11.226 6.511 0 10.937 11.578 12.535 
G.stearo 
2R6A_C 
13.578 14.268 5.870 13.097 10.937 0 8.780 9.014 
H.pylori 
4EHS_A 
18.049 19.743 13.047 12.254 11.578 8.780 0 0.444 
H.pylori 
4EHS_B 
17.751 19.735 12.891 15.522 12.535 9.014 0.444 0 
 
B. Number of aligned residues 
 E.coli 
1T3W_A 
E.coli 
1T3W_B 
E.coli 
2HAJ-19 
S.aureus 
2LZN-14 
G.stearo 
1Z8S-5 
G.stearo 
2R6A_C 
H.pylori 
4EHS_A 
H.pylori 
4EHS_B 
E.coli 
1T3W_A 
134 134 134 98 125 126 110 109 
E.coli 
1T3W_B 
134 135 135 126 134 126 95 94 
E.coli 
2HAJ-19 
134 135 135 125 132 126 95 94 
S.aureus 
2LZN-14 
98 126 125 143 139 140 114 85 
G.stearo 
1Z8S-5 
125 134 132 139 146 141 108 110 
G.stearo 
2R6A_C 
126 126 126 140 141 141 111 110 
H.pylori 
4EHS_A 
110 95 95 114 108 111 124 122 
H.pylori 
4EHS_B 
109 94 94 85 110 110 122 122 
 
Table S3: Residues of the twenty 2LZN ensemble structures that are in the 
Ramachandran plot disallowed regions 
 
Model 1: Asn 91 
Model 2: none 
Model 3: His 37, Glu 127 
Model 4: Glu 127, Thr 128 
Model 5: His 37 
Model 6: none 
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Model 7: Asp 53, Asn 91 
Model 8: Thr 128 
Model 9: none 
Model 10: His 37 
Model 11: Asn 91 
Model 12: none 
Model 13: none 
Model 14: Thr 128 
Model 15: Gln 126, Glu 127 
Model 16: Thr 128 
Model 17: His 37, Asn 91 
Model 18: Gln 126 
Model 19: Asn 91, Pro 109 
Model 20: none 
 
 
Table S4: Equivalent interface residues in the DnaC helicase N-terminal domain of G. 
stearothermophilus and S. aureus, where yellow highlights show interaction with primase 
C1 subdomain, and green highlight show interaction with primase C2 subdomain 
 
Clustal run 
G.stear       MSELFSERIPPQSIEAEQAVLGAVFLDPAALVPASEILIPEDFYRAAHQKIFHAMLRVAD-
60 
S.aureus      MDRMYEQNQMPHNNEAEQSVLGSIIIDPELINTTQEVLLPESFYRGAHQHIFRAMMHLNE 
              *..::.:.  *:. ****:***::::**  :  :.*:*:**.***.***:**:**::: : 
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G.stear       RGEPVDLVTVTAELAASEQLEEIGGVSYLSELADAVPTAANVEYYARIVEEKSVLRRLIR-
120 
S.aureus      DNKEIDVVTLMDQLSTEGTLNEAGGPQYLAELSTNVPTTRNVQYYTDIVSKHALKRRLIQ 
                : :*:**:  :*::.  *:* ** .**:**:  ***: **:**: **.:::: ****: 
 
G.stear       TATSIAQDGYTREDEIDVLL 
S.aureus      TADSIANDGYNDELELDAIL 
              ** ***:***. * *:*.:*  
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Chapter 7 
Enhanced Conformational Dynamics in a Parkinsonian Mutant of DJ-1 
Causes Pathogenic Instability at Physiological Temperature 
7.1 Introduction 
Parkinson’s disease results from the progressive death of dopaminergic neurons in the 
midbrain. While the cause of most cases of Parkinson’s disease is unknown, the study of 
heritable forms of parkinsonism has helped elucidate the biochemical basis of 
dopaminergic neurodegeneration. Recessively inherited mutations in three proteins can 
cause parkinsonism: parkin (PARK2), PINK1 (PARK6) and DJ-1 (PARK7).
1
 These three 
proteins are natively neuroprotective, particularly against mitochondrial dysfunction. 
Human DJ-1 is a conserved, ubiquitously expressed homodimeric protein that 
participates in multiple pathways
2-8
 to protect cells against oxidative stress
9-12
 and to 
maintain proper mitochondrial function.
13
 In addition to parkinsonism, loss of DJ-1 
mediated cytoprotection is also implicated in ischemia-reperfusion injury, as occurs in 
stroke and myocardial infarction.
14, 15
 Despite abundant evidence that DJ-1 participates in 
multiple cytoprotective pathways, the details of its molecular activity remain 
incompletely understood. 
Several pathogenic missense mutations in DJ-1 decrease protein stability, thereby causing 
disease.
3, 16
 For example, the L166P, L10P, and P158Δ parkinsonian mutations disrupt 
the DJ-1 dimer, causing poor folding and proteolytic degradation of the protein.
1, 17
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However, several other disease-associated mutants in DJ-1 are more structurally 
benign
16, 18, 19
 and thus the molecular basis of their pathogenicity is not understood.  
M26I DJ-1 is an example of a mutant whose underlying molecular defect is obscure. 
Steady state levels of M26I DJ-1 are lower than wild-type protein in cell culture
3, 20
 and 
in vivo,
21
 indicating reduced protein stability in the cellular environment.
3, 20, 21
 However, 
X-ray crystallography, NMR, and biophysical studies indicate that M26I DJ-1 is highly 
structurally similar to the wild-type protein and both proteins have comparable stability to 
thermal and chemical denaturation.
16, 17
 Therefore, it is not clear from prior work why 
M26I DJ-1 is less stable in cells than the wild-type protein.  
The absence of a structural explanation for the established pathogenicity of M26I DJ-1 
suggests that the conformational dynamics of the protein might be changed by the 
mutation, potentially decreasing DJ-1 stability. The dynamical hypothesis for M26I DJ-1 
pathogenesis is untested, as no comprehensive study of the dynamics of DJ-1 or any of its 
pathogenic mutants has been reported to date. However, recombinant M26I DJ-1 is prone 
to spontaneous aggregation in vitro that is not observed for the wild-type protein.
19, 22
 
This enhanced in vitro aggregation indicates that M26I DJ-1 has intrinsically reduced 
stability that would likely result in greater turnover and reduced steady-state levels of the 
protein in vivo. Such an effect in M26I DJ-1 would provide a rare example of a direct 
connection between aberrant protein dynamics and disease.  
Here we show that the M26I mutation does not alter the picosecond-nanosecond 
timescale dynamics of DJ-1 but does increase protein flexibility on longer timescales. 
The enhanced conformational dynamics of M26I DJ-1 causes transient exposure of the 
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hydrophobic core to solvent and results in pronounced aggregation near physiological 
temperatures (35-37°C) but not below. The dynamically driven instability of M26I DJ-1 
at physiological temperature provides an explanation for why the M26I mutation 
destabilizes the protein in cells and causes loss of DJ-1 protection. These results also 
illustrate a common and underappreciated limitation of in vitro experiments performed at 
room temperature, where the functional consequences of protein dynamics may not be 
evident. 
 
7.2 Materials and Methods 
7.2.1 Protein Expression and Purification 
Human wild-type and mutant (M26I, M26V, M26L, L101W, Y141W, M26I Y141W) 
DJ-1 proteins were expressed from pET15b (Novagen) constructs
23
 and purified using 
Ni
2+
 affinity chromatography as previously described
23
 except that all buffers contained 
freshly added 2.5 mM dithiothreitol (DTT). Uniformly 
15
N-labeled proteins (wild-type, 
M26I, M26L DJ-1) were expressed as previously described.
24
 
Purified proteins were dialyzed against storage buffer (25 mM HEPES pH 7.5, 100 mM 
KCl, 2.5mM DTT) overnight at 4C and concentrated to 1 mM using an ultrafiltration 
concentrator with a 10 kDa MWCO regenerated cellulose membrane (Millipore), snap-
frozen in small aliquots on liquid nitrogen, and stored at -80°C until needed. All proteins 
ran as a single band in overloaded Coomassie Blue stained SDS-PAGE gel and had 
correct intact masses determined using electrospray mass spectroscopy (Redox Biology 
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Center, UNL). Only DJ-1 that was >95% reduced at Cys106 was used for the 
experiments in this study. 
 
7.2.2 NMR Sample Preparation 
For NMR experiments, purified 
15
N-labeled DJ-1 samples were dialyzed against 25 mM 
MES pH 6.5, 25 mM NaCl, 2.5 mM DTT and concentrated to 0.9 mM. The 
15
N labeling 
efficiency as well as intact protein mass was determined using reverse phase liquid 
chromatography-mass spectrometry (LC-MS) as detailed previously.
16, 24
 Proteins were 
diluted in water and analyzed using an Agilent 1200 LC system (Agilent Technologies) 
and a Q-Trap-4000 MS (AB Sciex) at the Metabolomics and Proteomics Core Facility in 
the Redox Biology Center (RBC) and the University of Nebraska-Lincoln (UNL). 
Samples for T1, T2, and NOE measurements were prepared by adding D2O to a final 
concentration of 10% by addition of 99.9% D2O (Sigma-Aldrich) and the sample was 
transferred to a 5 mm, high-throughput 7” standard series NMR tube (Norell).  
Samples for NMR-detected H/D Exchange (HDX) experiments were dialyzed against 10 
mM ammonium acetate pH 6.7 and 5 mM DTT at ~21C. Samples were flash frozen with 
liquid nitrogen, lyophilized, and stored at -80C until needed. To ensure that 
lyophilization did not cause irreversible changes in DJ-1, we compared the 2D 
1
H-
15
N 
HSQC spectra obtained from protein before and after lyophilization. No differences were 
observed. HDX was performed by resuspending the lyophilized protein in 25 mM MES 
pH 6.1, 25 mM NaCl, 2.5 mM DTT in 100% D2O. The solution pH was adjusted to 6.1 
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with a 40% solution of NaOD (Sigma-Aldrich) and the pD calculated according to: 
pDcorrected = pH + 0.4 (therefore the final pD of this buffer was 6.5).
25
  
 
7.2.3 T1, T2 Relaxation and NOESY Experiments 
All 2D 
1
H-
15
N heteronuclear single quantum coherence (HSQC) spectra were collected 
using a Bruker AVANCE DRX 500 MHz spectrometer equipped with a 5 mm triple 
resonance, Z-axis gradient cryoprobe with a cold proton channel at the University of 
Nebraska-Lincoln’s Research Instrumentation Facility. 2D 1H-15N HSQC spectra 
acquired for T1 (Bruker pulse sequence hsqct1etf3gpsi), T2 (hsqct2etf3gpsi), and NOE 
(hsqcnoeetf3gpsi) measurements were collected at 35C. The delays for T1 (0.2696, 
0.05392, 0.5392, 0.005392, 0.4044, 1.0784, 0.1348, 0.6740, 0.2696 sec) and T2 (0.0176, 
0.0352, 0.0528, 0.0704, 0.0880, 0.1056, 0.1231, 0.1408, 0.1584, 0.1760, 0.1936, 0.2112 
sec) relaxation experiments were randomized to minimize systematic error. All spectra 
were collected using a total of 2048 and 256 data points and spectral sweep widths of 
7309.942 and 2027.164 Hz along the proton and nitrogen dimensions, respectively. Free 
induction decays (FIDs) were Fourier transformed, zero-filled, phased, and baseline 
corrected using NMRPipe
26
 and analyzed using NMRViewJ.
27
 Chemical shift 
assignments for wild-type DJ-1 were retrieved from the Biological Magnetic Resonance 
Data Bank with accession number BMRB 17507.
17
 Our 35C spectra are shifted ~0.16 
ppm in the hydrogen dimension compared to the previously collected 27°C spectra,
17
 as 
expected with an increase in temperature. 
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The relaxation times (T1, T2) for each amide resonance were calculated by fitting a 
decay curve (see Eq. 1) to the intensity of each peak plotted against the associated delay 
(in msec), where It is the intensity of each peak at the specified delay time t, and I0 is the 
initial steady state intensity. The inverse of the relaxation times produced relaxation rates 
(R1, R2) (converted to sec
-1
). 
 
 It = I0exp(-t/T1,2)         [EQ. 1] 
 R1,2 = 1/T1,2         
 
Interleaved 2D 
1
H-
15
N NOESY spectra were collected using 2048 and 128 data points 
along the direct and indirect axis, respectively, with 30 msec of proton saturation applied 
(or not) during a 5 sec relaxation interval. The NOE values were calculated by dividing 
the peak intensity for the saturated (Isat) spectrum by the unsaturated (Iunsat) spectrum (see 
Eq. 2) 
 
 NOE = Isat / Iunsat        [EQ. 2] 
 
The R1, R2 relaxation rates and NOE data were used to calculate the generalized order 
parameter (S
2
), internal motion (e), chemical exchange (Rex), and the overall correlation 
time (c) using Lipari-Szabo model free parameters in the FAST-Modelfree program 
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(Facile Analysis and Statistical Testing for Modelfree), interfaced with ModelFree 
4.20.
28-30
 The PDB coordinate files for the WT and mutant proteins were first input into 
PDBInertia to translate their centers of mass to the origin. For each R2/R1 list and 
respective PDB file output from PDBInertia, the R2R1-Diffusion program was used to 
predict the axially symmetric diffusion tensor based on the approach of Tjandra, et al.
31
 
The NMR spin-relaxation data (R1, R2, NOE) and the PDB obtained from R2R1-Diffusion 
was then input into the FAST-ModelFree software package.
30
 To ensure that the 
dynamics analysis was not converging on a local minimum, the random seed value was 
changed for each run and the same seed value was never used more than once. Further, 
each FAST-ModelFree run was done in triplicate to verify that the output values were 
reproducible. 
Temperatures for all NMR experiments were calibrated using 100% ethylene glycol as a 
temperature standard. Briefly, the separation between the OH resonances and the CH2 
resonances in ethylene glycol were measured (, ppm) and the sample temperature 
calculated, according to the following equation: T = (4.637 - ) / 0.009967, where T is 
the calculated temperature (Kelvin), and  is the shift difference (in ppm) between OH 
and CH2 peaks (Bruker Instruments, Inc. VT-calibration manual). 
 
7.2.4 H/D Exchange (HDX) NMR Spectroscopy 
For HDX measurements, protonated 
15
N-labelled proteins were lyophilized and 
resuspended in 500µL of 25 mM MES pH 6.5, 25 mM NaCl, 2.5 mM DTT in 100% D2O. 
2D 
1
H-
15
N HSQC spectra (sfhmqcf3gpph) were collected every 10 min for 60 hrs at 35˚C. 
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Spectra were collected using a total of 2048 and 256 data points with spectral sweep 
widths of 7309.942 and 3041.362 Hz along the proton and nitrogen dimensions, 
respectively. The pulse program was edited to use a reburp shape pulse
32
 and to include a 
delay equal to 300 sec. This delay occurs before data collection to allow the cryoprobe 
coil temperature to equilibrate after each acquisition. The 300 sec delay was only applied 
for subsequent acquisitions in the first 60 hrs of data acquired. Each spectrum had a 
reburp pulse duration of 1 msec, receiver gain set to 3k, SP23 set to 24.05 dB, SP24 set to 
13.11 dB, PC9 set to 3 msec, thereby making each SoFAST-HSQC’s total acquisition 
time 5 min 8 sec.  
HDX rates (kex) were calculated similarly to T1 and T2 relaxation rates (see above). A 
protection factor (PF) was calculated by dividing an estimated intrinsic rate (kint) for each 
residue by the measured rate (kex) for that residue,
33-36
 i.e. PF = kint/kex. The PFs presented 
within the manuscript are the log10(kint/kex) referred to as log10PF.
37, 38
 Due to rapid 
exchange, we had to estimate kex values for several residues for wild-type DJ-1 (47 for 
the monomer) and M26I DJ-1 (85 for the monomer) as described below. For residues that 
could be observed in a T1 HSQC but were not present in the first HDX HSQC, the rate 
constant for exchange was estimated to be ten times greater than the collection time for 
the HDX HSQC (e.g. kex=1/1.4 min
-1
 for an HSQC spectrum obtained after 14 minutes of 
H/D exchange); this affected 85 residues for M26I and 44 residues for wild-type DJ-1. 
For all residues present in the first HDX spectrum, but then exchanged before a second 
spectrum could be collected, the kex was estimated to be ten times faster than the second 
HDX HSQC collection time, in min
-1
; this affected three residues for wild-type DJ-1 
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only. There were also a total of six residues for M26I and 12 residues for wild-type 
DJ-1 that did not exchange with D2O over the 60 hr experiment.  
 
7.2.5 DJ-1 aggregation as a function of temperature 
Because Ni
2+
-NTA purified DJ-1 (referred to as ‘As Purified’ in Fig. 5a) has been 
reported to be more susceptible to aggregation than a sample that has not been exposed to 
transition metals,
39
 DJ-1 used for the aggregation experiments was supplemented with 10 
mM EDTA, dialyzed overnight against storage buffer containing 1 mM EDTA, then 
dialysed again against storage buffer alone (referred to as ‘EDTA treated and Removed’ 
in Fig. 5b.) Aggregation of 100 M DJ-1 was monitored by measuring the optical density 
of the sample at 400 nm every 30 min over 60 continuous hours with a BioTek Synergy 2 
multi-mode microplate reader (BioTek Instruments, Inc.). Sample temperature was 
controlled with the installed Gen5 software and data were collected at 30, 35, and 37C. 
WT, M26I, M26L, and M26V DJ-1 were diluted to a volume of 180 L with degassed 
storage buffer and placed in a 96-well plate (Costar 3595). 50 µL of light mineral oil 
(Fisher Scientific) was layered over the sample to prevent evaporation, the 96-well plate 
was sealed with optically clear polystyrene seals (VWR International), and the samples 
were allowed to equilibrate for 10 min prior to the start of the assay.  
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7.2.6 Fluorometry of DJ-1 Tryptophan Mutants 
Human DJ-1 lacks a Trp, making it necessary to introduce a Trp by site-directed 
mutagenesis. To identify minimally disruptive locations for introduction of a Trp residue 
into DJ-1, sequence alignments of various proteins in the DJ-1/PfpI superfamily that 
contain Trp residues were used. Proteins in this alignment were 40-46% identical to 
human DJ-1, maximizing the chances for identifying well-tolerated locations for Trp 
substitution. Leu101 and Tyr141 were identified as candidate sites for mutation that also 
corresponded to areas of DJ-1 with markedly different responses to the M26I mutation in 
HDX. All mutations were verified by DNA sequencing. Hexahistidine-tagged 
recombinant proteins were expressed using pET15b in BL21(DE3) E. coli and purified as 
previously described.
16, 23
 Due to solubility problems, M26I/L101W DJ-1 cells were 
induced with 0.2 mM IPTG followed by incubation at 20C overnight with shaking. 
Additionally, chloramphenicol (Fisher Scientific) was added to a final concentration of 
100 g/mL two hrs before cells were harvested to enhance the recovery of soluble 
protein.
40, 41
 
Intrinsic tryptophan fluorescence emission spectra were collected at 37°C using a Cary 
Eclipse fluorescence spectrophotometer (Varian) from 300-400 nm with excitation at 280 
nm, and excitation and emission slit widths set to 5 nm. A recirculating thermostated 
water bath (Varian) was used to control temperature. DJ-1 samples were diluted to 500 
M in storage buffer, the cuvette was capped, and the solution was allowed to equilibrate 
for 5 min. After correction for background scattering using a buffer control, the 
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fluorescence spectra of the samples were measured. All fluorescence intensities were 
normalized to the concentration of their respective protein.  
 
7.2.7 Chemical Cross-linking and Proteolysis of DJ-1 
Disuccinimidyl suberate (DSS) (Thermo-Scientific) was aliquoted into 2 mg portions in a 
Coy anaerobic chamber (Coy Lab Products) with plastic spatulas. All plastic material was 
equilibrated in this environment for at least two weeks prior to use in order to minimize 
metal or oxygen contamination prior to the experiment, which can reduce DSS cross-
linking efficiency. DSS aliquots were then stored in desiccant at 4C until ready to use. 
Wild-type and M26I DJ-1 were diluted to 100 M and subsequently dialyzed against 
storage buffer lacking DTT. Each protein was divided into two 200 L aliquots where 
one aliquot was incubated at room temperature (~22C) and the other at 37C. The 
samples were incubated at their respective temperatures for ~ 2 hrs prior to the initiation 
of cross-linking by addition of 100 mM DSS dissolved in DMSO to final concentrations 
of 0, 2, 3, 4, or 5 mM. DMSO alone was added as a negative control. After 30 min, the 
reaction was quenched with the addition of Tris-HCl, pH 7.5 to a final concentration of 
38 mM and incubated for an additional 15 min at their respective temperatures. All 
samples were then mixed with SDS-loading dye, heated to 95C for 5 min and analyzed 
using SDS-PAGE with a 12% gel stained with colloidal Coomassie blue dye (Life 
Technologies). 
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Wild-type, M26I and M26L DJ-1 were diluted to 100 M and subsequently dialyzed 
against PBS pH 7.4 (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 5 
mM EDTA). Each protein was incubated either at room temperature (~22C) or at 37C. 
The samples incubated at their respective temperatures for 0-3 hr, and at selected time 
points, a small aliquot was removed and either incubated with Bismaleimidoethane 
(BMOE) (Thermo-Scientific) (final concentrations: 0, 0.1, or 0.5 mM) or DMSO 
(negative control) for 45 min. After 45 min, the reaction was quenched with the addition 
of DTT to a final concentration of 20 mM and incubated for an additional 15 min. 
Samples were mixed with SDS-loading dye, heated to 100C for 5 min and analyzed 
using SDS-PAGE with a 12% gel stained with colloidal Coomassie blue dye (Life 
Technologies). 
 
7.2.8 Limited protease digestion 
Wild-type, M26I and M26L DJ-1 were diluted to 400 M in storage buffer. Trypsin, 
dissolved in storage buffer, was added to the protein sample at a final concentration of 
4.3 M. The samples were incubated in a water bath at 37C for 22.5 hrs. Aliquots were 
removed at various time points, mixed with SDS-loading dye, and heated to 100C for 5 
min to stop proteolysis. Digested samples were analyzed using SDS-PAGE with a 15% 
gel and stained with colloidal Coomassie blue (Life Technologies). 
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7.2.9 Thermal stability determination and far-UV circular dichroism (CD) 
spectroscopy  
The melting temperatures of DJ-1 proteins were determined using differential scanning 
fluorimetry as previously described.
24, 42
 The secondary structural content of the proteins 
was determined using far-UV CD spectroscopy following a previously reported 
protocol
24
 with minor modifications. CD spectra were measured for 13 M proteins in 10 
mM potassium phosphate pH 7.2, 2.5 mM DTT using a Jasco J-815 CD Spectrometer 
(Jasco, Inc.). Sample temperature was controlled with a Julabo AWC100 (Julabo USA, 
Inc.) recirculating water cooler and far-UV CD spectra were collected at 25 and 37C. 
Protein concentration in the cuvette was determined using Scopes’ method43 and used to 
calculate the mean residue molar ellipticity according to the formula below:
24
 
 
[Θ(𝜆)] =
𝜃𝑜𝑏𝑠(𝜆)
10𝑛𝑐𝑙
⁡⁡⁡⁡⁡⁡⁡⁡[EQ. 3] 
 
where Θ(λ) is the mean residue molar ellipticity as a function of wavelength (deg cm2 
dmol
-1
 residue
-1), θobs(λ) is the measured ellipticity as a function of wavelength (nm), n is 
the number of residues in the protein, c is the concentration of the protein (M), and l is 
the path length of the cuvette (cm). 
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7.2.10 Crystal growth, data collection and processing, and structure determination for 
M26V DJ-1 
M26V DJ-1 was crystallized using the sitting drop vapor diffusion method by mixing 2.4 
µL of protein at 1.3 mM and 1.8 µL of reservoir solution (100 mM Tris-HCl pH 9, 200 
mM sodium acetate trihydrate, 25 % PEG 4000 and 3 mM DTT), followed by 
equilibration against 1 mL of the reservoir solution. Bipyramidal crystals of M26V DJ-1 
in space group P3121 appeared in 2-4 days at room temperature. Crystals were 
cryoprotected by serial transfer through the reservoir solution supplemented with 
gradually increasing amounts of ethylene glycol until a final concentration of 25% (v/v) 
was reached. The cryoprotected crystals were removed from the cryoprotectant in nylon 
loops and mounted in a nitrogen cryostream for data collection.  
X-ray diffraction data were collected to 1.45 Å resolution from a single crystal at 110 K 
at the University of Nebraska-Lincoln Macromolecular Structural Core Facility using a 
MicroMax-007 copper rotating anode source (Rigaku) operating at 40 kV and 20 mA 
with Osmic Blue confocal optics, and a Raxis IV
++
 detector (Rigaku). In situ annealing
44
 
of all crystals was done by blocking the cold nitrogen stream for ~3 sec, which reduces 
mosaicity and improves data scaling statistics. All data were indexed, scaled, and merged 
using HKL2000
45
 with final data statistics in Table 1. 
Phases for M26V DJ-1 were determined by molecular replacement (MR) using the 
structure of human DJ-1 (PDB: 1P5F, 99% sequence identity
46
) as a search model in 
Phaser
47
 in the CCP4 suite.
48
 Manual adjustments to the initial top MR solution were 
made by inspection of 2mFO-DFC and mFO-DFC electron density maps in COOT.
49
 The 
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resulting model was refined in Refmac5
50
 against a maximum likelihood amplitude-
based target function with geometric and anisotropic atomic displacement parameter 
(ADP) restraints and including riding hydrogens. A test set of 5% randomly chosen 
reflections were used for the calculation of the Rfree
51
 value. The stereochemical, side 
chain rotameric, and packing quality of the final model was validated using COOT
49
 and 
the MolProbity server
52
. All residues except Cys106 were in favored regions of the 
Ramachandran plot, which is commonly observed in DJ-1 crystal structures. Final data 
and model statistics are provided in Table 1.  
 
Table 1: Data Collection and Refinement Statistics 
Data Collection  
Sample M26V DJ-1 
X-ray source Rotating Cu Anode 
X-ray wavelength (Å) 1.54 
Space group P3121 
Cell dimensions a, b, c (Å) 75.04, 75.04, 75.27 
, β,  (degrees) 90, 90, 120 
Resolution (Å)
a
 64.99-1.45 (1.49-1.45) 
Rmerge
b
 0.062 (0.523) 
<I>/<σ(I)> 56.6 (5.0) 
Completeness (%) 99.7 (97.0) 
Redundancy 20.4 (18.2) 
Refinement  
Program Refmac5 
Resolution (Å) 64.99-1.45 
No. of reflections 41569 
Rwork (%)
c
  0.110 (0.344) 
Rfree (%)
d
 0.135 (0.375) 
Rall (%)
e
 0.111 
No. of protein residues 189 
No. of water atoms 309 
No. of heteroatoms (ligand EDO) 4 
Beq factors (Å
2
)  
Protein 18.07 
Water 38.07 
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Heteroatoms 30.50 
r.m.s. deviations  
Bond lengths (Å) 0.013 
Bond angles (degrees) 1.63 
 
a
 Values in parentheses are for highest resolution shell 
b
 Rmerge is calculated according to Equation 4, 
 
Rmerge =⁡∑ ∑ |𝐼ℎ𝑘𝑙
𝑖 −⁡〈𝐼ℎ𝑘𝑙〉|⁡/⁡∑ ∑ 𝐼ℎ𝑘𝑙
𝑖
𝑖ℎ𝑘𝑙𝑖ℎ𝑘𝑙 ⁡⁡⁡⁡[EQ. 4] 
 
where i is the ith observation of a reflection with index h, k, l, and angle brackets 
indicate the average over all i observations. 
c
 Rwork is calculated according to Equation 5, 
Rwork =⁡∑|𝐹ℎ𝑘𝑙
𝑂 −⁡𝐹ℎ𝑘𝑙
𝐶 |⁡/⁡∑𝐹ℎ𝑘𝑙
𝑂 ⁡⁡⁡⁡⁡⁡[EQ. 5]
ℎ𝑘𝑙ℎ𝑘𝑙
 
 
where 𝐹ℎ𝑘𝑙
𝐶  is the calculated structure factor amplitude with index h, k, l, and 𝐹ℎ𝑘𝑙
𝑂  is the 
observed structure factor amplitude with index h, k, l. 
d
 Rfree is calculated as Rwork, where the 𝐹ℎ𝑘𝑙
𝑂  values are taken from a test set comprising 
5% of the data that were excluded from the refinement. 
e
 Rall is calculates as Rwork, where the 𝐹ℎ𝑘𝑙
𝑂  include all measured data (including the Rfree 
test set). 
 
7.3 Results 
7.3.1 M26I and wild-type DJ-1 have similar picosecond-nanosecond dynamics at 35˚C  
Consistent with previous NMR and X-ray crystallographic results, the solution structures 
of wild-type and M26I DJ-1 are comparable based on their highly similar two 
  
255 
dimensional (2D) 
1
H-
15
N heteronuclear single quantum coherence (HSQC) NMR 
spectra collected at 35°C (Figure 1).
16, 17
 This temperature was chosen because we sought 
to characterize DJ-1 near physiological temperature, however experiments at 37C 
resulted in aggregation of M26I DJ-1 (see below). The similar structures but divergent 
cellular stabilities of wild-type and M26I DJ-1 suggest the hypothesis that the M26I 
mutation may alter the conformational dynamics of DJ-1. 
We characterized the picosecond-nanosecond (ps-ns) time-scale dynamics of DJ-1 using 
NMR by measuring the R1 and R2 relaxation rates as well as Nuclear Overhauser Effect 
(NOE) ratios at 500 MHz and 35C (Figure 2). The R2/R1, and NOE ratios were similar 
for wild-type and M26I DJ-1 at 35C (Table 2, Figure 3). NOE ratios are bound by 0 and 
1, with lower values indicating areas of increased motion in the backbone of a protein.
17
 
The averaged NOE ratios at 35C for both wild-type (0.78  0.10) and M26I DJ-1 (0.77  
0.087) are lower than previously reported values at 27C (0.9  0.09),17 consistent with 
greater protein motion at higher temperature.  
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Figure 1: Wild-type and M26I DJ-1 have similar 2D 
1
H-
15
N HSQCs at 35°C. The 2D 
1
H-
15
N HSQC spectrum for wild-type (WT, black) is overlaid with the spectrum for M26I 
DJ-1 (red). M26I DJ-1 resonances mostly overlap with those observed for WT DJ-1, as 
was previously shown by Malgieri and Eliezer.
17
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Figure 2: Example fitting for T1, T2 relaxation curves of select residues in wild-type 
and M26I DJ-1 at 35°C. (A, C) Wild-type (WT) and M26I T1 relaxation fits for ten 
randomly chosen amino acids. (B, D) WT and M26I T2 relaxation fits for the same amino 
acids as in (A). (A-D)  
 
Table 2. 
 WT DJ-1  M26I DJ-1 
Model Free Input   
NOE 0.779  0.0997 0.770  0.0871 
R1 1.158  0.1398 1.219  0.288 
R2 19.303  2.309 18.821  1.727 
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R2/R1 16.877  2.643 15.911  2.271 
Model Free Output   
S
2
 0.912  0.0788 0.934  0.0544 
S
2
f 0.876  0.0492 --- 
S
2
s 0.916  0.0724 0.934  0.0544 
te 1313.9  714.923 622.75  656.975 
Rex 3.188  1.688 1.356  1.917 
SSE 1.977  2.742 1.545  2.238 
Values in the table are averages  SD 
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Figure 3: The R2/R1 and NOE ratios are similar for WT and M26I DJ-1 at 35°C. (A) 
The ratio of relaxation rates (R2/R1) is plotted for every observed backbone amide 
resonance in both wild-type (WT, black) and M26I (red) DJ-1. The R2/R1 ratio is similar 
for both proteins at 35°C. (B) WT (black) and M26I (red) NOE ratios. Four NOE ratio 
values for M26I DJ-1 are not bound by 0 and 1, and they are Met133, Ser161, Val169, 
and Val186. This is likely due to inadequate equilibration of NOE saturation for these 
few residues. 
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Lipari-Szabo model free analysis was performed using the measured R1, R2, and NOE 
ratios, generating generalized order parameters (S
2
) that describe the extent of motion of 
each assigned amide N-H pair using a “vector in a cone” description. S2 is bound by 0 
and 1, where lower values indicate areas of increased mobility of the backbone peptide 
groups.
30, 53
 The S
2
 values for wild-type and M26I DJ-1 at 35C are similar (Figure 4), 
with average values of 0.91  0.079 and 0.93  0.054, respectively (Table 2). We note 
that these values are high, indicating that DJ-1 is fairly rigid on the ps-ns timescale. 
These calculated S
2
 values are robust to changes in the selection of residues used for 
initial diffusion tensor calculation and different random number seeds, indicating good 
convergence in the calculations and low sensitivity to initial parameters. 
 
7.3.2 The M26I mutation increases longer time-scale dynamics at 35C  
Slower timescale (minutes to hours) dynamics of DJ-1 were investigated using NMR-
detected hydrogen/deuterium exchange (HDX). Because enhanced protein mobility will 
increase the solvent accessibility of backbone amide groups, NMR-detected HDX is a 
sensitive and site-specific probe of dynamics that occur on longer timescales than those 
characterized using NMR relaxation-based methods.  
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Figure 4: Wild-type and M26I DJ-1 behave similarly on a fast time-scale at 35C. 
The general order parameter (S
2
) for wild-type (WT, black) and M26I DJ-1 (red) at 35°C 
obtained from FAST ModelFree are plotted per residue. Picosecond-nanosecond motions 
for both proteins are nearly identical at 35C. The regions without a reported value 
indicate amino acids that could not be analyzed in FAST ModelFree, primarily due to 
unobserved or overlapping resonances in the NMR spectra. A schematic of the secondary 
structure of DJ-1 is shown below for reference (rectangles=-sheet, arrows=-helix.)  
 
HDX reveals that the hydrophobic core of M26I DJ-1 is substantially less protected (and 
hence more dynamic) than that of wild-type DJ-1, while both proteins have comparable 
HDX rates for solvent exposed residues. HDX rates measured at 35˚C were converted to 
protection factors (log10PF)
33, 34
 (Figure 5a, Figure 6) and were then mapped onto the 
crystal structure of dimeric DJ-1 (Figure 5b). Despite being structurally similar to the 
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wild-type protein, M26I DJ-1 experiences greater conformational fluctuations than 
wild-type DJ-1, particular for residues 15-35, 45-55, 110-120, 130-135, 140-190. The 
elevated exchange in the core of M26I DJ-1 is particularly noteworthy, as it indicates that 
the mutant protein transiently samples conformations that deviate markedly from the 
crystal structure and exposes the hydrophobic core to solvent. This is highlighted by 
inspection of difference log10PF factors, which clearly show that the hydrophobic core of 
DJ-1 is less protected (and hence more solvent exposed) in M26I DJ-1 (Fig. 5c). Because 
the hydrophobic core of DJ-1 spans both monomers in the dimer, the elevated exchange 
in the core of M26I DJ-1 could involve transient dimer opening, although M26I is highly 
dimeric in other studies,
16, 17, 19, 20
 suggesting that dissociation into monomers is less 
likely. 
Tryptophan (Trp) fluorescence spectroscopy was used as an additional probe of the 
influence of the M26I mutation on the flexibility of M26I DJ-1. The quantum yield of 
Trp is sensitive to its local environment, and thus Trp can serve as a reporter of site-
specific environmental changes resulting from mutation of residue 26. Human DJ-1 
contains no Trp residues, therefore we introduced Trp at two locations of the protein 
(residues Tyr141 and Leu101) that exhibited strongly differing HDX behavior in 
response to the M26I mutation (Fig. 5c). Both the Y141W and L101W mutations have 
small effects on the thermal stability and secondary structure of DJ-1, indicating that 
these mutations do not significantly perturb the DJ-1 structure (Figure 7). Tyr141 is 
located in a region of DJ-1 with low log10PF and whose HDX exchange rate is insensitive 
to the M26I mutation (log10PFWT=2.09 vs. log10PFM26I= 2.08). Consistent with the HDX 
results, the fluorescence quantum yield of Y141W is similar in wild-type and M26I DJ-1 
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(Figure 8). In contrast, the L101W substitution is located at a position that becomes 
mobile as a result of the M26I mutation, exhibiting a HDX log10PF decrease from 4.35 in 
wild-type to 1.75 in M26I DJ-1. Consistent with the HDX results, the fluorescence 
emission of M26I/L101W DJ-1 is markedly lower than that of L101W alone, indicating 
that Trp101 fluorescence in the M26I mutant is partially quenched due to a dynamically 
driven increase in solvent exposure (Figure 8). 
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Figure 5: HDX-detected dynamics are dramatically changed for M26I DJ-1 at 
35C. 
(A) Calculated log10 HDX protection factors (Log10PF) for wild-type (WT, black) and 
M26I (red) DJ-1. Lower Log10PF values correspond to backbone amide hydrogen atoms 
that exchange more readily with solvent deuterons. (B) Log10PF values from (A) have 
been mapped onto the structure of wild-type (WT, left) and M26I (right) DJ-1 dimer. All 
residues for which a Log10PF could not be assigned are shown in grey. M26I DJ-1 is 
more dynamic than WT DJ-1, particularly in the hydrophobic core of the protein. (C) 
Difference Log10PF (M26I Log10PF – WT Log10PF) mapped on to the dimer of M26I DJ-
1. Red indicates areas that are more dynamic for M26I DJ-1, while green indicates areas 
that are more dynamic for WT DJ-1. Areas that are similar between the two proteins are 
grey. The enhanced exposure of the hydrophobic core of M26I DJ-1 to solvent is evident.  
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Figure 6: Example fitting for HDX curves of select residues in WT and M26I DJ-1. 
(A, C) Fitted decay curves for ten amino acids in wild-type (WT) and M26I DJ-1 HDX, 
spanning a range of different log10PF values. (B, D) Expanded view of the boxed region 
in (A) and (C), respectively. For WT HDX, Leu185 (open squares) the data could not be 
adequately fitted due to chemical exchange (see L185 in (A)). 
 
7.3.3 Thiol cross-linking and proteolysis indicate that M26I DJ-1 is more flexible than 
wild-type DJ-1 at 37°C 
We have recently described the use of thiol cross-linking to probe DJ-1 flexibility.
24
 DJ-1 
contains three free thiols per monomer, only one of which (Cys53) is highly solvent 
accessible (Figure 9a). Cys53 is ~3.5 Å from its symmetry mate in the DJ-1 dimer. 
Consequently the Cys53 pair is readily cross-linked, while the other cysteines (Cys106 
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and Cys46) are not. However, conformational fluctuations in DJ-1 can transiently 
expose the other cysteines and make them available for reaction, increasing the number 
of cross-linked DJ-1 species that can be observed in SDS-PAGE.
24
 Therefore, thiol cross-
linking is a sensitive probe of large-scale conformational plasticity in DJ-1. 
  
Figure 7: Tryptophan mutations have modest effects on secondary structure and 
thermal stability of DJ-1 at 37°C. (A) Circular dichroism (CD) spectra were collected at 
37°C for wild-type (WT) (black), M26I (blue), L101W (green), M26I/L101W (magenta), 
Y141W (orange), and M26I/Y141W DJ-1 (purple). These proteins show no significant 
differences in the mean residue molar ellipicity ([]) as a function of wavelength, 
indicating that the Trp mutations are not highly disruptive to DJ-1 structure. (B) Thermal 
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stability for all proteins in (A) was determined by the thermofluor assay. Consistent 
with the CD spectroscopy data (A), only minor changes are observed. The melting 
temperature (°C) is plotted for all proteins (n=5, plotted as avg  SD.) 
 
Figure 8: Tryptophan fluorescence emission spectra reveal site-specific differences 
in M26I DJ-1 solvent exposure. Tryptophan emission spectra for L101W (), 
M26I/L101W (), Y141W (), and M26I/Y141W () obtained at 37°C. The M26I 
mutation results in quenching of L101W DJ-1 fluorescence, indicating Trp101 is more 
solvent exposed in M26I DJ-1. Leu101 is in a dynamic area of DJ-1 that is sensitive to 
the M26I substitution in HDX (Log10PF WTL101=4.35, Log10PF M26IL101=1.75.) In 
contrast, no differences are observed in the spectra for Y141W and M26I/Y141W DJ-1. 
Tyr141 is in a dynamic region of DJ-1 that is not sensitive to the M26I mutation 
(Log10PF WTY141=2.09, Log10PF M26IY141=2.08.)  
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Figure 9: Thiol cross-linking and limited proteolysis show that M26I DJ-1 is more 
dynamic than wild-type DJ-1 at physiological temperature. (A) Left: Cysteine cross-
linking with BMOE for wild-type (WT), and M26I DJ-1 at 22 and 37C resolved by 
SDS-PAGE. M26I DJ-1 forms a faster migrating, more extensively cross-linked dimeric 
species at 37°C that is absent at 22 °C and for WT DJ-1. Monomer and dimer DJ-1 bands 
are indicated. Right: Location of all six cysteine residues on dimeric DJ-1. (B) Limited 
proteolysis time course with trypsin for wild-type (WT) and M26I DJ-1 at 37C. M26I 
DJ-1 is more vulnerable to proteolysis, which is apparent by comparing the 8 and 22.5 hr 
lanes. 
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DJ-1 was cross-linked using the homobifunctional thiol cross-linker BMOE both at 
21C and at 37C. In SDS-PAGE, a dominant dimer band at ~50 kDa is observed for 
both wild-type and M26I DJ-1 at both temperatures (Figure 9a). However, M26I DJ-1 
also exists as a faster-migrating dimeric cross-linked species (~37 kDa) at 37C that is 
not observed at 21C and is never observed in wild-type DJ-1 (Figure 9a). This faster 
migrating species is likely a multiply cross-linked dimer. Therefore, increased flexibility 
of M26I DJ-1 allows it to transiently sample conformations at 37C that expose the more 
buried Cys46 and Cys106 residues, making them available for additional cross-linking. In 
contrast, cross-linking with the amine-reactive DSS (Figure 10) shows little difference 
between wild-type and M26I DJ-1 at room temperature and at 37C. This is consistent 
with the larger number of DSS-cross-linked species that can be formed between multiple 
solvent-exposed locations. 
Limited proteolysis with trypsin was used to further characterize DJ-1 flexibility on 
longer timescales. An increase in DJ-1 flexibility would be expected to result in more 
extensive digestion by the protease. M26I DJ-1 has an accelerated rate of cleavage by 
trypsin at 37C, with a digestion pattern at 8 hours (Figure 9b) that is comparable to that 
of wild-type protein at 22.5 hrs. In contrast, no loss of either protein was observed at 
22C over the same time-course. This proteolysis result is consistent with the HDX, Trp 
fluorescence, and cross-linking experiments, all of which demonstrate that longer 
timescale dynamics of M26I are enhanced at 37C compared to wild-type DJ-1. 
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Figure 10: Cross-linking behavior of DJ-1 proteins. (A) Primary amine cross-linking 
with DSS for wild-type (WT, left) and M26I (right) DJ-1 resolved by SDS-PAGE. Cross-
linking was performed at 1:20, 1:30, 1:40, and 1:50 (DJ-1:DSS) at both 22 and 37°C. 
Samples in lanes 1 and 2 for both gels are the input and protein + DMSO controls. There 
is no difference in DSS cross-linking between WT and M26I DJ-1 at either temperature. 
(B) BMOE cross-linking for M26L DJ-1 is similar to that of wild-type DJ-1 (Figure 9a.), 
consistent with this mutation being non-disruptive. 
 
7.3.4 M26I DJ-1 is unstable at physiological temperature  
Prior studies reported that M26I DJ-1 is more prone to aggregation in vitro, although a 
structural explanation for this aberrant behavior has been elusive. We monitored the 
aggregation of recombinant M26I in vitro by measuring its scattering of 400 nm light as a 
function of temperature (Figure 11a). Both wild-type and M26I DJ-1 remained soluble 
from 15 to 30C. Aggregation of M26I DJ-1 was apparent at 35°C and exacerbated at 
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37C, with a lag phase of approximately 20 hrs (Figure 11a). In contrast, wild-type 
DJ-1 was not observed to aggregate at these temperatures (Figure 11a). The onset of 
aggregation for M26I at physiological temperature provides an appealing explanation for 
the reduced stability of the protein in cells (grown at 37C)3, 22 and the apparent stability 
of the recombinant protein, which is typically handled at lower temperatures.
16, 17
  
The exposure of DJ-1 to transition metals such as Ni
2+
 and Fe
3+
 has been reported to 
enhance its instability.
39
 As all proteins used in this study were purified by Ni
2+
-NTA 
chromatography, we tested the influence of trace metal contamination by treating the 
samples with a large excess of EDTA followed by dialysis. Consistent with the prior 
report, the chelation and removal of trace metal diminishes M26I DJ-1 aggregation, 
although M26I is still unstable and aggregates at 35-37°C (Figure 11b).  
The crystal structure of M26I DJ-1 shows that the mutation creates both a small cavity 
within the hydrophobic core and a steric conflict with a neighboring Ile31.
16
 The steric 
clash with Ile31 is the most obvious structural change resulting from the M26I mutation, 
but it is minor (0.7 Å displacement). To determine whether the clash at Ile31 in M26I DJ-
1 is responsible for the increase in flexibility that drives aggregation of the protein, we 
created both the M26L and M26V mutations (Figure 12, Table 1). The M26L substitution 
eliminates the β-branched sidechain at position 26 and alleviates the clash with Ile31.16 
Many close homologues of DJ-1 natively have a Leu at position 26, indicating that this 
substitution is well-tolerated and preserves DJ-1 function. M26L DJ-1 does not aggregate 
at 37C (Figure 11) and is less dynamic as determined by thiol crosslinking (Figure 10). 
This demonstrates the importance of the steric conflict between I26 and Ile31 that leads 
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to M26I DJ-1 instability. The destabilizing effect of β-branched sidechains at residue 
26 was confirmed by the extensive aggregation observed for the M26V mutant at 35-
37°C (Figure 11), which, like M26I, places a hydrophobic -branched amino acid at this 
position. The crystal structure of M26V DJ-1 shows that the mutation is highly 
conservative, with a C-RMSD of 0.14 Å with M26I DJ-1 (Figure 12). The most 
significant structural change is the displacement of Ile31 resulting from a clash with the 
C1 atom of Val26, similar to M26I DJ-1 (Figure 12).  
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Figure 11: M26I DJ-1 is aggregation-prone at physiological temperature in vitro. 
(A) Aggregation of wild-type (WT), M26I, M26L, and M26V at 30, 35, and 37°C. There 
is no observable aggregation for wild-type and M26L DJ-1 at any of these temperatures 
(baseline). In contrast, M26I and M26V DJ-1 aggregate extensively at 35 and 37°C 
(labeled). (B) Aggregation was performed as in (A), but the samples were treated with 10 
mM EDTA and dialyzed to remove any trace metal contamination from the proteins 
before the start of the experiment. M26I and M26V DJ-1 still aggregate at 35 and 37°C 
(labeled), although to a lesser extent than in (A.) (A-B) All samples are in triplicate 
(plotted as avg  SD.) 
 
 
Figure 12: The M26I and M26V mutations cause similar steric conflicts with Ile31. 
(A, B) The local environment surrounding residue 26 are shown for wild-type (dark grey), 
M26L (blue), and either M26I (red) (A) or M26V (gold) (B). Ile31 and residue 26 are 
labeled. 
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7.4 Discussion 
This study demonstrates that the structurally conservative parkinsonian M26I mutation in 
DJ-1 causes an increase in slow protein conformational dynamics near physiological 
temperature that destabilizes the protein. M26I DJ-1 provides an attractive system in 
which to explore the connection between protein dynamics and disease, as X-ray 
crystallography and NMR spectroscopy both indicate a high structural similarity between 
M26I DJ-1 and the wild-type protein despite being a disease-causing mutation.
16, 17
 
Therefore, the observed dynamical changes in M26I DJ-1 are not confounded by large 
structural changes in the protein. Consistent with the structurally conservative character 
of the mutation, M26I does not alter fast timescale (ps-ns) backbone dynamics. However, 
this parkinsonian mutation does enhance slower motions detected by HDX as well as by 
tryptophan fluorescence, chemical cross-linking, and limited proteolysis. These slower 
motions destabilize M26I DJ-1 and, ultimately, cause parkinsonism. 
Considered together, our data suggest a model involving a slow transient opening of the 
M26I DJ-1 dimer that increases solvent exposure of its hydrophobic core, especially near 
physiological temperature. Difference log10PF values for HDX show a more exchange-
active core in M26I DJ-1, and greater H/D exchange at the edges of the central β-sheet 
(Figure 5c) are consistent with “fraying” of this central sheet at its edges. Some prior 
studies have reported modestly reduced secondary structural content for M26I DJ-1,
17, 19
 
which would be consistent with a transient loss of interstrand hydrogen bonds in these 
regions. Supporting this interpretation, the Trp fluorescence and thiol cross-linking data 
both suggest that largely buried regions of the structure become more solvent-exposed in 
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M26I at 37°C. In particular, the appearance of a distinct BMOE-cross-linked dimer 
species for M26I at 37°C that is not observed at lower temperature or in the wild-type 
protein indicates that increased solvent exposure of buried portions of M26I DJ-1 is a 
temperature-dependent phenomenon.  
The exposure of hydrophobic areas of DJ-1 near physiological temperature is the likely 
cause of the enhanced aggregation that we and others have observed in M26I DJ-1. We 
find that mutant DJ-1 aggregation is only apparent (over the 60 hour timescale) at 35-
37°C, indicating that M26I acts as a temperature-sensitive loss of stability mutant. In 
addition, M26I DJ-1 aggregation is distinct from thermal denaturation, as the melting 
temperature for M26I DJ-1 has been measured to be 52-63°C using various techniques.
16, 
17, 19, 54
 It is important to emphasize that DJ-1 aggregation in vitro would likely manifest 
as protein degradation in vivo, and thus would account for the reduced level of M26I DJ-
1 observed in cells grown at 37°C. The strong coupling between elevated temperature and 
M26I DJ-1 instability suggests that the greater flexibility of M26I mutant “softens” DJ-1 
and leads to loss of stability at physiological temperature where the wild-type protein is 
still stable and functional. Attractively, the onset of dynamically-driven instability in 
M26I DJ-1 at physiological temperature resolved conflicting reports of this mutant’s 
stability in cells (at 37°C) and in vitro (at room temperature). 
The dynamical changes in DJ-1 resulting from the M26I mutation are initiated by the 
steric conflict between Ile26 and Ile31
16
 that causes a ~0.7 Å displacement of Ile31 in 
M26I DJ-1. This clash is relieved by the engineered M26L mutant, which also abrogates 
protein aggregation, indicating that the Ile26-Ile31 clash is an important contributor to 
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DJ-1 destabilization.
16, 55
 The damaging effects of -branched amino acids at residue 
26 in DJ-1 is confirmed by the M26V mutation, which restores this clash and 
consequently causes aggressive aggregation of the protein. Our data indicates that the 
minor, local structural change caused by the introduction of a -branched amino acid at 
residue 26 causes large-scale, global changes in DJ-1 slow conformational dynamics that 
result in protein instability. We also note that trace transition metals in the DJ-1 purified 
in this work seem to enhance aggregation, consistent with a prior finding.
39
 This is 
intriguing, as iron (another transition metal) levels are elevated in parkinsonian nigral 
tissue 
56
 and may influence DJ-1 stability. The basis of this effect is a direction for future 
work. 
M26I DJ-1 is a rare case where principally dynamical, rather than structural, changes in a 
protein can be directly connected with instability and disease. However, other examples 
where protein dynamics have been connected to pathological dysfunction include the 
deletion of a single amino acid (F508) in the Cystic fibrosis transmembrane conductance 
regulator (CFTR) protein, which causes areas of inherent disorder and flexibility resulting 
in disease.
57, 58
 An additional example is copper-zinc superoxide dismutase (Cu-Zn SOD), 
where mutations associated with heritable forms of amylotropic lateral sclerosis (ALS) 
cause changes in protein dynamics.
59
 DJ-1, which is an easily handled protein amenable 
to multiple biophysical approaches, makes an attractive model system in which to further 
explore the connection between disturbed protein dynamics and disease. We propose the 
aberrant protein dynamics may be a more common contributor to disease than currently 
appreciated. 
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More generally, our results indicate that routine in vitro characterization of proteins 
lower than physiological temperature provides an inaccurate view of their behavior. This 
has been well established in the extreme case of X-ray crystallography of cryo-cooled 
samples, where proteins are characterized at ~-170°C. In these cases, significant 
alterations to the degree and correlation of sidechain disorder that effect functionally 
relevant dynamics has been described.
60
 The present study indicates that even a modest 
~15°C difference between room temperature and physiological temperature (for humans) 
is enough to conceal important aspects of protein conformational behavior. As the 
characterization of protein dynamics becomes more widespread and routine, these results 
indicate that samples should be studied at their physiologically relevant temperatures 
wherever possible. 
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Chapter 8 
15
N CEST Data and Traditional Model-Free Analysis Capture Fast 
Internal Dynamics of DJ-1 
8.1 Introduction 
NMR spectroscopy is a powerful tool for the study of protein structures and dynamics in 
the solution state. Over the years, many NMR methods have been developed to observe 
protein dynamics for a range of timescales.
1
 In which, fast timescale dynamics have been 
traditionally studied using 
1
H-
15
N HSQC R1, R2, and heteronuclear NOE experiments 
with the Carr-Purcell-Meiboom-Gill (CPMG) relaxation dispersion approach.
2
 The T1, T2 
and NOE data obtained from these experiments are routinely used to characterize sub-
nano to millisecond protein dynamics with modelfree formalism.
3, 4
 The CPMG approach 
has also been extended to the study of conformational exchange due to its sensitivity to 
chemical shift differences between ground and excited states.
5
 However, CPMG 
relaxation dispersion fails for proteins undergoing slow conformational exchange or for 
lowly populated excited states.
6
 
Recent advances employing saturation transfer, such as chemical exchange saturation 
transfer (CEST) and dark-state exchange saturation transfer (DEST), have enabled the 
detection of these previously invisible protein states.
6, 7
 Several studies have already 
reported the use of CEST to study the invisible conformers of slowly exchanging proteins 
on the millisecond to second timescale.
8-12
 Additionally, the fitting of CEST profiles have 
been shown to reliably extract R1 and R2 parameters that can be used for modelfree 
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analysis of fast timescale dynamics (ps to ns). Thus, the simultaneous measurement of 
both fast and slow timescale dynamics is possible with the CEST experiment. The 
extraction of the R1 and R2 parameters is particularly advantageous due to the fact that 
CEST and CPMG experiments can be acquired in a similar amount of experimental 
time.
12
 To date, however, no study has combined CEST-derived R1 and R2 parameters 
with 
1
H-
15
N NOE data to establish the picosecond to nanosecond dynamics of a protein. 
Instead, leaner versions of modelfree have been applied without the NOE data.
9
 
The NOE is a sensitive measure of the high frequency motions as it reports directly on 
the structure of the protein and is strongly associated with its correlation time ( c).
13
 
Therefore, the heteronuclear NOE experiment has been essential to traditional dynamics 
analyses in conjunction with R1 and R2 values. The importance of the NOE is 
strengthened by the fact that, at the expense of precise R1 measurements, only precise 
NOE and R2 values are necessary to calculate a reliable S
2
.
14
 Additionally, the NOE is 
more sensitive than the R1 parameter for capturing internal dynamics.
10
 The significance 
of the NOE to the understanding of fast protein dynamics is considerable and we present 
further evidence to substantiate the use of NOE data for modelfree analysis using 
15
N-
CEST experiments. 
 
8.2 Material and Methods 
NMR was used to investigate the dynamics of three DJ-1 oxidation states of Cys106 
corresponding to a reduced form (DJ-1 Cys106-H), a sulfinic acid form (DJ-1 Cys106-
SO2) and a sulfonic acid form (DJ-1 Cys106-SO3). The reduced DJ-1 Cys106 was 
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oxidized to a cysteine sulfinic acid by adding hydrogen peroxide at a molar ratio of 
1:7 and incubating on ice for 45 minutes. Similarly, the Cys106 sulfonic acid was 
prepared by adding hydrogen peroxide at a molar ratio of 1:100 and incubation at room 
temperature for 2.5 hours. Following incubation, the protein was subjected to a buffer 
exchange to remove excess hydrogen peroxide. All NMR experiments were collected at 
37 or 35
o
C on a 700 MHz Bruker Avance III spectrometer equipped with a 5 mm QCI-P 
probe with cryogenically cooled carbon and proton channels. 
15
N CEST experiments 
were performed as previously described
6
 with B1 field strengths of 12.5 and 25 Hz. The 
external field was scanned across the range of 100 to 140 ppm at a step size of 50 Hz 
(35
o
C) or 25 Hz (37
o
C). An interscan delay of 1.5s was employed and 
15
N saturation was 
applied for 0.5s. For each experiment a total of 4 transients were collected per 2D plane 
resulting in a total experiment time of approximately 7 hours. Processing was 
accomplished with NMRPipe
15
 and CEST profiles were fit with ChemEx (Figure 1).
6
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Figure 1. Representative CEST profiles for 3 residues in DJ-1 Cys16-H at 35
o
C. The 
profiles show the proper fitting of the dip in intensity and the lack of a noticeable minor 
state conformation. Residues were chosen based on position in the primary sequence to 
highlight the consistence of the fitting of the profiles. 
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Figure 2. A plot of the CEST derived R1 and R2 parameters for DJ-1 Cys106-H at 35
o
C. 
The cartoon
5
 represents the secondary structure of DJ-1 with helices in red, strands in 
green, and loops and disordered regions in blue. 
 
The fitting of the CEST profiles by ChemEx produces R1 and R2 relaxation parameters as 
standard output and is explained in detail in Vallurupalli et al., JACS (2012).
6
 The R1, R2, 
NOE, and S
2
 errors reported in Tables 1 and 2 were calculated as the standard error of the 
mean. Heteronuclear NOE experiments were performed as previously described
16
 and 
processed in NMRPipe. FAST-ModelFree analysis was done identical to our previous 
study to ensure a proper comparison of the methods.
16
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8.3 Results and Discussion 
The fast protein dynamics of reduced DJ-1 have been previously determined using 
traditional spin relaxation derived R1 and R2 values and 
1
H-
15
N NOE data.
16
 DJ-1 was 
found to be fairly rigid in solution at 35˚C, with most order parameters (S2) approaching 
the maximum theoretical limit (S
2 
= 1). Importantly, the previous dynamics finding from 
these traditional relaxation experiments was reproduced with the R1 and R2 values 
obtained from fitting of 
15
N CEST profiles and from 
1
H-
15
N NOE data (Table 1, Figure 
2). Per residue CEST profiles were reliably fit simultaneously for both external fields, 
although only one field was necessary (Figure 1). Unfortunately, the fitting of the CEST 
profiles did not reveal the presence of a minor state or chemical exchange, but this 
finding did not negatively affect the quality of the derived relaxation parameters. Our 
results further establish the robustness of the 
15
N CEST experiment and justify its 
adoption as an alternative to traditional relaxation experiments. The observed consistency 
between two distinct sets of R1, R2 and S
2
 values substantiates previous claims that CEST 
data is equivalent to traditional spin relaxation experiments.
9
 The calculated RMSDs 
values (Table 3) comparing the CEST and traditional R1 and R2 values are within the 
observed standard deviations for the data sets (Tables 1 and 2). An NOE RMSD of 0.13 
was obtained when we compared our original 
1
H-
15
N NOE data
16
 with an NOE data set 
recollected with the CEST experiments. Again, the NOE RMSD is within the observed 
experimental error and standard deviations (Tables 1 and 2).  
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Table 1. Average R1, R2, NOE, and S
2 
values from DJ-1 Cys106-H at 35
o
C. 
Exp. Type Protein Observed 
R1
 a 
R1 
Errorb 
Observed 
R2
 a 
R2 
Errorb 
Observed 
NOEa 
NOE 
Errorb 
Calculated 
S2a 
S2 
Error
b 
Traditional 
(35oC) 
DJ-1, 
Cys106-
H 
0.78 
(0.10) 
0.06 19.30 
(2.30) 
0.7 0.79 
(0.11) 
0.15 0.92  
(0.10) 
0.02 
CEST 
(35oC) 
DJ-1, 
Cys106-
H 
0.72 
(0.21) 
0.06 19.33 
(3.50) 
2.1 0.79 
(0.15) 
0.11 0.88 
(0.12) 
0.07 
a
Standard deviations are in parenthesis. 
b
The reported errors are the standard error of the mean. 
 
Table 2. Average R1, R2, NOE, and S
2 
values from different physiological states of 
DJ-1. 
Exp. 
Type 
Protein Observed 
R1
 a 
R1 
Errorb 
Observed 
R2
 a 
R2 
Errorb 
Observed 
NOE a 
NOE 
Error 
Calculated 
S2a 
S2 
Errorb 
CEST 
(37oC) 
DJ-1, 
Cys106-H 
0.72 
(0.22) 
0.06 19.50 
(3.46) 
2.1 0.79 
(0.16) 
0.11 0.86 (0.15) 0.07 
 DJ-1, 
Cys106-
SO2 
0.78 
(0.13) 
0.08 20.65 
(2.66) 
1.3 0.80 
(0.16) 
0.14 0.92 (0.13) 0.04 
 DJ-1, 
Cys106-
SO3 
0.71 
(0.21) 
0.06 18.47 
(4.96) 
1.0 0.64 
(0.42) 
0.10 0.76 (0.22) 0.04 
a
Standard deviations are in parenthesis. 
b
The reported errors are the standard error of the mean.  
 
 
Table 3. RMSD values comparing traditionally collected and CEST datasets  
for DJ-1 Cys106-H at 35
o
C. 
 
R1 R2 S
2
 
Traditional vs 
CEST 
0.18 1.95 0.02 
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Figure 3. A delta plot of the R1, R2, and generalized order parameters comparing 
traditionally collected data versus CEST derived data for DJ-1 Cys106-H at 35
o
C. The 
cartoon
5
 represents the secondary structure of DJ-1 with helices in red, strands in green, 
and loops and disordered regions in blue. 
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The per residue delta plots of the R1, R2 and S
2
 values shown in Figure 3 further 
illustrates the consistency between the two methods. The low variability in the R2 delta 
plot indicates that the CEST profile linewidths were robust in the reporting of the true R2 
values and that there was an absence of chemical exchange. Only a slight overall 
difference of the methods was observed based on an S
2
 RMSD of 0.02. This is despite the 
fact that the prior dynamics measurements were carried out on different NMR 
spectrometers at different field strengths (i.e., 500 MHz vs. 700 MHz). The largest 
variations in the observed ΔS2 values were primarily located in loop regions, which are 
expected to be more sensitive to subtle temperature and solvent differences. A few 
residues with large ΔS2 were removed from the comparison since the ΔS2 error was likely 
a result of peak overlap and not representative of the overall quality of the CEST data. It 
is again important to note that these datasets were collected several years apart on 
different protein samples, on different spectrometers, and by different spectroscopists. 
Therefore, although the reproducibility between the two datasets is not on par with prior 
results,
9
 our comparison does represent a more realistic scenario and a more accurate 
representation of the true uncertainty. Importantly, the final results of the modelfree 
analyses from both the CEST and CPMG datasets led to the same conclusions regarding 
the overall dynamic properties of DJ-1. 
Leveraging the 
15
N-CEST experiment, several naturally occurring oxidation states of DJ-
1 were studied (Cys106-H, -SO2, -SO3) to identify if there were any differences in their 
dynamic properties. At physiological temperature (37
o
C), none of the three forms of DJ-1 
exhibited a minor state conformer based on analysis of the CEST profiles. The CEST-
derived R1 and R2 parameters for each of the DJ-1 states were further analyzed to identify 
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any ps-ns timescale dynamics that may differ between the three states. Interestingly, 
there were only minor differences in the R1 and R2 relaxation parameters between the 
three states in addition to being comparable to our previous results (Tables 1 and 2). 
1
H-
15
N NOE experiments were subsequently performed to further explore the dynamic 
properties of the three DJ-1 states. A drastic change was readily apparent in DJ-1 
Cys106-SO3, where the average NOE is lower, and the NOE standard deviation is much 
larger compared to the two other DJ-1 states (Table 2). The CEST derived R1 and R2 
parameters and the heteronuclear NOE values were then used with FAST-ModelFree
17-19
 
to determine the per residue order parameters. The dynamic properties for the first two 
DJ-1 states are quite similar to our previously published results for the reduced form of 
DJ-1, where the protein exhibits minimal motion on the ps-ns time scale. Conversely, DJ-
1 Cys106-SO3 exhibits a significant increase in dynamics based on an overall lower S
2
 
value of 0.76 ± 0.22. Importantly, it appears that the main contributor to the increase in 
dynamics for DJ-1 Cys106-SO3 is a reduction in the average NOE from approximately 
0.80 to 0.64 ± 0.42. Further, it is well known that NOE data is essential for the accurate 
analysis of protein dynamics since the NOE is very sensitive to fast internal dynamics 
(e.g., e), as previously defined in Kay et al. (1989).
10
 In addition, the large standard 
deviation in the NOEs for DJ-1 Cys106-SO3 is also indicative of a substantial decrease in 
structural stability. This is consistent with the observation that DJ-1 Cys106-SO3 was less 
stable than the other two forms of the protein. DJ-1 Cys106-SO3 would aggregate and 
precipitate out of solution after approximately two days at 37
o
C.  Conversely, the reduced 
and sulfinic forms of DJ-1 were indefinitely stable. 
To gain insight on the impact of the NOEs on the per residue order parameters, the NOE 
  
299 
data from DJ-1 Cys106-SO3 was combined with the R1 and R2 data from DJ-1 
Cys106-SO2. DJ-1 Cys106-SO2 is arguably the most rigid form of DJ-1 since it has the 
highest average order parameter of 0.92 ± 0.13. Moreover, DJ-1 Cys106-SO2 has the 
lowest R1 and R2 standard deviations of 0.13 and 2.66, respectively. Any changes in the 
order parameters calculated by combining the DJ-1 Cys106-SO2 R1 and R2 data with the 
DJ-1 Cys106-SO3 NOE data will highlight the impact of the more dynamic NOEs on the 
calculated order parameters. Figure 4 shows the ΔS2 obtained from comparing the DJ-1 
Cys106-H and Cys106-SO3 NOE data. It is readily apparent that the more dynamic NOEs 
contribute significantly to the per residue order parameters as approximately 10 residues 
order parameters decreased by -0.25 or more. These differences are noteworthy because 
they may change the classification of a residue from “ordered” to “disordered”. 
Interestingly, a majority of the ΔS2 values are near zero, which indicates essentially 
identical dynamics between the two states. Not surprisingly, only the residues with a 
significant difference in NOE values were substantially affected. It is likely that these DJ-
1 residues in the Cys106-SO3 form have sub-ns internal motions, which make them 
sensitive to the 
1
H-
15
N NOE experiment. These findings are significant because exclusion 
of any NOE data would have hidden the true dynamics of these particular DJ-1 residues. 
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Figure 4. A delta plot of the generalized order parameters comparing DJ-1 Cys106-H and 
DJ-1 Cys106-SO3 NOE data. Data points below zero indicate an increase in internal 
motion due to the DJ-1 Cys106-SO3 NOE value. 
 
8.4 Conclusion 
The purpose of this study was to further evaluate the robustness of the 
15
N CEST 
experiments as an alternative method to determine the fast protein dynamics of three 
physiological states of DJ-1 while combining CEST derived R1 and R2 parameters with 
traditional NOE values. Initial results confirmed that this new method was comparable to 
traditional dynamics analyses as our results correspond well with previous findings. We 
have also reaffirmed the importance of the heteronuclear NOE to a dynamics analysis. 
Extremely low NOE values are strong indicators of protein disorder or unfolding and, in 
this study, were the only experimental evidence for this phenomenon in DJ-1 since the R1 
and R2 parameters were similar for the three DJ-1 states. To our knowledge, this is the 
first study that combines 
15
N CEST data with a traditional model-free analysis of a 
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biological system and also confirms the necessity of NOE data for exploring fast 
protein dynamics. 
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Chapter 9 
Summary and Future Directions 
9.1 Summary 
This dissertation has covered a wide variety of research projects revolving around the 
sequence, structure, function, and dynamics of proteins. Using both conventional and 
novel biophysical and bioinformatics approaches, we have made important contributions 
in the expansive field of structural biology. Structures for therapeutic and putative protein 
targets have been elucidated and advancements in evolutionary analysis have been 
discovered. Furthermore, we have reaffirmed the crucial role of NMR in the study of 
proteins. NMR has and will continue to be a significant instrument for probing proteins in 
environments closest to their most natural and physiological state.  
Beginning with Chapter 2, a novel approach to the evolutionary analysis of distant 
proteins was introduced. By simply using comparisons of active site structures we 
quickly and efficiently mapped the functional evolution of proteins regardless of their 
sequence or structure similarity. This method was first proven on the pyridoxal 5’-
phosphate (PLP) enzyme family, which began their divergence in the last common 
ancestor. Altogether, the PLP family has approximately 10% sequence identity within 
four structurally independent fold-types. Thus, conventional sequence based studies for 
the evolutionary analyses of this family have been narrowly focused on small subsets of 
functionally similar PLP enzymes. The application of CPASS, however, enabled the 
entirety of the family to be studied simultaneously and presented on a single phylogenetic 
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network. Within the generated network was a perfect clustering of the enzymes by 
fold-type, enzymatic function, and organism classification. Our bioinformatics 
investigation of the functional evolution of PLP-enzymes represents the first time ever 
that a single phylogentic tree was constructed that contained the four PLP fold-types. 
Consequently, our phylogentic tree captures the step-wise evolution of function for the 
entire PLP enzyme family.   
The success of the PLP active site evolutionary study led to a similar but greatly 
expanded project aimed at all of the ligand-bound proteins in the PDB. Approximately 
40,000 unique active sites exist in the PDB, which is significantly larger than the PLP set 
used previously (~200). To reduce the overall size of the data and improve visualization 
of the end results, the unique active sites were first grouped according to the identity of 
the bound ligand. A statistical tool known as Principal Component Analysis (PCA) was 
applied to each ligand defined group to identify a representative structure. This proved to 
be an effective approach to reducing the number of active sites to 10% of the total 
(~4000) while maintaining essential information since a representative structure was 
easily identified from the PCA scores plot for each ligand defined group. The resulting 
phylogenetic tree based on a CPASS similarity scoring matrix for the 4000 representative 
ligand binding sites resulted in a near-perfect functional clustering of the active sites 
based on EC function.  Importantly, the phylogenetic tree enables the functional 
evolution at the residue level to be visualized for the entirety of protein functions present 
in the RCSB PDB. This is a major achievement and advancement in our understanding of 
the evolution of protein function since it represents the first time the entire RCSB PDB 
has been functionally mapped according to active site structure similarity. 
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Obtaining a protein structure is fundamental to our understanding of the biological 
function of a protein; and its possible role in human disease; and as a either a therapeutic 
target or a new therapy. Accordingly NMR was used to investigate the structure of the 
Citropin 1.1 peptide and its analogs, which are potential novel antimicrobial therapies; 
the structure and dynamics of the S. aureus protein primase CTD, which is a potential 
novel therapeutic target for the development of next generation antibiotics; the dynamics 
of the human protein DJ-1 and its mutants, which is an important therapeutic target for 
Parkinson’s disease; and the structure and potential function for the functionally 
uncharacterized R. palustris protein RPA3313. The NMR structures of the Citropin 1.1 
peptide and its analogs were presented in Chapter 4. We found that the cationic residues 
at the N-terminus of the peptide formed essential hydrogen bonds and electrostatic 
interactions that synergistically worked to promote antimicrobial activity. Importantly, 
our structural analysis of the Citropin 1.1 peptides clearly demonstrated that the peptides 
adopt a single helical structure and forms a head to tail dimer in the presence of 
membrane-mimic. Thus, our results correct a mistake propagated in the literature that 
Citropin 1.1 peptides are a monomer composed of two separate helical regions. 
Moreover, we discovered an equilibrium between disordered monomer and helical dimer 
structures that was directly correlated with antimicrobial activity. Fluorescence and 
microscopy experiments indicated that the peptides mechanism of action involved 
disrupting the bacterial membrane through a “carpet model”. Our results identified 
sequence and structural features of the Citropin 1.1 peptide that are critical for 
antimicrobial activity. Furthermore, our results provide support for the peptides’ 
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mechanism of antimicrobial activity. This information is essential to evolve the 
Citropin 1.1 peptide into a drug-like candidate and to develop a new antibiotic.    
Chapters 5 and 6 presented the NMR structure determination of the R. palustris RPA3313 
protein and the S. aureus primase C-terminal domain (SaP-CTD), respectively. In both 
instances, the NMR solution structures provided critical evidence to possible protein 
function, protein-protein interaction sites, and putative ligand binding sites. RPA3313 
was observed to adopt a novel fold and was found to interact with the ribosome in R. 
palustris. Thus, the RPA3313 NMR structure extended our knowledge of protein 
conformational space through the identification of a new protein fold. Significantly, the 
RPA3313 structure can be extended to homologs of RPA3313, since the protein family 
was structurally uncharacterized prior to our study. While the structure of RPA3313 was 
used to infer a potential function, the NMR solution structure of SaP-CTD was used to 
identify potential ligands and ligand binding sites. This information is essentially to 
assessing the potential therapeutic utility of SaP-CTD as a drug discovery target. The 
NMR structure for SaP-CTD indicates that the protein is composed of two subdomains. 
Importantly, the relative orientations of the two subdomains (open or closed 
conformation) are correlated with helicase binding. SaP-CTD adopts the closed 
conformation, which does not bind helicase.  NMR dynamics experiments indicated that 
the two subdomains of SaP-CTD moved independently of one another with a binding site 
located between the two subdomains. An in silico virtual screen and subsequent NMR 
titration experiment found significant binders which could stabilize the two subdomains 
in the closed conformation and prevent proper protein function. In essence, our structural 
and dynamics analysis of SaP-CTD identified a potential novel ligand binding site, a set 
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of potential ligands and, importantly, a potential novel mechanism of inhibiting the 
primase and helicase interaction by capitalizing on the dynamic properties of primase. 
The relative flexibility between the two SaP-CTD subdomains allows the protein to 
readily adopt the open conformation and bind primase. Conversely, a ligand that binds 
between the two subdomains and locks the protein in the closed conformation may be a 
valuable antibiotic. In both projects, the NMR determined structures proved to be 
essential to the understanding of the proteins’ biological functions and therapeutic utility. 
The importance of NMR to the study protein dynamics was further demonstrated in our 
analysis of DJ-1 presented in Chapters 7 and 8. Human protein DJ-1 is a ubiquitously 
expressed homodimer, however, its molecular activity is largely unknown. M26I DJ-1 is 
an inheritable mutant that has been implicated in Parkinson’s disease; and adopts a fold 
structurally identical to the wild-type protein. The “benign” mutation does not alter the 
tertiary structure or disrupt dimer formation, yet it still leads to protein instability and 
disease. NMR relaxation studies revealed that the wild-type and M26I DJ-1 proteins are 
both rigid in solution. A hydrogen-deuterium exchange experiment discovered that the 
hydrophobic core of M26I DJ-1 was transiently exposed to solvent, which enabled it to 
subsequently aggregate, which, in turn, leads to a loss of function, and, presumably, is a 
cause of Parkinson’s disease. Thus, the NMR dynamics has provided an important insight 
into a potential molecular mechanism associated with Parkinson’s disease. This important 
finding further illustrates that changes in dynamics, rather than structure, may also be 
connect to protein instability and the diseased state of the protein.  
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DJ-1 dynamic properties were also investigated as a result of changes in the protein’s 
oxidative state. It was found that over-oxidized DJ-1 was extremely unstable in solution 
and began to unfold and aggregate at physiological temperature. This raised the 
possibility that DJ-1 may be regulated by its oxidation state and may serve as a cellular 
sensor for oxidative stress. Concurrently, improvements in the NMR experimental 
methods for probing protein dynamics were accomplished while investigating the 
dynamics of the oxidative states of DJ-1. Chemical exchange saturation transfer (CEST) 
experiments can be used to visualize the transient, invisible states of proteins in solution. 
Although no invisible state of DJ-1 was found, the fitting of the CEST profiles produced 
relaxation parameters of the fast timescale dynamics that were consistent with our 
previous findings. This observation demonstrated that the dynamics at multiple 
timescales can be studied simultaneously and expand the capabilities of NMR 
spectroscopy. This was particularly important in the case of DJ-1 because the CEST 
experiments were collected significantly faster than the traditional methods that required 
individual set of experiments to measure R1, R2 and NOEs. Rapid data collection was 
critical because different forms of DJ-1 had limited long-term stability.     
 
9.2 Future Directions 
Improvements to CPASS in the future should be aimed at increasing the utility of the 
software toward the functional annotation of proteins as well as increasing its usefulness 
as an evolutionary tool. Each day more active sites are deposited in the PDB, and it will 
become necessary to re-evaluate the active site representative tree. Although it is unlikely 
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that new representative active sites will need to be chosen, it is very likely that new 
functions are added or that improved annotation tools are developed. I firmly believe in 
the tenet, “If its not broken, don’t fix it”. CPASS is proven in its ability to annotate and 
evolutionarily relate active sites. Future efforts should be aimed at increasing the 
portability of the software and expanding its capabilities rather than modifications to the 
scoring function. Merging CPASS with an existing, popular software tool will 
undoubtedly increase its overall use. In parallel, the development of a process or pipeline 
to dock ligands in silico to both known and putative binding sites prior to CPASS 
analysis is necessary. This improvement would not only increase the use of CPASS, but 
could also significantly decrease experimental time in the determination of protein 
function.  
NMR will always maintain a significant role in the field of structural biology. For 
decades NMR has been used to solve the structures of proteins in the solution state. 
Improvements in the hardware and software of spectrometers; as well as in the 
preparation of the samples has significantly expanded the range of proteins that can be 
studied. However, the future of the field involves studying membrane proteins and their 
structures in membrane mimics. Significant development is still required to study 
membrane proteins by NMR. New isotopic labeling schemes, pulse programs, and data 
collection methods will all be needed to study membrane proteins. Although the task 
seems insurmountable, the ability to elucidate the structure of a protein in the solution 
state is valuable, as it closely resembles the physiological state of the protein. 
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NMR is one of the few techniques that are capable of studying the dynamics of 
proteins. Already discussed in this dissertation is the possibility that dynamics may play a 
more significant role in disease than previously considered. That being said, future 
developments are of the utmost importance. The extraction of even more information 
from the data rich NMR spectra will provide key clues into the dynamics of invisible or 
transient conformers. Additionally, it should be possible to collect distance restraints on 
the invisible states by using a paramagnetic ion or spin label in combination with a 
saturation transfer experiment. The distance restraints could then be used to refine the 
invisible state structure, which would be a significant accomplishment. Lastly, these 
structures would provide researchers with a superior target for drug design and 
development.   
